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Thesis summary 
There is a lack of published literature describing resource and support needs of paediatric 
prescribers and pharmacists. In order to understand how to support this group of healthcare 
professionals it is first necessary to identify their current use of resources when prescribing and 
providing pharmacy services in paediatrics. 
The methods used in this thesis were mixed. They included: focus groups with prescribers, self-
completed questionnaires with paediatric pharmacy staff and paediatric prescribers, interviews 
with electronic prescribing leaders and documentary analysis of board meeting minutes from 
paediatric hospitals in England.   
The resource reported to be used most frequently and most useful by both pharmacists and 
prescribers was the British National Formulary for Children. The BNFc was reported to be useful 
due to its current information and ease of use. Pharmacist and prescriber participants reported 
using a wide range of resources suggesting that there is no single resource that meets their 
information needs when working in paediatrics. There was general agreement that the current 
poor availability of some paediatric prescribing information could have an adverse effect on the 
care of patients. Pharmacy staff reported that an electronic medicines management system 
improved the supply of medication to inpatients, but described a need for additional 
development of the system for it to be suitable for all medication supply. Paediatric hospital 
board minutes reported a range of interventions to improve prescribing, but few reported 
outcomes.  
To conclude: this thesis describes the extensive resource needs of both paediatric pharmacists 
and prescribers. The choice of resource is not affected by the status of its accreditation with NICE, 
raising a question of the value of this accreditation process. The lack of collaboration between 
paediatric hospitals regarding strategies used to improve paediatric prescribing is not acceptable 
and may lead to duplication of work or investment in poor support solutions.  
 
Keywords: paediatrics, electronic prescribing, clinical decision support, pharmacy.  
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1. Introduction  
The major research question addressed in this thesis is: what are the current practices of decision 
support for healthcare professionals supplying and prescribing medication for paediatric 
inpatients? Medication errors in paediatric inpatients are reported at all stages of the medication 
supply process; from prescribing to administration. There are numerous published interventions 
demonstrating how to reduce these errors. In order to enable further progress in the reduction of 
medication errors in paediatrics it would be useful to understand what healthcare professionals 
working in the areas of prescribing and supply of medication use to support their work in this 
area. Without an understanding of healthcare professionals’ current use of information sources in 
paediatrics it will be difficult to make an evidence based decision on the appropriate decision 
support to be implemented and/or included in electronic prescribing systems for paediatrics. It is 
also necessary to understand the interventions and support currently provided by paediatric 
hospitals and if they are reported to be successful.  
There have been many studies demonstrating the effectiveness of electronic prescribing in 
reducing medication errors. It is important to note that these are largely single site case studies 
rather than controlled trials. Therefore the strength of the existing evidence is limited.  However, 
not all hospitals that have introduced electronic prescribing have reported the same successes. 
Therefore understanding what the leaders in electronic prescribing and the companies that 
provide this software believe to be the factors critical for success could provide valuable insight 
for hospitals that have yet to implement an electronic prescribing system. There is the potential 
to develop more appropriate solutions to reduce paediatric medication errors if a better 
understanding of resource use and support provided to healthcare professionals is recorded.  
“Clearly articulating the needs of paediatric care providers is critical in the use of 
information technology in paediatrics.” [1] 
The aim of this research programme was to determine current practice regarding healthcare 
professionals’ resource use to support their decision making when prescribing and providing 
pharmacy services to paediatric patients. In addition to determine the current prescribing and 
medication supply support provided by hospitals and companies for paediatric inpatients in 
England.  
Electronic medicines management is designed to replace the paper based systems used by 
pharmacy departments to record patients’ drug histories and make requests for medication 
supplies. There is limited published information on how to implement such a system and the 
benefits and disadvantages of using an electronic medicines management system. This study will 
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enable other hospitals to develop an evidence based plan for the implementation of an electronic 
clinical system.   
Current practice regarding information resource use by paediatric prescribers when prescribing 
for paediatric inpatients is not well understood. It is not known what information resources 
paediatric prescribers use or how often they use them when prescribing for children in hospital. 
Understanding the information needs of paediatric prescribers should provide evidence of the 
type of decision support required in electronic prescribing systems to be used in paediatrics. 
Similarly the current practice regarding information resource use by pharmacists providing 
pharmacy services to paediatric inpatients is also not well understood. This study data will provide 
further evidence of the type of decision support required in an electronic clinical system.  
Paediatric hospitals in England are anecdotally reported to have interventions in place to reduce 
medication errors and improve prescribing practice. By analysing the board minute meetings of 
the independent paediatric hospitals in England this thesis will enable identification of the current 
interventions being used. This will demonstrate the range of interventions being trialled in this 
area and the importance of medication errors and prescribing practice to the highest decision 
making entity in paediatric hospitals. Finally, the reported success of electronic prescribing has 
varied between hospitals. The final part of this research programme has identified the opinions of 
leaders in electronic prescribing and what they believe to be the actions required for successful 
use of electronic prescribing.  
1.1 Literature review 
The literature relevant to this research area is mainly derived from research methods that would 
be described as providing a lower quality of evidence; non-randomised intervention groups and 
case studies. The highest quality of evidence is found in randomised controlled trials as they 
minimise bias within their study design. [2] The quality of evidence determines how certain the 
researcher can be that the effect reported is a true measure. [2] 
Study methods such as case studies provide a lower quality of evidence as sources of bias are not 
minimised and there is not sufficient statistical precision on the effect measured. When a study 
uses a method that does not exclude bias and provides data with low statistical precision the 
result of the study cannot be confirmed as being caused by the intervention implemented. Study 
designs such as case studies may provide data that demonstrates correlation of an intervention 
with a result, but due to the reasons described above this correlation of the result and 
intervention should not be presented as a causative relationship. Therefore cautious 
interpretation of the studies presented in this review is recommended.  
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There have been many interventions trialled to reduce medication errors. The current focus of 
these is electronic prescribing and decision support software. There has been evidence that 
electronic prescribing can reduce medication errors, but there are also reports of difficulties in 
adapting this technology and its decision support for the paediatric market. [3] Paediatric 
prescribing is characterised by the necessity to calculate individual medication doses for each 
patient and often using medication off label or outside of its licensed indications/doses. [4] 
Determining the type and level of decision support to include in a paediatric electronic prescribing 
system is difficult, particularly when current literature describes practices such as ‘alert fatigue’ 
and the number of alerts ignored by prescribers. Alert fatigue occurs when a user is frequently 
presented with information alerts on an electronic system. After using the system for a period of 
time the user is less likely to acknowledge the content of the alert and more likely to continue 
past the alert without reading its contents.  Designing an appropriate decision support system for 
paediatrics is made more challenging by the lack of available information on the current practice 
of prescribers is their choice of information resources to support their decision making. The 
literature summarised in the following sections clearly demonstrates the lack of understanding of 
this area of prescribing practice. This research programme aims to add a substantial contribution 
to knowledge to this area, alongside research focussed on supporting the pharmacy and supply 
services of the medication process in a hospital.  
1.1.1 Paediatric medication errors 
The number of medication errors present in paediatric hospitals is difficult to estimate accurately 
due to the various methods, populations and definitions of medication error employed during 
studies. [5] Therefore it is not possible to present an accurate picture of the current level of 
prescribing errors in paediatric hospital practice. A typical prescribing error definition is:  
“A clinically meaningful prescribing error occurs when, as a result of a prescribing decision 
or prescription writing process, there is an unintentional significant (1) reduction in the 
probability of treatment being timely and effective or (2) increase in the risk of harm when 
compared with generally accepted practice.” [6]  
This definition was developed by a Delphi panel of experts. In a later study a paediatric Delphi 
panel also agreed that this was an acceptable definition for a prescribing error in paediatrics. [7] A 
review on paediatric medication errors published in 2007 reported that 5-27% of medication 
orders for paediatric patients contain an error at some point in the medication process. [8] Dosing 
errors are the most common type of medication error reported in paediatric patients. [5, 9, 10] 
This suggests that paediatric prescribers may require support when prescribing in order to 
minimise the number of errors made during the prescribing process. 
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In England there were approximately 2 million hospital admissions for children (0-14 years) in 
2012/13. [11] Extrapolating figures using the lowest medication error rate from UK studies on 
medication errors (see Table 1) indicates that approximately 3,000 paediatric admissions in 
England may be affected by a medication error each year. This research programme will provide 
information that could help reduce the number of paediatric patients affected by a medication 
error.  
The quality of the UK studies on paediatric medication errors is low as the most commonly used 
study method is a single site case study. One study by Ghaleb et al had a slightly higher quality 
from using a multi-site study method. Each study used a different definition of a medication error, 
with some studies including administration errors and some not. The range of definitions used 
means that it is not possible to directly compare the results of each study and the range of error 
rates reported is wide. The differences in error definition meant that some types of error may 
have been counted in one study but not in another study. For example, in the Ross, Paton and 
Wallace study a prescription that did not include an allergy status would not count as an error, 
but it would have counted as an error in the Bolt et al study.  
Three studies employed a manual method of data collection that was usually conducted by 
pharmacists or nurses. However, the study by Ross, Paton and Wallace relied on self-reported 
medication error reports. The use of self-reporting rather than active data collection may have led 
to a lower error rate being reported due to the reliance on staff reporting errors as part of their 
job rather than the deliberate efforts of the research team.  
The analysis of the errors was usually conducted by a member of pharmacy staff; however, Bolt et 
al used medical staff to conduct the analysis. It is not possible to determine from the published 
papers if using a different healthcare professional to complete the analysis has an effect on their 
likelihood to include a data point as an error or not.  
Without an accurate estimation of the frequency of paediatric prescribing errors it is difficult to 
coordinate and develop an appropriate intervention to reduce them.  
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Table 1: Summary of UK paediatric medication error studies 
 
Year Authors Measure Method Result 
2000 Ross, Paton and 
Wallace. [12]  
Medication 
errors 
Retrospective 
review of 
reports 
0.15% of 
admissions 
2007 Conroy et al. 
[13] 
Medication 
errors 
Pharmacists and 
nurse 
interventions, 
drug chart 
review and 
observation. 
139 
interventions in 
six weeks, 1.2% 
administration 
errors observed 
2010  Ghaleb et al. 
[14] 
Prescribing 
errors 
Prospective drug 
chart review 
13.2% 
2014 Bolt et al. [15] Assessed 
prescribing 
standard vs 
hospital 
standard 
Retrospective 
evaluation of 
drug charts 
13% of drug 
charts contained 
errors 
 
It has often been purported that prescribing errors in children are more likely because prescribing 
for children is more difficult. One of the reasons for this is that there are more calculation steps 
involved. [16] Wong et al found that if fewer calculations were required when writing a 
prescription then there was a lower risk of errors. [5] The lack of commercial formulations 
available for paediatric patients also generates chances for dosing errors through dilutions and 
manipulations of adult formulations before administration. [5]  The difficulty of prescribing for 
children has also been identified by the National Patient Safety Agency (NPSA). The NPSA report 
on patient safety for children and young people stated that paediatric patients are a group where 
safe use of medicines is challenging. [17] 
1.1.2 Reducing paediatric medication errors 
The most frequently published research on reducing paediatric medication errors concerns the 
use of electronic prescribing with or without clinical decision support. [9] Studies have been 
published that demonstrate electronic prescribing can be effective at reducing medication errors 
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with or without clinical decision support. Electronic prescribing can also produce new types of 
errors and there may be difficulties in developing electronic prescribing systems that meet the 
needs of paediatric prescriptions. [18, 19] There is also evidence to support the use of 
interventions that are not information technology focussed. For example, some success at 
reducing paediatric medication errors has been reported through the use of prescriber education, 
clinical pharmacy services and medication dose calculators. [20]  
The quality of this data is low for reasons similar the studies on paediatric medication errors in 
that these studies are also likely to be case studies rather than a higher level of evidence. It is 
important to acknowledge that each study is based at a different hospital with a different patient 
population and will have employed a different clinical system. This range in method and 
population makes comparison of study results challenging. Therefore it is not recommended that 
one relies on the results of a single study to support implementation of a particular clinical system 
or method to reduce paediatric prescribing errors.  
1.1.2.1 Electronic prescribing and clinical decision support in paediatrics 
NHS Connecting for Health has described electronic prescribing as 
“the utilisation of electronic systems to facilitate and enhance the communication of a 
prescription of medicine order, aiding the choice, administration and supply of a medicine 
through knowledge and decision support and providing a robust audit trail for the entire 
medicines use process.” [21] 
The following information is summarised from published research studies that are mainly case 
studies or reviews of multiple case studies. Therefore the quality of evidence is not near the top 
of the hierarchy of evidence. As such the benefits described below should be interpreted with 
caution as the correlation of the intervention and results presented may not be a causative 
relationship. The study methods employed are unlikely to provide a result free from bias and with 
sufficient statistical precision to be a true effect. [2]  
As a simple benefit electronic prescribing can ensure legible and complete prescriptions. [3, 21-
23] Clarity and quality of prescriptions can be ensured by included compulsory fields such as 
frequency and dose. [3, 24]  
There are a wide range of features in electronic prescribing systems that are designed to support 
the decision making of prescribers and those supplying and administering medication (i.e. 
pharmacists and nurses). Electronic prescribing can be used to inform prescribers if the weight for 
the paediatric patient is outside the usual range for a child’s age or if the weight was not current. 
[25] It can be used to force the entry of important information for patient safety; for example, 
confirmation of allergy status. [26] Access to up to date prescribing information  to support 
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prescribers and pharmacists can be provided in electronic prescribing systems via links to 
summaries of product characteristics, websites or local information. [26] The data from electronic 
prescribing systems can be used for a range of purposes. It can be used to monitor quality, 
facilitate audits and observe prescribing practice. [27] In addition, electronic prescribing can help 
those administering medication to reduce the number of missed doses. [22] Finally it can also 
improve compliance with formularies. [3, 23]  
Electronic prescribing can reduce prescribing errors in paediatrics with or without the inclusion of 
clinical decision support. [22, 25, 28-35] This reduction was observed in a range of specialties 
ranging from the paediatric intensive care unit to a renal outpatient clinic. One article also 
reported a reduction in mortality in a USA children’s hospital after the introduction of electronic 
prescribing. [36]  
Electronic prescribing can contribute to improved patient outcomes through the use of clinical 
decision support. [26] Clinical decision support provides advice and guidance to support 
prescribers and pharmacists when they are making medicines related decisions. It can be 
provided actively requiring the prescriber to respond to information alerts or passively where the 
prescriber is not required to respond to the information or is invisibly guided towards the correct 
medication choice, for example by making the recommended treatments the easiest to prescribe 
in an electronic system. In order to ensure a successful clinical decision support system four 
factors have been identified that are essential for success. These are: automatic provision of 
decision support; provision of advice rather than assessments; provision of decision support at 
the time and location of decision making; and computerised decision support. [37] 
The varying anatomy and physiology of paediatric patients combined with off label and 
unlicensed use of medicines in this population can make design of paediatric decision support 
challenging. [4] With the addition of weight based medication calculations for individual patients; 
a meticulous approach is required when designing paediatric clinical decision support systems. [9, 
38] An existing system designed for use in adult patients may need a paediatric drug dictionary 
writing before it is suitable for use in the paediatric setting. This can be difficult and time 
consuming. [39]  
There have been two relevant Cochrane systematic reviews concerning clinical decision support in 
paediatrics. The first Cochrane review on on-screen computer reminders concluded: 
“Further research must identify design features and contextual factors consistently 
associated with larger improvements in provider behaviour if computer reminders are to 
succeed on more than a trial and error basis.” [40] 
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The second Cochrane review concluded that there is not enough evidence to assess the 
effectiveness of clinical decision support in neonatal care, and the related benefits or harm cannot 
be determined. [41] 
1.1.2.2 Features of clinical decision support systems 
There are a range of alerts utilised in clinical decision support systems. Duplication alerts inform 
the prescriber when there is more than one of the same medicine is prescribed. This could 
prevent the patient receiving unsafe duplications of medication. This can be challenging if the 
clinical system does not have the functionality to prescribe different doses at different times of 
the day or if it cannot distinguish between the same medicine prescribed as two different 
formulations. [4, 33] Allergy alerts inform the prescriber if they have selected a medication that 
the patient has a recorded allergy to. Allergy alerts were the most frequently overridden alert 
type in one study. [42] This suggests that the information that triggered the alert was either 
incorrect or not clinically relevant. Maintaining an accurate allergy status on the patient record 
should increase the relevance of allergy alerts. Interaction alerts inform the prescriber when they 
have selected a medication that interacts with the patient’s current medication or condition. For 
example, this type of alert could be used to inform prescribers if a medication may worsen a 
condition such as myasthenia gravis.  
Dosing calculators provide an appropriate dose based on the patient information recorded and 
the drug dictionary embedded in the clinical decision support system. Dosing calculators have 
been shown to reduce errors in calculations of paediatric doses. [43-45] However, adding weight 
based doses and dosing limits for all medication can demand a large amount of time and money, 
with further costs incurred for checking the information. [26] Dose rounding is used to ensure the 
prescriber prescribes a dose that is measurable and suitable for administration. For example, if a 
dose was calculated to be 5.9mL dose rounding might recommend a dose of 6mL to ensure the 
administration of the drug was practical for the nurse.  
Patient test results or observation alerts can inform the prescriber when a patient factor has 
changed that could mean a prescription needs reviewing. For example, the display of relevant 
laboratory results for medication that relies on certain drug plasma levels or good renal function. 
[26] Adverse events may be more easily detected by using an alert to inform prescribers that a 
patient’s International Normalised Ratio (a measure of the clotting ability of the blood and an 
indirect measure of the effect of an anticoagulant - INR) is above a certain level. [46] Patient 
observations can also be used to guide treatment choice. For example, an acute respiratory 
infection in children template provided recommendations for management and led to a reduction 
in the use of antibiotics.  [47] 
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Order sets inform the prescriber of the appropriate choice of medication(s) for an indication or 
condition. For example, guiding the prescriber to the most suitable medications to be used as 
post-operative analgesia or to treat an asthma exacerbation. Order sets can be used to improve 
compliance to guidelines or formularies. [4, 26] Advanced order sets will take patient specific 
factors into account when providing recommendations. [26] 
Weight checks inform the prescriber if the patient is within the usual weight range for their age 
and if the current recorded weight is ‘out of date’. Provision of a weight check alert within an 
electronic prescribing system contributed to a reduction in inappropriate doses in a renal 
paediatric clinic. [33]  
1.1.2.3 Disadvantages and new errors associated with electronic 
prescribing and decision support 
Despite the positive experiences reported in the previous section there have been less beneficial 
experiences reported in some hospitals including increased mortality rates and no reduction in 
medication errors. [26, 48-50] New types of errors associated with electronic prescribing systems 
have been reported and few studies have reported improvements in patient outcomes from using 
clinical decision support. [18, 19] It is important to note that computerised systems for prescribing 
cannot prevent all medication errors or adverse drug events. [23, 24] 
Drop down menus can cause selection errors, particularly if the menu that the end user is 
selecting from is long. [26, 50, 51] However, this type of error can be reduced by using shorter 
drop down menus. [26] Free text entry sections can be associated with prescribing errors. [24, 50, 
51] Free text entry allows prescribers to make errors typically seen with hand written 
prescriptions such as spelling errors and unclear instructions. Technical slips in log on and log off 
procedures may also lead to prescribing errors. [48, 51] A technical slip can lead to medication 
being ordered for the wrong patient if the prescriber inadvertently uses the electronic prescribing 
system when another prescriber is logged in. [48] Duplication errors can occur when the 
electronic system does not allow an individual to write the prescription as it would normally 
appear on a paper chart. [50]  
The user interface of electronic prescribing and clinical decision support systems can be poorly 
designed. For example, it could be easy to select the wrong patient if the font is small and patient 
names don’t appear on all screens of the system. [48] Selecting the correct item or information 
can be made more difficult if differing typefaces and colours are used for the same type of 
information. [48] It can be difficult to see all of a patient’s medication on a single screen. This can 
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lead to a variety of errors including: failing to order a medication, selecting the wrong medication, 
and not viewing ‘when needed or PRN’ medication. [48] 
A review published in 2006 reported that between 49-96% of drug safety alerts are overridden. 
[52] The setup of the alerts in an electronic prescribing system may create scenarios where 
medication errors are more likely. This could occur when alerts lack: specificity; sensitivity; clear 
information or seamless integration with the prescriber’s workflow. [51, 52] Repeated ineffective 
alerts can result in prescribers failing to acknowledge the alert or misunderstanding or incorrectly 
responding to an alert. [52] This is known as alert fatigue. Alert fatigue develops when alerts are 
irrelevant, not serious or are shown repeatedly. [53] Alert fatigue can be used to describe the 
mental state of the prescriber affected by too many alerts that use up time and mental energy; 
critically it may lead to important alerts being ignored. [52]  
Hospitals may need to rely on their system provider to respond to suggestions for improvements 
to the prescribing software. [26] For example, in the UK if you had chosen an American based 
electronic prescribing system you could find yourself disadvantaged if the majority of updates and 
developments focus on the needs of the American market. Many hospitals may also not have the 
resources to improve their own system. [54] The market of system providers is continually 
changing; providers can go out of business or merge. This requires hospitals to have a strategy to 
manage these risks.  
There is a lack of literature describing if the same disadvantages and errors are associated with 
the use of electronic prescribing and decision support in the paediatric environment. An 
understanding of the effect of such systems in paediatrics is required to enable an evidence based 
decision on their regarding their implementation in paediatrics.  
1.1.2.4 Further methods of reducing paediatric medication errors 
The quality of paediatric prescribing can be increased by many approaches. [20] This section 
describes some approaches that do not rely on hospital wide information systems to improve 
paediatric prescribing and reduce paediatric medication errors.  
Prescriber education is the most commonly referred to intervention used to reduce medication 
errors after electronic prescribing and clinical decision support. Education programmes in a 
number of paediatric hospital environments have been shown to improve prescribing practice or 
reduce prescribing errors. [9, 55-60] Prescribing education in hospitals is often led by pharmacists 
during induction programmes for doctors. [59, 60] Pharmacist led education may include: how to 
complete prescriptions correctly, induction packs (containing further information) and 
information on common prescribing errors. [60] Some education programmes may also include an 
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assessment of prescribing skills. [57, 60] Better undergraduate and postgraduate prescribing 
education have been recommended to prevent prescribing errors. [61, 62]  
In addition to providing prescriber education as described in the above section pharmacists are 
also effective at intercepting paediatric prescribing errors. [54, 63, 64] Pharmacists can then 
provide feedback and teaching to prescribers on these errors. This can be done in real time. 
Feedback on prescribing errors is valued and wanted by junior doctors, particularly when the 
feedback is personalised and regular. [65] Group feedback to prescribers by pharmacists on 
common or serious errors was also beneficial. [65] Daily feedback on prescribing errors to 
prescribers alongside a zero tolerance prescribing policy (designed to eliminate distractions and 
interruptions) on a  paediatric intensive care unit (PICU) in England correlated to a fall in 
prescribing errors. [66] Further research on the use and effectiveness of provision of feedback to 
prescribers in paediatrics is required to determine if this can be attributed as the causal factor in a 
reduction in prescribing errors.  
Other technologies used include smart infusion pumps, unit dose dispensing and drug dose 
calculators. In a comprehensive review of strategies to reduce medication errors in paediatrics 
smart infusion pumps and unit dose dispensing systems showed reductions in dosing errors in 
paediatric patients. [9] Online or computer based calculators have been shown to reduce 
calculation errors for a limited number of medicines. [9] For example, the use of an online total 
parenteral nutrition (TPN) calculator led to a reduction of errors in TPN orders. [45] The TPN 
calculator ensured calculations were correct and reduced the number of orders with osmolarity 
outside of the recommended range. [45] However, dosing calculators may be discontinued as 
they become built into clinical decision support or electronic prescribing systems. [9] Dosing 
calculators can introduce risks or errors if they are not built securely or tested sufficiently. An 
Excel spreadsheet used to calculate doses in a paediatric emergency department was determined 
to be the cause of an error in drug calculation. The reason was that the cells of the pre-
programmed Excel document could not be locked and one of the formulae had been 
inadvertently changed leading to the incorrect drug calculation. [67] More widespread use of drug 
dose calculators cannot be recommended currently due to the lack of high quality evidence to 
support their effectiveness.   
Hospitals may also introduce reminder tools or display guidelines prominently to improve 
prescribing practice. A consultant-led ward round checklist on paediatric wards in a London 
hospital led to improvements in the quality of prescription writing, but had no effect on clinical 
errors. [68] A similar strategy in oral and maxillofacial surgery in Sheffield included a credit card 
sized ‘aid-memoir’ with prescribing doses. [15] There was no report on the success or effect of 
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this intervention. A bedside prescribing guideline was introduced onto a paediatric unit of a 
general hospital in the UK. The bedside guideline contained information on the 22 most 
frequently prescribed medicines on the children’s unit. [69] Unfortunately, there was no report on 
the success of this intervention or a similar intervention at Alder Hey Children’s Hospital.  [70] The 
robust evaluation of such interventions would be valuable to improve the quality of evidence 
regarding their use.  
Paediatric medication errors can also occur at the dispensing (pharmacy) stage of the medication 
process within a hospital. The pharmacy team are responsible for clinically screening medicines as 
well as ensuring their safe and efficient supply. New electronic systems are now available to 
support the pharmacy team to accurately record medication histories and medication supply. 
However, the experiences of pharmacy staff when implementing an electronic medicines 
management system and the effect of such a system in a paediatric hospital have yet to be 
investigated. The initial study of the thesis will aim to contribute knowledge to this new and 
developing area of pharmacy clinical system technology.  
1.1.3 Resource or reference use to support decision making in 
paediatric prescribing 
There is very limited evidence on the resources or sources of information used by prescribers to 
support decision making when prescribing for paediatric patients. The available evidence can be 
split into two distinct groups: evidence from outside the UK and evidence from within the UK.  
The majority of published research on resource use when prescribing for paediatric patients has 
involved participants from the USA. The most recent study, 2011, reported that Lexi Comp was 
used frequently by hospital based doctors and nurse practitioners. [71] Respondents in this study 
were generally satisfied with the available resources but reported that a tool that could provide 
individualised patient dosing would be valuable. [71] This study confirmed that resources are 
important for providing dosing information for paediatric patients. A small study (20 participants) 
from 2005 reported that colleagues, paediatric texts, drug formularies, government/professional 
organisation websites and medical portals were the preferred sources of information for primary 
care paediatric doctors. [72] This demonstrated that prescribers may have needed to refer to 
different information sources to support their prescribing for paediatric patients. Finally, a USA 
report on access to paediatric prescribing information noted that there was no indication of 
increased access to paediatric prescribing information in the Physician’s Desk Reference in the 
period studied (1998-2007) [73] Over the period studied the number of medications licensed for 
children reduced by a third and there was a decrease in the number of formulations suitable for 
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children. [73] It is important to note that the PDR is a voluntary listing and charges a fee, which 
may have deterred manufacturers from including their medicines. It is also important to note that 
the healthcare system in the USA is very different to that in the UK and therefore the results of 
these studies may not be directly applicable to UK healthcare. 
A study conducted in Canada published in 2003 reported that the most common reference source 
used by family physicians was the “Compendium of pharmaceuticals and specialties” when 
looking for paediatric drug information. [74] Available sources of paediatric prescribing 
information were thought not to be adequate by 40% of the 261 respondents and not readily 
available by 27%. [74] The study concluded further work was needed on provision of paediatric 
prescribing information. [74] Other sources of information used by respondents included: 
community pharmacists, children’s hospital dosing manuals, paediatric textbooks and drug 
companies; again demonstrating that the information needs of paediatric prescribers were not 
met by a single resource. The number of respondents in this study is unlikely to reflect the total 
physician population of Canada; therefore these results may not be generalisable to all Canadian 
physicians.  
In the UK the British National Formulary (BNF) for Children provides information on medication 
for children.  After the first edition of the BNF for children (BNFc) was published in 2005 research 
was conducted to determine how well it was meeting the needs of its users. Information 
regarding dosage was considered the most important information in the BNFc and the top reason 
for referring to the BNFc. [75] When referring to medicines information the highest priorities 
were how fast and easy the information was to access and the reliability of the information. [75] 
The BNFc was praised for its clinical advice and the logical order of medicines (grouped by body 
system) as well as for having the level of information right for most users. [75] BNFc producers 
responded to users’ needs for easy access to dosing information by displaying this information in 
tinted panels in future editions. [75] This study had over 1200 responses supported by further 
work with focus groups. Despite its focus on a single resource; it is the strongest evidence 
currently available on the resource use of healthcare professionals in the UK. There is no further 
literature on the use of other resources by doctors or pharmacists that provide information to 
support decision making in paediatric prescribing.  
A small study on the resources used by doctors when making decisions in one UK neonatal 
intensive care unit reported that the most common sources of information were observations of 
the child and information from computerised monitors when respondents self-reported their use 
of resources. [76] However, on observation, information from colleagues also played an 
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important role in supporting decision making. [76] This study provides some evidence that more 
than one source of information is used by doctors to support decision making in paediatrics.  
1.1.4 The National Health Service in England  
Health services in the UK are devolved to the separate governments of England, Northern Ireland, 
Scotland and Wales. In England, the area of this research programme, health services are run by 
NHS England. NHS England splits the country into four regions that have oversight and leadership 
of the NHS in each region. Within each region hospital services are provided by organisations 
called acute NHS Trusts. Paediatric hospital services may be provided as part of an acute NHS 
Trust that also provides adult health services or as separate standalone paediatric NHS Trusts. 
There are four NHS Trusts that provide solely paediatric health services. These are: Alder Hey 
Children’s NHS Foundation Trust; Birmingham Children’s Hospital NHS Foundation Trust; Great 
Ormond Street Hospital for Children NHS Foundation Trust and Sheffield Children’s NHS 
Foundation Trust. The four standalone paediatric acute NHS Trusts alongside the other 156 acute 
NHS Trusts provide paediatric hospital services to the paediatric population of England. [77] 
The estimated population of persons aged between 0 and 19 years old in England in 2012 was 
12.7 million. [78] Approximately one in 10-15 children will be admitted to hospital each year in 
England and one in 11 will be referred to a hospital outpatient clinic each year in England. [79]  
1.1.4.1 The current status of electronic prescribing in hospitals in the 
National Health Service 
Currently the use of electronic prescribing by general practitioners (GPs) is widespread and 
embedded in their current practice. [21, 80] However, the use electronic prescribing in the 
hospital sector is less widely implemented than in the primary care sector, despite considerable 
interest in electronic prescribing systems being reported. [81] There are few hospitals that use 
electronic prescribing comprehensively. [80] The leaders in hospital based electronic prescribing 
in England, such as Burton and Arrowe Park (Wirral), have had this type of system in use for more 
than fifteen years, yet many UK hospitals are yet to make the move to implement electronic 
prescribing.  
A recent study of electronic prescribing in English NHS hospitals in 2013 concluded that 69% of 
hospitals had an electronic prescribing system in place and more than half of these had more than 
one electronic prescribing system in use. [82] Only 13% of hospitals in this study reported using 
electronic prescribing across all adult medical and surgical wards and of these hospitals just one 
did not require any additional paper drug charts to be used. [82] 
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An earlier study published in 2010 reported that 82% of English NHS hospitals (n=56) were 
considering implementing or in the process of implementing electronic prescribing.  [81] The 
functions that had the most reported interest were: knowledge and decision support and links 
within the system to other areas of the patient record. [81] All respondents reported that they 
would procure an existing system and the two most popular electronic prescribing system choices 
were Ascribe and JAC. [81] 
1.1.4.2 National information technology projects designed to drive the 
use of technology and improve patient safety in the NHS 
The UK government has run several projects to drive the use of technology in the NHS with the 
aim of improving patient safety and efficiency. The first of these projects to drive the use of 
technology in the NHS was the National Programme for IT. It was launched in 2002. [83] Its aim 
was to reform the way the NHS in England uses information. The project suffered many delays 
and was eventually dismantled in 2011.[83] The project should have implemented the RiO, 
Lorenzo (in the midlands, east and north) or Fujitsu (in the south) care records system nationwide. 
[83] A nationwide electronic record system may have had significant benefits in the areas of 
efficiency and patient outcomes. The failure and delays of the national project for IT may have 
made it harder to obtain financial backing for separate electronic prescribing projects. [80] 
The next government led project was NHS Connecting for Health.  
“NHS Connecting for Health is part of the Department of Health Informatics Directorate. 
Our role is to maintain and develop the NHS national IT infrastructure.” [84]  
Earlier tasks included providing guidance on electronic prescribing and its implementation. It 
started services such as the Electronic Prescription Service in primary care and the development 
of Summary Care Records to be used across care interfaces. [84] The Connecting for Health 
organisation ceased to exist from March 31st 2013 and these tasks were taken over by the Health 
and Social Care Information Centre. [84] 
In 2009 Connecting for health issued an information resource designed to support the 
implementation of electronic prescribing. It presented the current challenges and lessons learnt 
so far. The document provided information on electronic prescribing systems; lessons learned; 
planning and managing electronic prescribing; technologies involved in electronic prescribing and 
integrating electronic prescribing into systems and practice. [21] The key points of information it 
provided to organisations are summarised in Table 2 below.  
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Table 2: Key information from ‘Electronic Prescribing: Challenges and Lesson Learned’ 
 
Key information from ‘Electronic Prescribing: Challenges and Lessons Learned’ 
Electronic prescribing must be thought of through the whole medicines process and not just in the 
context of prescribing. Administration and supply are important features.  
Electronic prescribing is used in various forms in the NHS; from standalone systems to integrated 
whole hospital clinical systems. 
The initial benefit of electronic prescribing is legible and complete prescriptions.  
Electronic prescribing systems can provide varying levels of clinical decision support.  
A major motivational factor for implementing electronic prescribing is the safer use of medicines.  
End users will need to understand the overall vision of the system and where it will benefit them. 
The implementing team should be multidisciplinary with senior management support. 
Implementing electronic prescribing is not a quick process and the time taken to go live should 
not be underestimated. 
The team should be open with progress made and invite participation from end users. 
The order and speed of roll out requires careful planning.  
The project does not end once the roll out is completed.  
Electronic prescribing systems require constant management and development.  
“Electronic prescribing will change how people work”. 
Staff will find their own ‘workarounds’ for the system, which may or may not be useful or harmful.  
Electronic prescribing needs to be seen as part of the overall information strategy for the hospital 
and be useful to all healthcare professionals working with patient information.  
 Table reference ‘Electronic Prescribing in Hospitals: Challenges and Lessons Learned’. [21] 
The Connecting for Health group also provided specific information regarding: allergy checking, 
dose checking, tall man lettering, miss-selection of opioids and hazard review; all in relation to 
electronic prescribing. The Health & Social Care Information Centre is the current national 
provider of information, data and IT systems for health and social care. The Health and Social Care 
Information Centre is responsible for collecting data from the health and social care system. Their 
aim is: 
“We support the delivery of IT infrastructure, information systems and standards to ensure 
information flows efficiently and securely across the health and social care system, to improve 
patient outcomes. We are committed to putting the needs of patients and the public at the 
heart of everything we do.” [85]  
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The Safer Hospitals, Safer Wards Technology Fund was established in 2013 to encourage and 
provide financial resources for the use of technology in healthcare. There was initially £260 
million available for NHS hospitals and other care providers to bid for which then increased to 
over £500 million. [86]The stated purpose of the fund is as follows: 
“The Technology Fund is available to NHS Trusts, including Foundation Trusts, to support 
the rapid progression from paper-based systems for patient notes and prescriptions to 
integrated digital care records (IDCRs) and the development of ePrescribing and eReferral 
systems.” [86]  
It is too early to confirm if this information technology project will prove succesful in 
implementing technology that improves medication safety and access to patient information in 
the NHS.  
1.1.5 National resources to support prescribing in England 
The National Institute for Health and Social Care Excellence (NICE) provides national guidance and 
advice that aims to improve health and social care. [87] The guidelines cover a wide range of 
paediatric conditions and there are frequent reviews of existing guidelines and introductions of 
new guidelines. NICE also evaluates medical technologies and interventions. [87]  
NICE have recently implemented a new medicines optimisation guideline. This guideline is 
designed to help the delivery of: 
“the safe and effective use of medicines to enable the best possible outcomes.” [88] 
The guideline has two recommendations that are particularly relevant to the studies of this thesis. 
The first is that hospitals should consider the implementation of clinical decision support systems. 
[88] The data presented later in this thesis will describe the type of information that prescribers 
and pharmacists report to use in current practice. Therefore this type of information should be 
considered to be part of future clinical decision support provided. Additionally, this thesis will also 
provide data that describes the information needs of pharmacists when providing pharmacy 
services such as medication review. Medication review is another recommendation of the NICE 
medicines optimisation guideline. [88] The research recommendations of this guideline include 
looking at process measures for using clinical decision support. [88] This might include how end 
users use and/or interpret clinical guidance.  
The BNFc is jointly produced by the British Medical Association, the Royal College of Paediatrics 
and Child Health, the Royal Pharmaceutical Society, and the Neonatal and Paediatric Pharmacist 
Group. The BNFc aims to provide practical guidance on the use of medicines in children.  A second 
paediatric formulary is produced by Guy’s and St Thomas’, King’s College and University Lewisham 
Hospitals. This is a specialist paediatric formulary produced jointly across three hospital groups. It 
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provides information on paediatric dosing that may be off label or unlicensed as well as licensed 
paediatric doses. [89] There are no data available on the use of these resources in practice.  
The National Prescribing Centre has a competency framework for all prescribers that describes 
the common competencies required of a prescriber. [90] The General Medical Council ‘good 
practice in prescribing and managing medicines and devices’ guideline provides guidance to all 
doctors on prescribing ranging from reviewing medicines to prescribing unlicensed medicines. 
[91] In addition to these organisations there are Royal Colleges that focus on a clinical speciality 
and provide guidance for it. Royal Colleges, alongside national societies, for example the British 
Thoracic Society, produce clinical guidelines to be used by healthcare professionals. The Meds IQ 
initiative is the most recent Royal College of Paediatric and Child Health project designed to 
collate interventions to reduce paediatric medication errors on a single website. [92] The 
interventions reported in the minutes of paediatric hospital board meetings could be shared as 
part of this projects focus on paediatric prescribing safety.  
1.2 Aim and objectives of this research programme 
From the gaps identified in the above literature review the following research questions were 
identified: 
 What new errors or disadvantages are associated with using electronic prescribing in 
paediatrics? 
 What initiatives are currently used to improve paediatric prescribing practice in the UK? 
For example, dose calculators or feedback on errors? 
 Are initiatives designed to improve paediatric prescribing practice effectively evaluated in 
the UK? 
 Is there a single source of comprehensive information on paediatric prescribing available 
to healthcare professionals in the UK? 
 How do healthcare professionals use and value prescribing guidance in the UK? 
 What resources are used by doctors and pharmacists in paediatrics to support prescribing 
decisions in the UK?  
 Are current resources for paediatric prescribing effective? 
The research questions guided the development of the aim of this research programme. The aim 
of this research programme was to identify current practice of healthcare professionals’ resource 
use to support their prescribing and medication supply work and the current prescribing and 
medication supply support provided by hospitals and companies to paediatric patients in England.  
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The specific objectives of this research programme were: 
 Identify and describe the experience of pharmacy staff of the implementation of an 
electronic medicines management system at Birmingham Children’s Hospital; 
 Identify the current practice of prescribers at Birmingham Children’s Hospital concerning 
their resource use to support prescribing decisions for paediatric patients; 
 Identify the current practice of pharmacist members of the Neonatal and Paediatric 
Pharmacist Group concerning their resource use to support the provision of pharmacy 
services for paediatric patients; 
 Identify the current practice of independent English paediatric hospitals provision of 
paediatric prescribing support as recorded in the minutes of their board meetings; 
 Identify the current views and experiences of leaders in electronic prescribing concerning 
current benefits/barriers/issues, and their advice for hospitals to ensure successful 
implementation.  
These objectives will allow for a substantial original contribution to the field of pharmacy practice 
research as there is minimal published research available on the above research objectives. The 
results of this research will ensure there is data available on the resources used by both 
prescribers and pharmacists in the supply and prescribing of medication to paediatric inpatients. 
It will also provide information on strategies used by English paediatric hospitals on improving 
prescribing practice and reducing medication errors. The research will also provide evidence 
regarding the use of electronic medicines management to support the supply of medication 
within a paediatric hospital. Finally, it will bring together advice and expertise from a range of 
leaders in electronic prescribing that could serve as guidance for paediatric hospitals that have yet 
to implement electronic prescribing and decision support.  
1.2.1 The theoretical perspective of this PhD 
1.2.1.1 Epistemology and theoretical perspectives 
Deciding on an appropriate paradigm for a mixed methods study is difficult as there appears to be 
large theoretical differences between the paradigms in which each type of research is usually 
grounded. Typically quantitative research will be based in the positivist paradigm, whereas 
qualitative work may be interpretive or constructionist in paradigm. To understand what 
paradigm is best suited to this study it is important have an understanding of each paradigm 
before judging which will best suit the aim of this research.  
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Positivism assumes there is a stable actuality ‘out there’ and that phenomena (e.g. health) are 
present whether we detect them or not and that they are present in the same way whether we 
comprehend them or not. [93] Our comprehension of phenomena may be incorrect, but there is a 
‘correct’ understanding that we will get nearer to defining. [93] Research in the positivist 
paradigm has a focus on empiricism; collecting data directly from the phenomena being studied. 
Another focus is ‘unity of method’; this is a concept that all sciences and research will use 
identical methods. [93] The final important aspect is that science is separate from society and is 
rational, free from bias and objective thus ensuring that ‘knowledge’ gained from scientific 
methods is impartial and ‘true’ for all periods and locations. [93] Positivism may lean towards 
deductive reasoning; linking premises with a definite conclusion. [94]   
From the interpretative perspective the most important research is not about the stable actuality 
‘out there’ but people’s understandings of it. [93] The interpretative paradigm focusses on the 
meaning of phenomena and its aim is to comprehend the world from the perspective of people 
rather than to define a cause and effect relationship or laws for the phenomena. [93] It uses 
inductive reasoning where the premises give evidence for the likely conclusion.  
Constructionism queries whether there is a single stable actuality that pre-exists and instead 
suggests it is socially constructed. [93] Instead of defining things through our knowledge from 
scientific methods, constructionist researchers focus on how these things are constructed via the 
outcome of social, political and historical processes. [93]  Constructivist views may allow for the 
definition of more than one reality as knowledge is socially constructed.  
Finally there is the pragmatic approach. This has neither a qualitative or quantitative focus; 
instead it has the aim of using the most appropriate method for the research objectives. 
Pragmatism is the result of decades of debate concerning whether qualitative and quantitative 
methods can be used together under one paradigm. Before the mid-1980s the two approaches 
were divided and people would argue for the greatness of one over the other. [95] By the late 
1970s people started to agree that the two approaches could complement each other. [95] For 
example, running a qualitative focus group to explain further the statistical results. In the last 25 
years it has been agreed that qualitative and quantitative methods could be combined for 
research under the paradigm of pragmatism. [95] Pragmatism acknowledges that quantitative 
work may not be free of social influences or completely impartial. For example, when conducting 
an experiment we use our qualitative understanding based on prior experiences, common sense 
and our judgement to decide if our findings are likely to be ‘true’. [96] This qualitative 
understanding of context is also used when we trust prior research when comparing and 
interpreting our new data or knowledge.  
31 
 
1.2.1.2 Paradigm and theoretical perspective of this research 
The paradigm for this research can be described as pragmatist. It is combining the best of 
qualitative and quantitative methods to meet the research aim. An advantage of taking a 
pragmatic approach is that the methods can be mixed to provide a complete answer to the 
research question. [95] This mix of methods is particularly useful within the development of 
recommendations for practice and policy (which this research aims to do) as there is a need to 
explore the study population as a whole as well as studying individual differences or 
circumstances. Pragmatism allows individual experiences and/or anomalies to be explored 
alongside population statistics.  
A mixed method approach can give greater validity to research by allowing corroborative findings 
to be drawn from across several methodically diverse studies. Quantitative methods usually have 
high levels of internal validity whereas qualitative methods are more likely to have high levels of 
external validity. Quantitative methods can ensure internal validity by obtaining precise, reliable 
and replicable measures, samples and conditions. [97] High internal validity allows you to define 
causal relationships as other explanations can be removed or measured. [97] However, by having 
high internal validity, external validity (the degree to which the relationships/results identified are 
generalizable to real world circumstances) may be compromised as the controlled conditions may 
result in an environment that is different to the ‘real world’. In contrast, qualitative research 
obtains and analyses data in context, usually with a reduction in control. [97] However, this allows 
for exploration of real life situations that may have been excluded from or not anticipated by a 
quantitative study. In summary, combining qualitative and quantitative research and their 
associated internal and external validity can be an effective way of increasing the overall validity 
of research.  
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2. Methods 
This chapter contains a description of the research method used for each study.  
2.1 Initial exploratory focus groups on current resource use when 
prescribing and thoughts on electronic prescribing 
Focus groups were used to gain an insight into the research area and familiarise the researcher 
with the language used to describe current practice. The aim of the focus groups was to provide 
the researcher with a general understanding of current resource use during paediatric prescribing 
and prescriber opinions on electronic prescribing.  The objectives were: 
 Provide an insight into current paediatric prescribing practice 
 Explore attitudes towards systems designed to improve paediatric prescribing practice 
such as electronic prescribing 
 Inform the design of future studies regarding methods used to support medicines related 
decisions in paediatrics.  
2.1.1Timing of the study 
Four focus groups were held at Birmingham Children’s Hospital. Focus groups one and two took 
place on 11th May 2012 (at an update day for non-medical prescribers). Focus groups three and 
four took place on 16th August 2012 (at a training day for doctors). Both sets of focus groups took 
place in the education centre at Birmingham Children’s Hospital, which was the participant’s 
workplace and therefore convenient for participants.  
2.1.2 Ethical approval 
Ethical approval for the preliminary focus group study was gained from Aston University (#328, 
24/05/2012) and it was registered as an audit at Birmingham Children’s Hospital (PHA32, 
31/01/2012) for this study.  
2.1.3 Focus group design 
Table 3: Numbers of participants in preliminary focus groups 
Focus group Number of participants 
Non-medical prescribers (1) 9 
Non-medical prescribers (2) 8 
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Medical prescribers (3) 8 
Medical prescribers (4) 5 
 
All focus group participants were attendees at training days that were run independently from 
this study. The focus groups were run as one of the sessions that attendees of the training day 
were asked to participate in. There were no attendees at the study day that chose not to 
participate in the focus groups.  In focus group one all non-medical prescribers were nurses; in 
focus group two there was one pharmacist prescriber and seven nurse prescribers. Focus groups 
three and four were solely made up of medical prescribers.  
Before the focus group started informed written consent was obtained from each participant. The 
focus groups followed the topic guide developed by the researcher (see Appendix 1). The topic 
guide was developed by using a review of the current literature to identify areas where further 
research was needed as well as consultation with the Deputy Medical Director at Birmingham 
Children’s Hospital to ensure the topic guide was compatible with local practice and met the 
needs of the hospital’s electronic prescribing project (which this study contributed to). Minimal 
directions and instructions were provided to the participants during the focus group by the focus 
group coordinator unless they veered off the research topic and needed to regain focus on the 
topic of interest.  
The focus groups had an audio recording taken which was transcribed by the researcher. All audio 
files were transcribed by the researcher using Windows Media Player and Microsoft Word. This 
ensured that the researcher was familiar with the data set before beginning the analysis. The 
transcript was then used for the qualitative analysis of the focus groups. Applied thematic analysis 
was used with the support of NVivo (version 9) software to analyse the focus groups. The function 
of applied thematic analysis is to identify themes and patterns in qualitative data. This technique 
identified and labelled extracts of relevance/interest to the research theme as codes. After all the 
transcripts had been coded they were checked for uniformity of coding. Some extracts were 
recoded to ensure the coding used was consistent. After the coding was completed the codes 
were brought together into themes. The themes were based on frequency of the code, relevance 
to the research theme and areas of importance to the participants.  
2.1.4 Rationale for method 
Focus groups were suitable as the initial research method for exploring and gaining an 
understanding of the research question and the context of the research in current hospital 
practice. The open structure of this method enabled a wide ranging discussion of the research 
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questions and their context in a paediatric hospital. This ensured the focus of future studies was 
relevant to current practice.  
Disadvantages of the focus group method are that the results are unlikely to be reproducible. It is 
not likely that the participants will provide the same responses if the focus group was repeated, 
particularly if there were any changes to the membership of the focus group. It is important to 
note that the responses from the participants are a narrative and therefore may not be indicative 
of what they do in practice. [93, 94] 
The advantages of the focus group method are it is a quick and convenient method to collect data 
from a number of participants at the same time. [93, 98] Focus groups can allow the participants 
to discuss freely the research topic and take cues from other participants to trigger contributions 
that may not have been added otherwise. [99]  Participants are free to use language they feel 
comfortable with and are not limited by the research method in the length or detail of their 
response. Participants can also emphasise the areas that are most important to them. [99] 
Several techniques were actively employed in this study to improve the quality of the focus group 
method. It is important that the researcher has a good understanding of the language used by the 
participants. [93] This was assured in this study as the researcher was a hospital pharmacist with a 
good understanding of the research area gained during prior hospital work experience. The 
location of the study is also important and it is thought that it is best to conduct the focus groups 
in a place that the participants feels is ‘theirs’. [93, 99] This advice was heeded in this study as the 
focus groups were conducted at the participants’ place of work. Finally to encourage the 
participants to speak freely and provide complete answers the researcher running the focus group 
must be receptive. [93] This can be achieved by not interrupting the participants and recognising 
the participants answers by nodding or saying “mm”. [93] 
2.2 Questionnaire studies 
This section describes an oversight of the methods used for all the questionnaire based studies 
within this thesis followed by the specific methods of each study (sections 2.3 to 2.5). The three 
questionnaire studies were retrospective self-completed questionnaires (see Appendices 2 to 4). 
Questionnaire study 1 was paper based. Questionnaire studies 2 and 3 were electronic. The 
details unique to each individual study follow this information that is common to the three 
studies.  
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2.2.1 Ethical approval 
Questionnaire study 1: Experience of pharmacy staff from moving from a paper based to an 
electronic medicines management system was approved as a service evaluation audit by 
Birmingham Children’s Hospital Clinical Governance team (audit number 682, 09/10/2012) and 
Aston University Ethics Committee (#416, 15/03/2013).  
Questionnaire study 2: Resource use during prescribing decisions by prescribers at Birmingham 
Children’s Hospital was approved as a service evaluation audit at Birmingham Children’s Hospital 
(PHA32, 31/01/2012) and by the Aston University LHS Ethics Committee (#455, approved 
26/09/2013). 
Questionnaire study 3: Resource use during paediatric pharmacy services provision was approved 
by the Aston University Ethics Committee (#486, 28/10/2013). 
Information sheets were provided for each study either on paper or electronically. Consent was 
obtained from all participants.  
2.2.2 Confidentiality 
For questionnaire study 1 which was paper based; the consent forms were separated from the 
questionnaires to ensure confidentiality and anonymity were maintained. Participants were asked 
to provide their email addresses if they were interested in future research; this data was stored 
separately from the completed questionnaire. Questionnaires and consent forms were stored in a 
locked cupboard that was only accessible to the researcher. 
For questionnaire studies 2 and 3 the researcher did not collect or have access to any personal 
data during these studies as no personal data was collected. The distributors (Birmingham 
Children’s Hospital and the Neonatal and Paediatric Pharmacist Group) of the questionnaires did 
not share the email addresses of the participants with the researcher. All email addresses were 
blind copied when each email was sent. The questionnaire data were stored on a password 
protected account that only the researcher had access to.  
2.2.3 Data entry 
The first questionnaire study was paper based; as such the data had to be entered by hand into 
Microsoft Excel for analysis. To ensure data entry precision, all entries were triple checked for 
accuracy prior to analysis. This was conducted by the researcher on separate days. Minor errors 
occurred due to the software spell check auto-correction and in these cases the verbatim 
responses were identified and the responses were returned to the original wording used by the 
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questionnaire respondent. Comments that had been added to closed answer questions were 
disregarded. Incorrectly completed questions were also disregarded.  
For the online based questionnaire studies Survey Monkey (Gold survey package) was used to 
export the data directly into Microsoft Excel (2010) and SPSS (version 21). Transfer of the data 
was necessary for its analysis. 
2.2.4 Data analysis 
The closed answer questions in the questionnaire based studies required statistical analysis 
whereas the open ended questions required qualitative analysis. Microsoft Excel (2010) and SPSS 
(version 21) were used for quantitative analysis. Two software programmes were required as 
Microsoft Excel enables data to be easily manipulated and provides more flexibility in the 
production of graphs. It also allows easier importing of graphs into Microsoft Word compared to 
SPSS. SPSS enables full statistical analysis to be completed. NVivo (version 9) was used for the 
qualitative analysis.  
2.2.4.1 Qualitative analysis of open ended questions 
The chosen method of analysis was applied thematic analysis. The following table summarises the 
processes undertaken to conduct the analysis.  
Table 4: Steps of applied thematic analysis used  
Step 1. Acquainted oneself with the data Transcribed data, read and re-read through 
the data, wrote down initial ideas.  
Step 2. Produced initial codes Coded thought-provoking data in a systematic 
manner across the data set.  
Step 3. Explored for themes Brought codes together into themes. 
Step 4. Evaluated themes  Did the themes work in relation to extracts 
and entire data set?  
Step 5. Defined and named themes Determined the specifics of each theme, each 
had a clear definition and name. 
Step 6. Wrote up Selected appropriate examples of extracts, 
related back to research question and current 
literature, produced report/article of the 
study.  
Table 4 is adapted from ‘Table 1 Phases of analysis’ in ‘Using thematic analysis in psychology’. 
[100] 
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Counts of frequency of codes were used to help define themes and to decide if there was enough 
evidence to support a theme. However, the main evidence for each theme was determined by the 
content of each extract rather than the quantity of codes that fitted to that theme.  
2.2.4.2 Quantitative analysis of closed answer questions 
In the questionnaire studies the two independent variables identified that may influence 
responses to the questions are profession (e.g. is the respondent a pharmacist or a doctor?) and 
experience (e.g. how many years of experience at Birmingham Children’s Hospital does the 
respondent have). The demographics of the participants were described. This recorded how many 
participants from each profession completed the studies and their years of experience. In each 
study descriptive statistics of the participants overall and for each profession were also recorded. 
Some comparisons between the professions were able to be made at that stage. The null 
hypothesis was that profession or experience would not affect the use of resources by the 
participants. Table 5 describes the most appropriate measures of central tendency to be used in 
questionnaire study one. The mean will only be computed for experience as the other variables 
have ordinal data. For ordinal data the mode would be the most appropriate measure of central 
tendency.  
Table 5: Appropriate measures of central tendency for medicines management data 
Variable Most appropriate measure of central tendency 
Experience Mean 
Level of satisfaction with training Mode 
Level of satisfaction with implementation Mode 
Attitude to change before Mode 
Attitude to change after Mode 
 
The variability of experience was recorded using the range (i.e. the most years of experience 
minus the least years of experience). This was recorded overall and for both groups within the 
profession variable. With the exception of years of experience, all data collected was of ordinal 
data type (i.e. there is a natural scale to the data but there is not an equal difference between 
each point of the scale). Because of this non-parametric statistical tests were used for data 
analysis. For ordinal data (e.g. profession vs level of satisfaction with training) the Mann-Whitney 
U test was used.  The Mann-Whitney U test compares mean rank differences between two 
independent groups. [101] It is the non-parametric alternative to the independent t-test. 
Assumptions of normality and homogeneity of variance do not apply to this test, but observations 
must be independent of each other. [101] In  questionnaire study one this test was used to see if 
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there were any differences between the pharmacist and non-pharmacist groups in terms of: level 
of satisfaction with training, level of satisfaction with implementation, attitude to change before 
electronic medicines management and attitude to change after electronic medicines 
management. In questionnaire study two this test was used to test the null hypothesis that there 
is no difference between medical and non-medical prescribers and their reported frequency of 
use of each information source.  
The Wilcoxon test is used to compare mean rank differences between related groups (i.e. 
repeated measures). [101] It is the non-parametric equivalent of the paired t-test. Assumptions of 
normality and homogeneity of variance do not apply to this test, but the observations must be 
independent of each other. [101] In questionnaire study one this test was used to compare 
attitudes to change before implementation of electronic medicines management with attitudes to 
change after electronic medicines management. The details of the tests to be carried for 
questionnaire study one are described in Table 6. The null hypotheses were that there would be 
no difference between the professions when the following were considered: training satisfaction, 
implementation satisfaction, attitude to change before and attitude to change after. The final null 
hypothesis was there would be no difference in the attitude to change of participants before or 
after the study. 
Within the prescribers at Birmingham Children’s Hospital there will be medical and non-medical 
prescribers (nurses and pharmacists). To determine if there is any difference between the years of 
experience of these two groups the Kruskall-Wallis test will be used. The Kruskall-Wallis test is 
used with non-parametric data to test if three or more samples have the same distribution. [101] 
The null hypothesis stated that there would be no difference in the distribution of years of 
experience of medical and non-medical prescribers.  
Table 6: Statistical tests used in pharmacy staff experiences of the change from paper to 
electronic medicines management systems study 
Data to be tested Selected test 
Profession vs training satisfaction Mann-Whitney U 
Profession vs implementation satisfaction Mann-Whitney U 
Profession vs attitude to change before Mann-Whitney U 
Profession vs attitude to change after Mann-Whitney U 
Attitude to change before vs attitude to change 
after 
Wilcoxon 
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2.2.5 Rationale for method 
The chosen method for these studies was a paper or electronic self-completed questionnaire. The 
versatility of the questionnaire and the low costs of a self-completed questionnaire were 
important advantages of this method choice. [94] The data collected is more easily generalizable 
to the chosen study population compared to if a smaller sample was used via interviews or focus 
groups. [94] The respondents invited to participate in these studies did not have spare time at 
work to enable interviews to be conducted, although it is acknowledged they may have provided 
richer data on the experiences of staff. 
The choice of a self-completed questionnaire allowed a large quantity of data to be gathered 
efficiently and in a timely manner with minimal costs. It was important in these baseline studies 
that respondents had an opportunity to comment on their current practice as these studies may 
have implications on the development of electronic clinical system design and that could 
ultimately affect all healthcare staff using such a system. Therefore it was important to gain 
opinions from as many people as possible within the population rather than fewer rich 
descriptions from targeted interviews or observations. The questionnaire studies have provided 
data that can be easily compared if the study is repeated after the introduction of an electronic 
clinical system or if the study is conducted at another paediatric centre.  
Satisfaction questions employed a five point Likert-style scale to enable opinions to be quickly 
identified. These closed questions ensured responses were clear and unambiguous. The 
accompanying open ended questions ensured experiences and reasoning were also provided, 
enabling a rich data set that has been used to assist in the explanation of the quantitative results.  
Challenges with this method include the possibility that the responses may not reflect the 
participants practice in reality. [94] However, this problem would also be encountered if the study 
had an interview or focus group method.  
Methods to improve the response rates in these studies were employed due to the known 
difficulties in recruiting healthcare professionals into questionnaire based studies. This included 
careful design of the questionnaire to ensure the length was minimised and the number of open 
questions was minimised. [102] It has been reported that lower response rates may be found 
when using open questions in comparison to closed questions. [102] Therefore in this study only 
essential open questions were asked. Further ‘design incentives’ included dissemination of the 
study to participants by direct email from a medical or pharmacy peer (a medical/pharmacy 
director at the hospital) and organisational endorsement of the study by a professional 
organisation such as the Neonatal and Paediatric Pharmacist Group. These ‘design incentives’ 
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have been previously recognised as one way of improving response rates of doctors by Van Geest 
et al. [102] 
Although earlier research has suggested that web based questionnaires may offer a lower 
response rate than mail based questionnaires, more recent studies have indicated this may no 
longer be the case. [103] It is reasonable to use web based questionnaires with employees that 
are IT literate and have access to the internet in their work; both criteria would be met by the 
staff at BCH and members of the NPPG indicating that a web based questionnaire was a 
reasonable choice. [103] 
2.2.6 Rationale for qualitative analysis method 
The analysis type for this qualitative study was thematic content analysis following the principles 
described by Braun and Clarke. This is the most common approach to qualitative analysis. [93] The 
main advantage of using thematic analysis is that it is not tied to one particular theoretical 
framework. [100] It is therefore flexible to the data available and does not require detailed 
technical knowledge and as such is a practicable choice of analysis. The disadvantage of this 
technique is that context can be lost when categorising themes. [100] However, this can be 
avoided during the evaluation of themes stage of the analysis process. By evaluating the themes, 
the researcher will be able to see which themes are supported with data and if they reflect the 
meaning found in the data set.  
2.3 Experiences of pharmacy staff when moving from a paper based 
to an electronic medicines management system 
The aim of this study was to explore the opinions and experiences of pharmacy staff at 
Birmingham Children’s Hospital after they switched from using a paper based medicines 
management system to an electronic medicines management system. The study collected data 
on: advantages and disadvantages of each system; training for the electronic system; 
implementation of the electronic system and staff recommendations for improvements.  
2.3.1 Timing of the study 
The study was conducted as soon as practically possible after the implementation of the new 
electronic medicines management system. Delays in the ethics process meant the intended start 
of one month after the system roll out was not met. The questionnaire was intended to be 
disseminated to participants in January 2013. However, the questionnaire was subsequently 
available to participants from 4th April 2013 until 30th June 2013. Participants were told they could 
complete the questionnaire during working hours as the questionnaire was also a registered audit 
at the hospital. 
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2.3.2 Sample size 
The eligible population was pharmacy staff who had used both the old paper based medicines 
management system and the new electronic medicines management system. This totalled 54. The 
aim was to recruit 35 respondents to achieve a confidence interval of ± 10 and a 95% confidence 
level.  
2.3.3 Questionnaire design 
The questionnaire design was based on a discussion with two non-pharmacist staff members, one 
pharmacist and one pre-registration pharmacist; four participants in total. The participants were 
encouraged to draw the medicines management process as a flowchart both for paper based 
system and for the new electronic system. The participants were asked to label and describe the 
advantages and disadvantages for each process. Finally, they recorded the timeline as they 
remembered it for the training and implementation periods. This discussion was not audio 
recorded, but the flowcharts and timelines drawn by the participants were used to inform the 
questionnaire design.   
The software used for the questionnaire design and production was SNAP (version 10). This was 
chosen due to existing experience of using this programme in the pharmacy practice research 
office at Aston University and the availability of a licence for the researcher. The original intention 
was to have an electronic online questionnaire; however it proved too time consuming to arrange 
the setup of this with the necessary information technology teams within the university. The 
software was used to develop and print the questionnaires. A paper based format was 
determined to be manageable for this study. The first reason for this was the study population 
was small and the resulting data entry would be manageable. Secondly, using a paper 
questionnaire would ensure the participants could complete it without the need to access a 
computer. Thirdly, the pharmacy department was not required to share the email address data of 
its staff. To avoid unnecessary delays to the data collection in this study the choice was made to 
switch to paper. To prevent a participant completing more than one copy of the questionnaire an 
administrator ensured only one copy was received from each participant. 
See Appendix 2 for final version of the questionnaire.  
2.3.4 Pilot of questionnaire 
The questionnaire was piloted with one pharmacist and one non-pharmacist member of staff 
from the pharmacy department at Birmingham Children’s Hospital. Due to the small numbers of 
staff in the team at the study hospital further pilot participants were not selected so as not to 
impact on the potential sample number. The pilot helped determine the face validity of this study 
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as the researcher could be sure the questions were measuring the concept they were intended to 
measure. Comments from the pilot were positive and the participants stated the questionnaire 
was understandable to them and relevant to the systems being evaluated. Two additions were 
made to the questions about the perceived advantages/disadvantages of the systems. The 
disadvantages added were: pharmacists use Ascribe (pharmacy dispensing and medicines 
management software) less often so it takes them time to put the medications onto it and 
pharmacy technicians are able to resupply a medication for a repeat when it may have not been 
approved by the pharmacist.  
2.3.5 Distribution of the questionnaire 
The study was introduced to the pharmacy department at the regular departmental meeting for 
all staff and at the same meeting an initial distribution of the questionnaire was made to all 
eligible participants present by the researcher. Not all staff attended this meeting so this meeting 
was followed up with further introductions to the study and distributions of the questionnaire by 
the researcher at pharmacy technician and pharmacist meetings. Copies of the questionnaire 
were handed out personally to individual members of staff. Further distributions, email reminders 
and visits to the department were also made to encourage a higher response rate.  
Table 7: Timetable of reminders for medicines management questionnaire 
Date Activity 
04/04/2013 Questionnaire launched at pharmacy 
department meeting 
09/04/2013 Completed questionnaires collected and 
email reminder sent to pharmacy staff 
16/04/2013 Email reminder sent by pharmacy team 
leader to pharmacy staff. Completed 
questionnaires collected, verbal reminders 
provided to pharmacy staff 
18/04/2013 Attended pharmacists meeting to introduce 
the questionnaire and hand out to eligible 
pharmacists 
23/04/2013 Completed questionnaire collected and verbal 
reminders provided to pharmacy staff by 
researcher 
30/04/2013 Attended pharmacy technician meeting to 
introduce the questionnaire and hand out to 
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eligible pharmacy technicians by researcher 
08/05/2013 Email reminder sent to pharmacy staff. 
Completed questionnaires collected and 
verbal reminders provided to pharmacy staff 
by researcher 
13/05/2013 Completed questionnaires collected and 
verbal reminders provided to staff by 
researcher 
22/05/2013 Delivered further copies of questionnaire to 
pharmacy department and gave verbal 
reminders to pharmacy staff by researcher 
06/06/2013 Pharmacy team leader to chase non-
completers of study (audit is part of contract 
for NHS staff) via email and in person 
08/07/2013 New pharmacy audit lead sent email 
reminders to pharmacy staff 
 
2.4 Resource use during prescribing decisions by prescribers at 
Birmingham Children’s Hospital 
The aim of this study was to determine the usual practice of resource use during prescribing by 
prescribers at Birmingham Children’s Hospital. Resource use refers to the use of any source of 
information during the process of prescribing that aids the prescribing process. The study 
collected data on: prescriber details (profession, level of experience, frequency of prescribing 
habit); resource use (frequency, what resources, which resources are preferred) and availability of 
prescribing information for children. The chosen method for this study was an electronic 
questionnaire distributed to participants via email. The questionnaire provided both quantitative 
and qualitative data on current practice of resource use when prescribing.  
2.4.1 Sample size 
The number of prescribers at Birmingham Children’s Hospital at the time of the study was 423. 
That included: consultants, medical trainees and non-medical prescribers. Inclusion criterion for 
this study was that the individual was a prescriber at Birmingham Children’s Hospital NHS Trust. 
The aim was to have a sample of at least 202 respondents resulting in a confidence interval of ±5 
with a confidence level of 95%. 
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2.4.2 Timing of this study 
This study was launched at the end of 2013 when Birmingham Children’s Hospital was in the early 
stages of procuring an electronic prescribing system. At the time of the study the provider for the 
electronic prescribing system had not been confirmed. The predicted launch of electronic 
prescribing is now summer 2016 so it is anticipated that data from this study will inform the 
development of this system.  
2.4.3 Questionnaire design 
Design of the questionnaire was informed by the initial exploratory focus groups held early on in 
this research programme in addition to the available research literature. These were held with 
both medical and non-medical prescribers, who were the population to be targeted by this study. 
Therefore the selection of participants for the focus groups was adequate to inform the 
development of this study.  
The list of potential resources for inclusion in the questionnaire was drawn from the focus group 
discussions and the acquired knowledge of the researcher. The researcher acquired knowledge 
through prior work as a healthcare professional and being a member of the multidisciplinary team 
that was developing an electronic prescribing and decision support system at Birmingham 
Children’s Hospital. This information led to the development of questions on how often a 
resource is used when prescribing, which resources are used and how often a specific resource is 
used. The focus groups also discussed that there was a lack of paediatric advice in certain 
paediatric areas at the time of the study, for example, information regarding renal and hepatic 
doses. This prompted the researcher to ask the questionnaire respondents whether there was a 
lack of paediatric prescribing information in general as well as for specific clinical areas. 
Participants in the focus groups also commented that certain resources were easier to use than 
others for a variety of reasons. Consequently questions were developed to cover the reasons why 
resources would be considered useful or not.  
Originally it was intended to employ the Snap Surveys software (version 10) for the questionnaire 
design and distribution of the questionnaire. However, there were considerably difficulties getting 
the same version of the software available at both the university and hospital sites. This was a 
problem as the questionnaire was designed in Snap version 10 and this was incompatible with the 
earlier version of Snap software used in the hospital. The hospital did not want to have staff email 
addresses released to be used in the university’s version of Snap, but it was also unable to 
upgrade its version of Snap to be compatible with the questionnaire developed at the university. 
An agreement regarding the distribution of the questionnaire online and compatibility of Snap 
software at the two sites was not available in a timeframe that enabled the research programme 
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to continue at a reasonable pace. In order to launch the questionnaire in a timely manner another 
option was developed. The option chosen was the Survey Monkey Gold plan. This version of 
Survey Monkey had the necessary question and response designs needed for this study alongside 
advanced routing features. The Survey Monkey Gold Plan version also came with SPSS integration 
which would be valuable for the statistical analysis. Neither the university nor Birmingham 
Children’s Hospital raised any ethical concerns about the change of survey software.  
A copy of the questionnaire can be found in Appendix 3.   
2.4.4 Pilot of questionnaire 
The questionnaire was piloted by a group of medical and non-medical prescribers at Birmingham 
Children’s Hospital. There were six participants, two non-medical prescribers and four medical 
prescribers. Participants were asked to complete the questionnaire and comment on the ease of 
completion and clarity of the questionnaire. Participants in the pilot were also asked to time 
themselves completing the questionnaire so that the information sheet and email requests would 
contain accurate time commitments required from participants.  
Several small changes were made to the questionnaire as a result of the pilot study, but no major 
changes were required. This may be because a combined team of a doctor, pharmacist and non-
medical prescriber had provided pre-pilot comments on the face validity of the questionnaire. The 
non-medical prescriber pilot participants had fewer comments than the medical prescriber 
participants. The non-medical prescriber participants had “no real issues” with the questionnaire 
and found it to be “thought provoking”. Medical prescribers commented on the clarity and 
comprehensiveness of the questionnaire. One participant stated it was difficult to rank some 
areas of the questionnaire as they all were equally important, but no other participants 
mentioned this difficulty therefore the ranking questions were not altered. The instructions for 
the ranking questions differed slightly in the pilot to see if there was any preference for either 
style of questioning. One participant (who commented that English was not his/her first language) 
noted that the second set of instructions was clearer and easier to follow. For the final version of 
the questionnaire both ranking questions were altered to use the second set of instructions.  
Another participant commented that the questionnaire was useful for staff members to feel 
involved in the design of the new prescribing process for the hospital. This participant felt that if 
this was the case it could help ensure the resulting system was user friendly and it will facilitate 
the change process.  
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The pilot was also useful for determining how the questionnaire functioned on smaller screened 
devices such as smart phones. One participant reported that he had completed the questionnaire 
on his smart phone with no problems.  
2.4.5 Questionnaire distribution 
The researcher could not gain access to the email addresses of the prescribers at Birmingham 
Children’s Hospital so the questionnaire was distributed by a member of staff at the hospital 
instead of directly from the survey software. This improved the anonymity of the potential 
participants as the researcher did not have their email address at any point in the study. The 
questionnaire was hosted by Survey Monkey and a direct link to the questionnaire was sent to 
participants. The researcher and participants were blind copied into all emails sent by the hospital 
staff member. This enabled the researcher to confirm the email had been sent as requested 
without revealing the email addresses of the potential participants.  
The questionnaire email and two subsequent reminder emails were sent from the account of the 
Deputy Medical Director at the hospital who was a clinical supervisor on the research study. 
However, the researcher remained in charge of the timing of the reminders and tracking the 
number of respondents. For a reminder to be sent the researcher had to request this be done by 
the Deputy Medical Director, who would then send the required email out to participants. 
Without access to the participants email addresses there was no method for the researcher to 
track who had completed the questionnaire. Therefore targeted reminders to solely non-
respondents could not be sent and as such they went to all potential participants. Table 8 shows 
the timetable of emails sent to potential participants.  
Table 8: Timetable of reminders for prescriber resource use questionnaire 
Date Activity 
28/10/2013 Initial questionnaire email sent to consultants 
04/11/2013 Initial questionnaire email sent to trainees 
05/11/2013 Initial questionnaire email sent to non-
medical prescribers 
21/11/2013 Reminder email sent to trainees 
24/11/2013 Reminder email sent to consultants 
17/11/2013 Reminder email sent to non-medical 
prescribers 
20/12/2013 Reminder email sent to consultants 
14/01/2014 Reminder sent to trainees 
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2.5 Resource use during paediatric pharmacy services provision 
The aim of this study was to determine current practice of decision support resource use when 
providing clinical pharmacy services to paediatric patients. Pharmacy services were defined by the 
researcher as services provided by pharmacists working in a hospital environment. This could 
include, but was not limited to: supplying medication, clinically screening medication, answering 
medication queries and medication reviews. 
The study collected data on:  
 Pharmacist details (level of experience, frequency of paediatric pharmacy 
services);  
 resource use (frequency, what resources, which resources are preferred);  
 availability of prescribing information for children.  
The chosen method for this study was an electronic questionnaire distributed to participants via 
email. The questionnaire provided both quantitative and qualitative data on current practice of 
resource use when prescribing.  
2.5.1 Sample size 
The questionnaire was delivered to members of the Neonatal and Paediatric Pharmacists Group 
(NPPG) the UK’s leading group for paediatric pharmacists based on membership numbers. It was 
sent to 280 potential participants (i.e. all members with an email address). The aim was to have a 
sample size of 167 and therefore have a confidence interval of ±5 and a confidence level of 95%.  
2.5.2 Questionnaire design 
The questions of this questionnaire were designed to provide a direct comparison to the 
prescribers’ questionnaire run at Birmingham Children’s Hospital. Therefore the questions 
remained almost identical so this purpose could be met. The wording of the questions was 
amended to reflect the new audience. For example, instead of referring to prescribing or 
prescribers the questionnaire now refers to paediatric pharmacy services or pharmacists. The 
questionnaire continued to use Survey Monkey as the design tool and host.  
A copy of the questionnaire can be found in Appendix 4.   
2.5.3 Pilot 
This questionnaire was not piloted as it was the same questionnaire as conducted at the 
Birmingham Children’s Hospital prescribers’ questionnaire. There was no change in questions or 
profession completing the questionnaire so it was not deemed necessary to conduct a second 
pilot as there were pharmacist participants in the pilot of the initial study.  
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2.5.4 Questionnaire distribution 
The questionnaire was distributed by the NPPG via email using their database of contact details of 
members. Potential participants were asked to provide their membership number in the 
questionnaire so the researcher could validate all responses were legitimate. The researcher 
contacted the Secretary of the NPPG each time a reminder needed to be sent out. On sending of 
the reminders the researcher was copied into the email to confirm the reminder had been sent as 
requested. Reminders were sent to all potential participants as there was no method of 
determining who had completed the questionnaire as the researcher was not permitted to access 
the email addresses of the potential participants.  
Table 9: Timetable of reminders for NPPG questionnaire study 
Date Activity 
15/11/2013 Initial email regarding questionnaire sent to 
NPPG members 
06/12/2013 Reminder email sent to NPPG members 
09/01/2014 Reminder email sent to NPPG members 
 
2.6 Analysis of documents: support for prescribers: what is 
discussed at hospital board level? 
The aim of this study was to determine the extent and content of paediatric prescribing support 
discussions at board meetings of NHS paediatric hospitals. The chosen method for this study was 
qualitative analysis of documentary sources. The documentary sources to be analysed were 
publically available minutes and papers from board meetings of NHS Trusts. 
2.6.1 Sample size 
There are four independent paediatric NHS Trusts in the UK. To include other NHS Trusts that 
have paediatric hospitals within them was deemed inappropriate as it may not have been possible 
to tell if references in the minutes referred to the adult or paediatric site within that trust. 
Therefore only the four paediatric NHS Trusts were included in order that the researcher could be 
certain that any reference to improving prescribing were aimed at those prescribing for paediatric 
patients. 
2.6.2 Period of study 
The chosen period of study was three complete calendar years from January 2010 to December 
2012. This period of time was chosen as it was recognised that in recent years there has been an 
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increased focus on medication safety in hospitals and as such the minutes from this period should 
reflect this. A study period of three years was selected because it is recognised that in the NHS it 
can take many months for projects to be approved, make the transition to being live and for 
results to be reported back to the board.  
Initially a period of two years was selected but after preliminary examination of the data it was 
determined that an extra year of data was needed in order to fully represent current practice in 
the study data set. Previous experience of the researcher regarding NHS projects confirmed that it 
would be prudent to add another year to the study period.   
2.6.3 Ethical approval 
No ethical approval was required from the university for this study as the data used was available 
in the public domain.  
2.6.4 Data collection 
The data for this study was publically available. Therefore the researcher needed to download the 
required minutes from each of the study sites NHS Trust website or request the required minutes 
via the freedom of information request manager. A total of four freedom of information requests 
were made. Each request was made via email and all study sites supplied the required data via 
email. One freedom of information request was required for Birmingham Children’s Hospital 
because there were three board meetings that did not have papers available to download from 
the website. One freedom of information request was sent to Sheffield Children’s Hospital 
because due to broken links on their website a full data set could not be downloaded. One 
freedom of information request was sent to Great Ormond Street Hospital because there were 
ten sets of minutes that were not available on the website. One freedom of information request 
was sent to Alder Hey Children’s because the minutes for 2010 and 2011 were not available to 
download from their website. The average number of board meetings per year at each hospital 
was 10.  
2.6.5 Data entry 
Data for analysis was entered into NVivo (version 9). This piece of software was valuable in this 
study due to the large volumes of data that needed to be managed. It did not manage the large 
PDF documents that contained the board meeting minutes. Therefore data needed to be modified 
before importing it into NVivo. This resulted in cutting the minutes/papers documents into 
smaller files that the NVivo software could manage. As a significant proportion of each meeting’s 
documentation was dedicated to issues not related to prescribing, for example financial and 
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human resources reports, these sections were removed. Only sections related to prescribing 
support and medication safety were imported into NVivo.  
2.6.6 Data analysis 
The chosen method of analysis was applied thematic analysis. Please see section 2.2.4 to refer to 
the exact procedure followed.  
2.6.7 Rationale for method 
The analysis of documents is an established method in qualitative research and this method is a 
valuable way of exploring what is happening within an organisation. [93] It was more efficient to 
collect the minutes from prior board meetings rather than to observe current meetings or 
processes over a similar period of time. The organisations in this study have a far greater capacity 
for producing this data than an individual researcher so it was more efficient to make use of the 
data freely available. Public records, such as board meeting minutes, have been considered one 
way of indicating what is important to an organisation at that time. [93] Therefore the amount of 
data regarding paediatric prescribing support and prescribing errors may be indicative of the 
importance attached to these issues by each of the hospitals. Authenticity of the information is 
likely as these are public documents that are required to be an accurate reflection of the meeting. 
[94]  
2.7 Interviews with selected leaders in paediatric electronic 
prescribing 
The aim of this final study was to collect experiences and advice from the selected leaders in 
electronic prescribing and decision support. Data was collected on: advantages and disadvantages 
of electronic prescribing/decision support; future developments of electronic prescribing/decision 
support and advice for organisations yet to implement electronic prescribing. The chosen method 
for this study was semi-structured interviews.  
2.7.1 Sample size 
The experts in electronic prescribing needed to be identified. Prior knowledge indicated there 
were two hospitals that each had over ten years of electronic prescribing experience, which led to 
their selection as a source for participants. These hospitals also had experience of using electronic 
prescribing in paediatric populations. The participants selected were individuals who were leading 
the electronic prescribing programme at the hospital. Commercial awareness and company staff 
availability led to the selection of two UK based providers of electronic prescribing software, who 
were also leading suppliers of this technology. Further participants were selected from 
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independent UK paediatric NHS Trusts to explore the paediatric perspective in this research area. 
These participants were leading on the development of electronic prescribing within each 
hospital. Birmingham Children’s Hospital was excluded due current involvement in their electronic 
prescribing initiative. It was felt that this long term commitment of work on the electronic 
prescribing initiative may bias the reporting of data from this hospital, hence its exclusion from 
the study.  
Selection of a suitable participant from each location relied in part on the organisation and the 
judgement of the researcher. Ideally the hospital participants were part of the team leading the 
implementation or management of electronic prescribing so they have the necessary experiences 
to provide an overview of electronic prescribing at that hospital. The researcher did not have a 
choice of participant with the companies as they determined who would be available to 
participate in the study. The possible influences of participant selection on the findings are 
discussed in the analysis of the study in chapter 7.  
2.7.2 Ethical approval 
This study was approved by Aston University Ethics Board (#546, approved 24/10/2013). 
Gaining ethical approval for this study from the university was a particularly challenging process. 
There was a delay of several months between the initial approval subject to amendments and the 
approval of the amendments sent through. Interviews with companies were approved and could 
go ahead, but interviews with any NHS staff member would require the university ethics 
committee to see an approval from each trust involved in the study. This meant that individual 
approval had to be sought from each NHS trust and added to the university’s approval before the 
interview could take place. The ethics committee also determined that participants must be able 
to review and amend their transcript after the interview if they chose to. It was agreed that seven 
days was a suitable period of time for them to do this.  
2.7.3 Development of the interview guide 
The design of the interview guide was directed by the emerging themes from the earlier studies 
and current literature. The importance of implementation was noted in the literature and as such 
questions regarding the implementation process were asked. The primary focus of the two 
previous questionnaire studies had been the resources used to support prescribing decisions, so 
questions regarding prescribing support offered by the system in question were included in the 
interview guide. Much of the published research in this area describes improvements attributed 
to electronic prescribing (for example, legibility of prescriptions) or new areas of concern that 
have arisen as a consequence of electronic prescribing. Therefore both these topics were included 
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in the interview guide. During the initial focus group study participants were very optimistic about 
the functions that could be included in electronic prescribing systems in the future.  As a result of 
this, interviewees were asked to reflect on where their prescribing systems might be in five or ten 
years time. Finally, recent conferences such as “Electronic Prescribing in Hospitals: Moving 
Forward” contained case reports of advice from hospitals, but much of this data has not been 
published elsewhere. Therefore participants who had implemented electronic prescribing or were 
part way through the process were asked what advice they would give to hospitals that have yet 
to take this step. During the interview process the topic of training came up several times (it was 
also mentioned often in the “Electronic Prescribing in Hospitals: Moving Forward” conference) so 
this was added to the interview guide for the later interviews.  
Please refer to Appendix 5 for the interview guide. 
2.7.4 Data collection 
The majority of data was collected by audio recording the interviews at a location of the 
participant’s choice. These were largely at their places of work, but there was an interview held in 
a hotel’s meeting area at the request of the participant. Written informed consent was gained 
prior to commencing each interview and this was reconfirmed verbally also. Participants received 
an information sheet to read through before the interview and were told the topic of the 
interview was electronic prescribing and prescribing support. Participants had seven days to 
review their transcript (required by the university ethics board). Here there was a final 
confirmation of consent when the participant approved the transcript. One company was unable 
to provide a participant to complete the interview, but instead completed the interview via email. 
The audio recording device failed at one interview, so the transcript was created from the 
researcher’s notes.  
2.7.5 Data entry 
All audio files were transcribed by the researcher using Windows Media Player and Microsoft 
Word. This was a timely process with each hour of audio taking up to ten hours to transcribe. 
However, it did ensure that the researcher was familiar with the data set before beginning the 
analysis.  
2.7.6 Data analysis 
The chosen method of analysis was applied thematic analysis. Please see the previous table in 
section 2.2.9 to refer to the exact procedure followed.  
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2.7.7 Rationale for method 
Interviews were a suitable method for this aim as it is not possible to gain rich data on 
experiences and opinions using quantitative methods. The results were a valid record of the 
participants’ experiences and views. The quality of the data set gained has been improved 
through the use of purposive sampling. Purposive sampling is the selection of participants by the 
researcher to ensure a representative sample is participating; it is particularly useful when 
different perspectives are required from a limited population of experts. [99] Each participant was 
chosen for their prior experience in the research area or their knowledge in the more specialist 
field of paediatrics and electronic prescribing. The semi-structured interview allowed the 
researcher to provide focus on a wide ranging topic area.  
Disadvantages of the semi-structured interview method are that the results are unlikely to be 
reproducible. It is not likely that the participant will provide the same responses if the interview 
was repeated. It is also important to note that the responses from the participants are a narrative 
and therefore may not be indicative of what they actually do. [93, 94] 
Several techniques were actively employed in this study to improve the quality of the interview 
method. It is important that the interviewer has a good understanding of the language used by 
the participants. [93, 94] This was assured in this study as the researcher is a hospital pharmacist 
with a good understanding of the research area gained during the earlier years of the PhD 
programme. The location of the interview is also important and it is thought that it is best to 
conduct the interview in a place that the participant feels is ‘theirs’. [93] This advice was heeded 
in this study as participants were interviewed at their place of work or in one case a location of 
their choosing that was more convenient for them. Finally to encourage the participant to speak 
freely and provide complete answers to questions, the interviewer must be receptive. [93] This 
can be achieved by: not interrupting the participant; recognising the participants answers by 
nodding or saying “mm”; and finally when the participant finishes speaking leaving a slightly 
longer silence than usual to allow them to add any extra details if they choose to. [93] 
2.8 Use of software to support data collection and data analysis 
Use of software in these studies has ensured effective use of time by the researcher. A variety of 
software has been used to maximise the reliability and validity of the data collection and data 
analysis. The software that has proved to be valuable in this research is:  
 Survey Monkey (Gold survey package),  
 SNAP (version 10),  
 Microsoft Excel (2010),  
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 Microsoft Word (2010),  
 Adobe Reader (version XI),  
 SPSS (version 21),  
 NVivo (version 9),  
 Windows Media Player (Windows 7).  
Microsoft Word was useful for recording the transcriptions of the interviews and focus groups. It 
has also been useful for formatting qualitative question answers before copying them into NVivo 
for analysis.  
NVivo has enabled a systematic and thorough thematic analysis to be done more efficiently that if 
it had been done by hand. It is easier to view everything coded under a single code on a page 
together to ensure coding consistency. Viewing everything under one code on a computer also 
ensures everything under than code is seen by the researcher. This cannot be guaranteed if the 
analysis is completed by hand. Although there were some problems importing large PDF files into 
NVivo no further problems were experienced. It ensured there was a high level of rigour applied 
to all qualitative analysis throughout this PhD.  
The researcher completed a one day course at Aston University on using NVivo for qualitative 
analysis alongside a two day course at Oxford University on methods of qualitative analysis. 
Specific software training for SPSS was provided by Aston University. 
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3. Initial exploratory focus groups 
The purpose of this study was to explore the current practice of paediatric prescribers and 
pharmacists regarding resources used when making medicines related decisions for children. It 
also investigated attitudes towards systems such as electronic prescribing that have been 
designed to improve prescribing practice. Data were collected from four focus groups at 
Birmingham Children’s Hospital (BCH) in 2012. Details of the method can be found on page 32. 
The objectives were to: 
 Provide an insight into current paediatric prescribing practice 
 Explore attitudes towards systems designed to improve paediatric prescribing practice 
such as electronic prescribing 
 Inform the design of future studies regarding methods used to support medicines related 
decisions in paediatrics.  
3.1 Context of this study 
Alongside analysis of the current literature this study was required to develop the further studies 
presented in this thesis regarding supporting medicines related decisions in paediatrics. The four 
focus groups were conducted early in the research programme at BCH with both medical and 
non-medical prescribers. Prescribers with a range of experience participated, including non-
medical prescribers in training and consultants with over ten years of experience in paediatrics. 
The discussion points of the focus groups were designed using the available literature and prior 
hospital experience of the researcher. 
3.2 Results and discussion 
3.2.1 Resource use in paediatrics 
The use of various resources was the theme with the most data points in both the medical and 
non-medical prescribers focus groups (n=33 and n=30). Paediatric prescribers reported to use a 
range of resources to support their work. This included: BNFc, trust guidelines, Frank Shan (a 
specialist paediatric intensive care prescribing guide), local standard infusions card, pharmacy 
staff and other colleagues. Participants often used the BNFc and trust guidelines to support 
decisions regarding doses. However, information about other aspects of prescribing such as 
interactions and administration was less frequently referred to. There were no clear differences 
between the resources used by medical or non-medical prescribers.  
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3.2.2 Current difficulties with available paediatric resources 
Both medical and non-medical prescribers reported difficulties with the currently available 
paediatric prescribing resources (n=8 and n=15). Non-medical prescribers reported more 
difficulties than medical prescribers. Non-medical prescribers were more likely to refer to a lack of 
access to certain types of patient information. In particular, they had difficulty accessing patient 
information that was either held in the clinical notes or on the pharmacy dispensing system 
(Ascribe). In contrast, medical prescribers referred to a lack of specialist paediatric prescribing 
information within specialties such as liver or renal impairment. Non-medical prescribers also 
referred to a lack of specialist paediatric prescribing information, but less frequently than their 
medical peers did. Medical prescribers reported a frustration that they could not access the 
specialist pharmacists out of hours. 
“The pharmacists are a fantastic resource we use all the time but then at the weekend 
they’re not there, which I find quite bizarre.” 
3.2.3 Decision support expected in electronic prescribing for paediatrics 
Both medical and non-medical prescribers agreed that dosing support should be a key function in 
an electronic prescribing system for use in paediatrics. The participants expected a paediatric 
electronic prescribing system to be able to calculate doses using individual patient factors such as: 
weight, age and body surface area. This is in line with currently available functionality as reported 
by Stultz and Nahata. [4] Both medical and non-medical prescribers expected prescribing to be 
part of a wider electronic patient record that included test results and images. The reported 
reason for this was to minimise the time spent moving between electronic systems.  
“I want it to be interactive, particularly with results systems. So I don’t have to log out of 
that.” 
3.2.4 Current concerns and potential benefits regarding using electronic 
prescribing in paediatrics 
Both medical and non-medical prescribers could anticipate many potential benefits from the 
introduction of electronic prescribing (n=56 and n=36). One benefit identified, by both medical 
and non-medical prescribers, was the ability to be able to see from any location with access to the 
system if a patient had received the medication the participant had prescribed. A second benefit 
identified by both professional groups was that electronic prescribing systems had the potential 
to improve the speed and accuracy of supply of medicines to the patient.  
 “It will be safer and quicker once you’ve learnt to use it.”  
Non-medical prescribers also identified that easier access to the patient’s medical and drug 
history would be one of the most significant benefits to them. Improved access to patient history 
57 
 
would remove one of the difficulties non-medical prescribers reported having currently. Finally, a 
further benefit to non-medical prescribers, which was not reported by medical prescribers, was 
the ability to more easily monitor their own practice and to identify trends in their prescribing 
habits. Medical prescribers reported that it would be beneficial to be able to see a snapshot of a 
patient without having to find or be in the same location as the paper patient notes.  
However each focus group also had several concerns about using electronic prescribing (medics 
n=33, non-medical n=32). The majority of participant’s concerns focussed on the provision of 
suitable information technology infrastructure/hardware. All participants were concerned that 
the current infrastructure/hardware could not support an electronic prescribing system. 
Participants were concerned that there was not sufficient numbers of computers available in 
clinical areas and that IT support was too “relaxed”. The security of the IT system was discussed 
by both groups as an important issue that needed to be addressed without causing lengthy log on 
procedures and slow access.  
Non-IT related concerns focussed on staff training, the handling of alerts in an electronic system 
and testing the system to ensure it fitted with current workflows and practices.  
3.2.5 Alerts in clinical systems 
The non-medical prescribers focus groups had extensive discussions about the use of alerts in 
clinical systems (n=17). However medical prescribers were less focussed on this topic (n=6). Both 
professions of participants agreed that the same alerts should be displayed to the prescriber 
regardless of experience or specialist clinical area. Each group discussed the optimum way that 
healthcare professionals would be expected to interact with alerts. Some participants reported 
that if you were to override an alert then you should be expected to comment as to why you took 
that action. In line with current literature that has stated the alerts could be presented according 
to their severity, participants agreed that alerts should be triaged. Each type of alert should then 
require a different response from the user depending on its level of severity. [104, 105]   
3.3 Impact on study development 
These focus groups alongside the existing literature provided valuable information regarding the 
development of the studies in this research programme.  
The focus groups provided initial data on the resources currently used to support paediatric 
prescribing. The resources referred to above, along with the information in the introduction and 
the researcher’s prior knowledge were used to populate the questions on resources put to 
respondents at BCH and from the NPPG.  
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Information was provided on current prescribing practice. This suggested that information such as 
type of healthcare professional, years of prescribing experience and frequency of prescribing may 
influence the way in which healthcare professionals use resources to support prescribing in 
paediatrics.  
The discussions regarding alerts demonstrated that the accuracy and relevance of these alerts 
was important to the participants of the focus groups. In order to produce alerts in a clinical 
system that are accurate and relevant to the user the system developers first need to understand 
the information that they value. Therefore further questions on the type of information used by 
prescribers and pharmacists were included in the questionnaires.  
The references to a lack of available literature in these focus groups supported some information 
reported in the previous literature that current resources may not be adequate to support 
prescribing in paediatrics. This prompted the researcher to include questions to pharmacists and 
prescribers to determine if they thought there was a lack of paediatric prescribing information; if 
so what information was lacking and did this lack of information have an effect on patient care.  
Pharmacists and pharmacy systems were referred to in all focus groups as an important source of 
information and support when prescribing for children. Pharmacists were valued for their 
specialist knowledge and their interpretation of specialist paediatric prescribing information. As 
pharmacists would also be a key user of an electronic prescribing system it was also important to 
determine what their resource needs were. Hence a study with a pharmacist population was also 
conducted. In addition, pharmacy electronic systems were referred to as a useful source of 
information. As pharmacy systems are used to record and manage the supply of medicines, a vital 
part of the medicine process in hospitals, a study detailing how the supply of medicines can be 
managed electronically was also conducted.  
Throughout the focus groups there were references to other interventions designed to support 
paediatric prescribing. For example: paediatric prescriptions for infusion card. These references in 
combination with the variety of interventions reported in the literature formed the basis of the 
study on the paediatric prescribing improvement initiatives reported by paediatric hospitals in 
England.  
A large proportion of the discussion within the focus groups was based around the potential 
benefits and concerns of electronic prescribing in paediatrics. The current literature in this area is 
largely derived from studies based in the USA, where the healthcare system is set up differently to 
the UK.  Therefore benefits and disadvantages of electronic prescribing, alongside 
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recommendations from experienced users, were prioritised as key interview topics with selected 
leaders and/or experts in electronic prescribing.  
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4. Electronic Medicines Management 
The purpose of this study was to explore staff experiences of the implementation, training and 
functionality of a new electronic medicines management system that was introduced in the 
Pharmacy Department at Birmingham Children’s Hospital (BCH) in 2012. Data was collected using 
a retrospective self-completed questionnaire by Pharmacy Department staff at BCH. Details of the 
method can be found on page 34. The objectives were to:  
 identify attitudes to change before and after the introduction of electronic medicines 
management 
 assess satisfaction with training for electronic medicines management 
 assess satisfaction with the implementation process for electronic medicines 
management 
 identify advantages and disadvantages, according to pharmacy staff, of paper and 
electronic medicines management systems 
 identify pharmacy staff opinions on how to improve the electronic medicines 
management system. 
4.1 Context of this study 
Prior to the introduction of the electronic medicines management system, Birmingham Children’s 
Hospital operated a paper based system for the medicines management process run by the 
Pharmacy Department. This system was only used by pharmacy staff. During this process 
pharmacy technicians would visit the wards to assess each patient’s drug history; whether they 
had brought their own medication onto the wards (patient’s own drugs – PODs) and whether any 
medication needed to be supplied from pharmacy. The pharmacy technician would also create or 
update the patient profile on the pharmacy dispensing computer system (Ascribe). The paper 
system involved the pharmacy technicians leaving handwritten notes for the relevant ward 
pharmacist regarding any apparent discrepancies with the patient’s medication or other queries 
relating to the supply of medication. The pharmacy technician would complete paper order forms 
for medicines that were not stocked on the wards and then take these orders down to the 
dispensary for dispensing when he/she had completed their ward visit. After each order had been 
approved by the pharmacist it could then be supplied to the ward. The paper medicines 
management process was used across all 15 wards in the hospital.  
The electronic medicines management system implemented to pharmacy staff only was an 
extension of the existing pharmacy dispensing computer system – Ascribe. Several iterations of 
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the electronic medicines management system were tried in conjunction with software developers 
at Ascribe and the multidisciplinary operational group of pharmacy staff, starting in June 2012, 
before an agreement was made that it was suitable to be used for inpatient medication supply in 
January 2013. The new electronic medicines management functions of Ascribe allowed the 
pharmacy staff to record medication histories electronically and order inpatient medication 
electronically. At the same time, all outpatient medication was supplied by a separate newly 
opened outpatient pharmacy. The intended launch of the survey instrument for this study was 
one month after the roll out was completed. However this target was not met due to a delay in 
receipt of ethical approval and the launch of the survey instrument was commenced in April 2013. 
This was three months after the final iteration of the system was confirmed at the end of January 
2013.  
During the implementation pharmacy managers reported that training was offered to all staff. A 
variety of training opportunities were available that pharmacy staff were required to ‘self-sign up’ 
to. These included group training sessions for both staff groups (pharmacist and non-pharmacist) 
and one to one training. A multidisciplinary operation group was in place throughout the process 
to enable staff to participate and engage in the plans for development and implementation of the 
electronic medicines management system. Each ward pharmacist chose when their ward would 
go live. A list of wards using the electronic medicines management system was also put on display 
in the dispensary and a guideline was provided.  
The survey instrument had five main topics. These were:  
 satisfaction with the training provided for the electronic medicines management system;  
 satisfaction with the implementation process of electronic medicines management 
 attitude towards change;  
 advantages and disadvantages of both systems; 
 recommendations for future improvements.  
4.2 Results  
 
4.2.1 Response rate 
The combined response rate was 48% (n=26/54). The response rate for pharmacists was 56% 
(n=14/25). The response rate for non-pharmacist staff was 41% (n=12/29).  
62 
 
4.2.2 Respondent characteristics 
All respondents reported that they were aware of the change from paper based to electronic 
medicines management. All respondents were either pharmacists or non-pharmacist members of 
the Pharmacy Department team at the study site. Non-pharmacist members were: pharmacy 
technicians, student pharmacy technicians or dispensers. 14 respondents identified themselves as 
pharmacists. 12 respondents identified themselves as non-pharmacist members of pharmacy 
staff.  
Respondents were asked to record the number of years/months they had worked at Birmingham 
Children’s Hospital. Two respondents (one pharmacist and one non-pharmacist) did not provide a 
clear answer to this question as there was no unit of time alongside their response. The range of 
time worked at BCH was 2 years to 27 years. The median and the mode were both 7 years. The 
mean was 9.5 years. There was no significant difference between the experience of pharmacists 
compared with non-pharmacist staff (Mann Whitney U test, z value -1.026 and p value 0.108).  
4.2.3 Attitude towards change 
Participants were asked to record their attitude towards change both before the introduction of 
electronic medicines management and after the introduction of medicines management.  
Figure 1: attitudes towards change of pharmacists and non-pharmacists before the 
introduction of electronic medicines management. 
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Figure 1 shows that before the introduction of electronic medicines management the majority of 
respondents had a neutral attitude to change. There was no apparent difference between 
attitudes of pharmacist or non-pharmacist staff.   
Figure 2: attitudes of pharmacists and non-pharmacists towards change after the 
introduction of electronic medicines management 
 
Figure 2 shows the attitudes of respondents to change after the introduction of electronic 
medicines management.  
The Wilcoxon Signed Rank Test was performed to compare statistically the attitude before and 
after the introduction of electronic medicines management.  The z value was -2.546 (p = 0.011). 
The r value (effect size) was 0.3 indicating a medium sized effect. This is a statistically significant 
result (when p = <0.05) that indicates the attitude to change after the implementation of 
electronic management is significantly different to the attitude before implementation.  
There was no significant difference between the attitude to change of pharmacist compared with 
non-pharmacist respondents before and after the introduction of electronic medicines 
management (Mann Whitney U Test, p values 0.300 before and 0.305 after).   
4.2.4 Satisfaction with training 
Respondents were asked to rate their satisfaction with electronic medicines management training 
using a five point scale from very satisfied to very dissatisfied. Results are shown in Figure 3.  
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Figure 3: the satisfaction of pharmacists and non-pharmacists with electronic 
medicines management training 
 
 
 
There was no statistical difference between pharmacists and non-pharmacists concerning their 
satisfaction with electronic medicines management training (Mann Whitney U, z value -1.784, p 
value 0.074). 10 of the 12 non-pharmacist respondents were either neutral or satisfied with 
training, with 2 reporting to have been dissatisfied. 6 of the 14 pharmacist respondents reported 
to have been dissatisfied or very dissatisfied with training and 8 reported to have been neutral or 
satisfied.  
4.2.5 Satisfaction with implementation 
Respondents were asked to rate their satisfaction with electronic medicines management 
implementation using a five point scale from very satisfied to very dissatisfied. The results are 
described in Table 10 below. 
Table 10: Satisfaction with electronic medicines management implementation 
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Dissatisfied 12 
Neither  6 
0
1
2
3
4
5
6
7
Very dissatisfied Dissatisfied Neutral Satisfied Very satisfied
N
u
m
b
e
r 
o
f 
p
ar
ti
ci
p
an
ts
 
Level of satisfaction 
Pharmacists Non-pharmacists
65 
 
Satisfied  6 
Total 26 
 
The majority of respondents (14/26) were dissatisfied with the implementation of electronic 
medicines management (see Figure 4).  
Figure 4: the satisfaction of pharmacists and non-pharmacists with the 
implementation of electronic medicines management  
 
  
There was no statistical difference between the satisfaction of pharmacists and non-pharmacists 
with the implementation of electronic medicines management (Mann Whitney U, z value -1.811, 
p value of 0.070).  
4.2.6 Thematic analysis of open ended questions 
Eight open ended questions were asked in the survey instrument; these are represented by an 
italic font in each section. This section of the chapter describes the themes developed from using 
applied thematic analysis. The themes are sections 3.2.6.1 to 3.2.6.5 below. 
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4.2.6.1 Training needs to be structured and coordinated with implementation 
This theme was supported by responses from the questions: Please describe how you prepared for 
the change to eMedMan; Please describe how you feel the training could have been improved. 
Just half of the respondents (n=13) stated they had attended a training session in preparation for 
the implementation of electronic medicines management. There was a variety of experiences 
described in relation to training undertaken; suggesting that not everyone attended a training 
session with the same “eMedMan champion” (a member of pharmacy staff who had the role of 
championing the new system or being involved in a pilot or providing training).  
 13 respondents stated they attended a training session. 
 Three respondents stated they did not receive training. 
 Three respondents were ‘eMedMan champions’ who provided training. 
 One respondent stated they received  “training by eMedMan designated champion” 
 One responded reported “I had no ward based training at all”.  
 One respondent described their training experience as “…observing someone for 5 
minutes then working along and asking questions when needed”  
 One respondent described their training experience as “looked at templates on Ascribe”.  
 One respondent who had attended a training session described the training provided as 
“brief” 
 One respondent described their training as “half an hour… that was all”  
 One respondent referred to the training session as a “demo”.  
The most frequent complaint about training referred to the timing of the training in relation to 
the implementation of the electronic medicines management system (n=16). Examples regarding 
overall planning included:  “I think training could have been planned and improved” and 
“…allocated time dedicated to practical training instead of just fitting it in”. Regarding the timing 
of the training; comments included “implementation of a training schedule earlier” and training 
provided in advance”. The result of the training schedule provided at BCH was that respondents 
felt they should have been “given more time to know what to do” and that “everybody needed to 
be fully prepared before going live”. These comments and the low number of positive comments 
(n=2) regarding the training provided suggest that not everyone considered themselves 
appropriately trained before the roll out began.  
Two respondents recommended that training needed to be more structured and that competency 
should be signed off to formalise the training. “More structured, formalised and standardised so 
everyone had the same level of training”. Comments such as “more trainers to disseminate 
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training” and “more trainers to go to for help” indicated the need for further use of trainers.  
Although some described their own self-motivated training plans (for example, speaking with 
dispensary staff who had used the system) as satisfactory one respondent was not happy that 
he/she had not been able to attend an ‘official’ training session as they were on annual leave for 
their allocated session.  
The overall subject emerging was that training should have been of better quality and better 
timed so respondents were ready to use the system before it went live at Birmingham Children’s 
Hospital.  
4.2.6.2 Project status and changes need to be clearly communicated 
This theme is supported by answers from the following questions: Please describe your experiences 
during the changeover process: what do you think went well or less well during the changeover 
process? Please describe what do you feel could have been done to improve the implementation of 
the eMedMan system.  
In this study staff were confused as to which wards were using electronic medicines management 
and which were using the old paper based system. Individual respondents commented that the 
implementation should have had “less ambiguity” and there was “confusion which wards were 
fully eMedMan”. One respondent stated that it “was confusing on when to use it [electronic 
medicines management] and when not to” and another respondent commented they had 
received “confusing and conflicting advice”. Respondents intimated that they needed to know 
which wards were using the new system and when wards were moving to the new system. 
From the description of the implementation process it can be seen that many changes or issues 
were raised and these would have required clear and accessible communications to all staff using 
the system. Respondents felt the processes for use of the new system needed to be “well defined 
and clear” and “uniform” accompanied by “SOPs” or “clear guidelines”. It could be suggested that 
had this taken place during this implementation staff may have found it easier to understand 
when to use the new system and when to continue with the paper based system. Suggestions for 
improving the implementation process included the development of SOPs before the system goes 
live that have been tested and are therefore usable in practice. The SOPs available during the 
implementation of electronic medicines management “weren’t fit for purpose” according to one 
respondent and needed to have been “checked and validated before distribution” by another. 
The overall theme was that the development of the project and stages of implementation needed 
to be clearly communicated to staff and supported by SOPs at Birmingham Children’s Hospital. 
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4.2.6.3 Staff involvement or input is require at all stages of the project 
This theme is supported by answers from the following questions: Please describe your experiences 
during the changeover process: what do you think went well or less well during the changeover 
process? Please describe what do you feel could have been done to improve the implementation of 
the eMedMan system.  
Five respondents felt that end users and staff expertise were not as involved in the project 
development and roll out as they should have been. Comments from individual respondents 
included: “involve practitioners in the development of the system”; “engagement with staff in the 
implementation stage and before”, include “input from staff who work in clinical areas” and “ask 
for input from staff”. 
Respondents wanted those who would be using the system to have had more input into its design 
so the end result would have been more suitable for purpose. Respondents’ comments suggested 
that the changes to workload and workflow had not been anticipated by the development team, 
but respondents suggested these could have been had the development team sought further 
input from the potential users of the electronic system. “Staff were not asked about the 
practicalities or how it could be done”.  
The overall view was that had staff been more involved from the beginning of the process 
electronic medicines management at Birmingham Children’s Hospital would have been more 
successful and a better fit for purpose.  
4.2.6.4 System compatibility with current practice needs to be carefully considered 
This theme is supported by answers from the following questions: Please describe any further 
advantages or disadvantages of eMedMan that are not mentioned above. Please list any 
improvements that could be made to the eMedMan system. 
Many comments from the respondents stated that the system was not suitable for use for its 
intended tasks (n=5), particularly for ‘to take out’ (TTOs – prescriptions issued on discharge) or 
outpatient prescriptions. Staff were frustrated that the new system was more time consuming 
than the old system (n=4) and did not have the necessary drug templates built into it (n=4). Drug 
templates are forms that enable pharmacy staff to record the drug and full details of its 
prescription. For example: a drug template would contain boxes in which the dose, frequency, 
route and other relevant information regarding its prescription to be recorded. It also required 
extra effort as checks on both the paper copy and electronic copy needed to be made for TTOs 
and outpatient prescriptions: “The dispensing and checking process was longer for TTOs”. 
Respondents described the new system as “time consuming” on a number of occasions for a 
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variety of tasks. There were more comments about the lack of suitability of the system for TTOs 
than for other types of supplies made by the pharmacy. “TTO supplies using eMedMan did not 
work very well”.  Although the TTOs were being done on the electronic system staff reported that 
paper copies of TTOs were also received which “seemed long winded”.  
General negative comments regarding the suitability of the system were recorded such as: “lots of 
issues with the software” and “poor design of the system”. The main issue with the new 
medicines management system was with regard to the templates built into the system. Templates 
were a feature that existed in Ascribe prior to the use of the electronic medicines management 
module. Drug templates were prefilled items that described the usual route, frequency, dose of 
the drug. The overall use of the electronic system could have been made more time consuming by 
the lack of suitable templates, but this was a problem that existed prior to this change. Comments 
such as “templates were a big issue as many unfit for purpose” and “templates are a mess” 
indicated the lack of suitable templates in the electronic medicines management module on 
Ascribe. Templates were also described as “frustrating”. Templates were an important part of the 
new electronic medicines management system as they ensured all necessary information about a 
drug was recorded to enable it be supplied accurately from the pharmacy.  
Other comments on the suitability of the system related to “input errors” which were described 
as “dangerous”. During the roll out the old paper system continued to be used on wards until they 
were switched over to the new electronic medicines management system. This meant two 
processes for medicines management were running concurrently. The combined system of paper 
and electronic systems for TTOs and outpatient prescriptions “didn’t add anything”. The running 
of the two systems alongside each other was described as “awkward” and “…introduced extra 
risk”.  
Finally, some comments were raised regarding clinical screening on the new system. It was noted 
that pharmacists spent more time inputting information onto the electronic medicines 
management system (Ascribe) which left them with less time for clinical checking. There was also 
confusion over when the medication needed to be ‘rescreened’(i.e. checked to ensure the 
medication remained suitable) by the pharmacist. In addition, one respondent was worried that 
medication could be dispensed without being clinically screened by the pharmacist. There was 
also a comment that inputting data onto Ascribe is a skill, and input errors would decrease as level 
of skill increased.   
The prevalent theme was that the new system was not fit for purpose for medicines management 
processes for outpatient or TTO medication and further adjustments needed to be made to 
ensure it was less time consuming and as usable as the previous paper system at Birmingham 
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Children’s Hospital. The new system was described as suitable for use for managing inpatient 
medication.  
4.2.6.5 Electronic medicines management in its current format is suitable for inpatient 
supplies of medication 
This theme is supported by answers from the following question: Please describe any further 
advantages or disadvantages of eMedMan that are not mentioned above.  
Three individuals commented that the benefit of the electronic medicines management system 
was its suitability for inpatient medication supplies and the improvement it had made to speed of 
dispensing of inpatient medication supplies. The reasons the inpatient supply worked well 
included: “no paper requisitions were needed”, “I could order things on the ward which were sent 
straight away to disp (dispensary)”, “ ward orders were started more quickly in disp (dispensary)”, 
medication orders were “received quicker”, “turnaround for inpatient items quicker” and the 
Pharmacy Department “can keep an accurate record of meds”. The supply of inpatient items using 
electronic medicines management was purely electronic and as such the orders could be sent to 
the dispensary instantly where the dispensing process could begin as soon as the order was 
received. This was a notable improvement when compared to the paper system as pharmacy 
technicians or pharmacists may not have brought the orders down to dispensary until they had 
finished their ward round previously.  
In summary, electronic medicines management enabled faster, and accurately recorded, supply of 
inpatient medication to the wards at Birmingham Children’s Hospital.  
4.2.6.6  Final comments from respondents 
Question asked: please provide any final comments you have or experiences you’d like to share 
about the paper based or eMedMan systems you feel are important or have not been covered in 
the questionnaire.  
The respondents were invited to provide any final comments on the electronic medicines 
management process that they felt may have not been covered by previous questions. The 
comments referred to two respondents’ reservations regarding relying on electronic systems: 
“cannot be completely paperless – this can be dangerous as important errors such as inputting 
the drug can have disastrous consequences” and “when Ascribe fails the whole dispensing system 
fails”. These two comments have been highlighted as they indicated an element of concern 
regarding the safety of the new medicines management system and raised the question that 
some staff may not believe that electronic systems are suitable in general.  
71 
 
4.3 Discussion  
Prior to the introduction of electronic medicines management (as an extension of the pharmacy 
dispensing software Ascribe) the process of the paper system was well established and 
understood by members of the pharmacy team and other healthcare professionals at the 
hospital. However, there was a need to upgrade to a more efficient system as several 
disadvantages of the paper system had been identified. Information recorded on pieces of paper 
as communications between the pharmacy technician and the pharmacist could get lost meaning 
that important information may not be available to the pharmacist. The paper medication orders 
for the ward could also get lost resulting in a failure to supply the medication to the ward. Finally, 
delays to medication supply could occur as the paper medication orders were all submitted when 
the pharmacy technician returned to the pharmacy.   
In order to solve the issues that had been identified in the paper system an electronic medicines 
management system was proposed. This is in line with the paperless NHS target to be met by 
2018. [106] At the end of May 2012 the electronic medicines management module was added 
onto Ascribe and was ready to be used. Prior to this staff had been added to the Ascribe system 
so they would be able to use it once the electronic medicines management process was live. The 
roll out of electronic medicines management started on the 5th June 2012 and ward pharmacists 
chose when their ward would go live with the new system. A list of wards using the new system 
was displayed in the dispensary and a printed guideline describing how to use the system was 
available. 
After roll out started the electronic medicines management system continued to be fine-tuned 
and improved. The week after the roll out an electronic support box for pharmacists was added 
where they could email the electronic medicines management team with any problems. Further 
changes were also made through June to December 2012. In December 2012 the use of the new 
system was paused and a discussion document was developed to review the suitability of the 
electronic medicines management system for future use. This was reviewed at the end of January 
2013 when it was decided than the electronic medicines management system would be used 
solely for inpatient medication orders. In January 2013 a new outpatient pharmacy opened at 
Birmingham Children’s Hospital and took responsibility for all outpatient prescriptions. This study 
took place in April 2013 when electronic medicines management was used for inpatient 
medication orders only.  
An important finding from this study was that respondents reported a more positive attitude to 
change after changing to electronic medicines management compared to their attitude before the 
change to electronic medicines management. The shift to a more positive attitude to change 
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occurred despite the reported dissatisfaction with the implementation and training provided for 
electronic medicines management. It was not possible to confirm using the data from this study 
that the implementation of electronic medicines management was the causative factor in the 
shift in attitude to change. However, some potential explanations for this result could be drawn 
from the responses provided in the free text answers. Respondents recognised that electronic 
medicines management was beneficial in its current form for inpatient medication orders. It had 
allowed the medication orders to be processed more quickly as they were sent to the dispensary 
electronically. This in turn meant that the medication was available to the patient on the ward in a 
shorter period of time. Respondents also recognised that it was easier to find details of previous 
medication supplies on the electronic system and it removed the need to transcribe from the 
paper medication order onto Ascribe. These benefits could imply that staff felt this change was 
the right choice and therefore may have impacted their attitude to change. In this study the new 
medicines management system has allowed staff time to be better used in terms of inpatient 
medication ordering. For inpatients the new electronic medicines management system appears to 
follow the NICE recommendation that one purpose of medicines reconciliation is to  
“Improve the efficiency of a service, making the best use of staff skills and time.” [88] 
The difference in satisfaction of pharmacist and non-pharmacist staff with electronic medicines 
management implementation was not significant. However, the satisfaction with implementation 
had the possibility of being different as the pharmacist and non-pharmacist staff used the 
electronic medicines management system for different purposes. Pharmacists were using the 
system to record and complete clinical checks of medication and record the patient’s medication 
history. The non-pharmacist staff were using the system to dispense medication; record patient 
medication histories and place orders for medication. Comments from both pharmacists and non-
pharmacists referred positively to the inpatient medication processes as the electronic medicines 
management system enabled medication orders to be dispensed quicker and ensured all 
instructions were legible to the dispensary staff. Non-pharmacist staff complete the majority of 
dispensing at Birmingham Children’s Hospital. The dispensing process was one area where 
respondents identified an improvement in medication supply processes; therefore it could be that 
staff responsible for dispensing (non-pharmacist) are more likely to be satisfied with the new 
system. However, the small size of this study may have prevented statistical significance being 
identified. There were several negative comments made regarding the clinical screening process 
on the new electronic system by both pharmacist and non-pharmacist respondents. Clinical 
screening is only carried out by pharmacists. Respondents were concerned about the length that 
a clinical screen was valid for and the risk that a medication could be re-dispensed when the 
pharmacist hasn’t approved a second supply. In summary, respondents identified that an area of 
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non-pharmacist work had seen an improvement (supply of inpatient medication) whereas an area 
of pharmacist work (clinical screening) had been highlighted as an area of concern within the 
electronic medicines management system.  
The difference in satisfaction of pharmacist and non-pharmacist staff with electronic medicines 
management training was not significant. The responses in the free text answers provided some 
anecdotal evidence for this. There were five negative comments regarding the training provided; 
four of these comments came from pharmacist respondents. Prior to the introduction of 
electronic medicines management pharmacists would have used Ascribe less frequently than non-
pharmacist staff as they would only have used it for recording medication histories and 
occasionally for dispensing medication. In contrast, non-pharmacist staff would have used it 
frequently for dispensing medication and recording medication histories. This difference in duties 
could have meant that pharmacists and non-pharmacists had different levels of familiarity and 
skills with the Ascribe software. Hence, it may have meant that pharmacists required different 
training in order to be able to use the electronic medicines management module effectively. 
Different training sessions were provided for the different staff groups, but if the pharmacist 
training sessions did not meet the needs of the pharmacists, this might partially explain why the 
pharmacists reported more negative comments regarding training.   
Respondents reported a variety of experiences of the training process, despite all staff being 
offered the same training opportunity. This may be partially explained by eMedMan champions 
providing group and one-to-one training options. In one case training was not available to a 
respondent as the session offered was when the respondent was on annual leave and an 
alternative was not believed to have been available. Some respondents also reported training ‘on 
the job’ rather than attending a training session led by an electronic medicines management 
champion. This training type could refer to the one to one training reported to have been offered 
to pharmacy staff. Despite these differences, some respondents did identify the presence of 
electronic medicines management champions and were satisfied with the training provided. 
Education for a new system is one feature that is thought to be important in the success of clinical 
system implementation, so this is an area could be developed for future system implementations. 
[107] Appropriate training of staff conducting medicines reconciliation, in this study the pharmacy 
staff, is also advised by NICE. [88] 
The pharmacy at Royal Cornwall Hospitals Trust has been referred to in an article with regard to 
its electronic medicines management processes on JAC (a pharmacy management software 
system that can be used for dispensing, electronic prescribing etc). [108] The benefits of their 
system were that it demonstrated the workload of the ward pharmacy technician and it 
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highlighted the areas where pharmacist services were to be targeted. [108] It is not clear whether 
the system at Birmingham Children’s Hospital could be used to identify the same. This raises the 
question whether electronic tools should record information that captures the contributions of 
the pharmacy team to patient care. Royal Cornwall Hospitals reported that a key point regarding 
electronic medicines management is the electronic tool should not be “a burden to complete” 
and should fit into normal working patterns. [108] At the time of the study Birmingham Children’s 
Hospital is not meeting this ideal as respondents reported that the new system took longer to use 
than the previous system and the drug templates on the system were not fit for purpose. 
However, the drug templates were part of the system that was in use prior to the extension to 
electronic medicines management. This suggests that this was not a new problem generated by 
the extended use of Ascribe. Unsuitable drug templates made it more difficult for the details of a 
patient’s medication to be recorded compared to the paper based system as there was not an 
appropriate space available to record some drug information. Respondents identified improved 
drug templates could be developed further to ensure the system fits pharmacy working patterns 
in the future. Recording relevant information is an important function of a medicines 
management system. [88] 
Recommendations from previous studies on the successful implementation of clinical systems 
state the importance of end users in the development process. [107, 109] This study further 
highlights the importance of engaging staff when developing and implementing clinical pharmacy 
systems as respondents commented staff should have been more involved in the development 
stages. This study also highlights that individual engagement of pharmacists with new electronic 
systems can be challenging; particularly when the pharmacist believes that the new system may 
take time away from patient care. However, this attitude is in contrast to that expected from the 
NICE guideline on medicines optimisation that highlights the importance of accurate record 
keeping of medication information. [88] The comments of the respondents reflected previous 
studies that suggest the system would have been more successful had they been able to influence 
its development more and ensure the new system fitted in with their usual working patterns. 
Another feature reported to affect the success of a system’s implementation is responding to 
ideas for enhancement. [107] Again, this is an area where respondents in this study were not 
satisfied as they did not feel their ideas or issues were always responded to appropriately.  
4.4 Limitations 
The greatest limitation of this study was its size, influenced by the choice of study site and the 
response rate. The small site meant the amount of data that could be collected was limited and 
the quality of the data relied on obtaining a very high response rate. The choice of site could not 
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have been different as Birmingham Children’s Hospital was the only site available to the 
researcher where it was known that the change process from paper to electronic medicines 
management could be evaluated. Access to research at this site was practicable for the researcher 
as an honorary contract was in place to facilitate research in conjunction with Birmingham 
Children’s Hospital. The study was also registered as an audit at Birmingham Children’s Hospital 
and as research is part of the normal NHS staff contract it was anticipated that response rates for 
this audit would match the high response rates (over 90%) for audits conducted in the pharmacy 
department previously. Unfortunately this was not the case. The study was introduced to staff at 
several meetings to ensure all staff received a personal invitation to complete the study. There 
were also email reminders and visits to the department to increase participation and inform 
people about the purpose of the study to further encourage staff to contribute. Pharmacy staff 
were informed that they could complete the study during work hours or in their own time. On 
reflection it is difficult to see what further strategies could have been employed to gain a higher 
response rate. Because of the lower than anticipated response rate (48%) the findings may not 
accurately reflect the view of all staff of the electronic medicines management process. Non-
respondents were not followed up as there was no method available to do so due to the paper 
process involved.  
Another limiting factor was the timing of the study. The unforeseen delays in ethical approval 
meant the study could not be launched until several months after the electronic medicines 
management process had been in place. The intention was that the study would be conducted 
after the roll out had been completed and initial issues or changes had been managed in order to 
ensure respondents had these processes fresh in their memory. Ideally the study would have 
been co-ordinated with the roll out so each staff member completed the questionnaire after using 
the new system for the same period of time. The delay of the study could mean that respondents 
are no longer able to recall the details of the changeover process or their training. This is an 
important limitation. The delay in launching the survey may also have affected the likelihood that 
respondents provided socially desirable results due to the pressure of already having to use the 
system and not wanting to appear difficult to managers when the results were collected.  
Finally, there was a set of questions that required the advantages and disadvantages of each 
system to be ranked. These were not completed correctly in the study, but there were no 
problems detected with these questions in the pilot. This is a disadvantage of the paper based 
survey method. Respondents in the study either did not rank the ideas listed or gave more than 
one idea the same rank. Therefore it was not possible to fully analyse these questions. . The 
results from these questions may have identified the benefits of the paper and electronic 
medicines management systems that staff felt were most important as well as the disadvantages 
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they felt were most in need of addressing. The lack of data then available on the advantages and 
disadvantages of each system was therefore limited to the comments provided by respondents in 
the open ended questions.  
This study is a case study from a single site so it is unlikely to be generalizable. The study raises 
issues that need to be assessed in a larger study, but this would not be easy to conduct as there 
are unlikely to be sites in the same stage of development of the electronic medicines 
management process. Other hospital sites may not use Ascribe software. However, the themes 
that emerged that are not related to Ascribe may be useful to other hospital pharmacies that are 
considering making the change to electronic medicines management, particularly as there is 
limited published work describing this area of pharmacy practice.  
4.5 Conclusion 
 In spite of the negative results for training and implementation satisfaction, after 
experiencing a change from paper based medicines management to electronic medicines 
management respondents were more likely to report a more positive attitude to change.  
 This study demonstrated that despite a lack of satisfaction in the training and 
implementation process respondents could identify benefits of moving to electronic 
medicines management.  
 Respondents valued the improved supply of inpatient medication that electronic 
medicines management has enabled.  
 The study identified a number of factors that are required to ensure a smooth 
implementation and training process for movement to an electronic medicines 
management system. These included: appropriately timed and assessed training; 
validated SOPs for the new process and engagement of staff at all phases of developing 
and implementing a new medicines management process.  
4.6 Recommendations for practice  
 Involving staff who will be end users of the electronic medicines management system in 
the development and planning process is important.  
 The timing and structure of training are important for training and implementation 
satisfaction of staff. The training should take place near the date the system goes live and 
should also include an SOP for staff to use after their training.  
 Regular communications regarding project progress are essential. 
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 The suitability of the new system to fit into current working practices, whilst enabling its 
benefits to be supported by staff, should be carefully evaluated.  
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5. Information resource use by 
prescribers at Birmingham Children’s 
Hospital 
The purpose of this study was to examine the use of and satisfaction with prescribing resources in 
paediatrics by prescribers at Birmingham Children’s Hospital. The study aimed to identify a base 
line measure of prescribing habits and use of prescribing information resources before the 
introduction of electronic prescribing at Birmingham Children’s Hospital. The objectives were to: 
 Identify the current prescribing habits reported by prescribers at Birmingham Children’s 
Hospital in terms of prescribing frequency, prescribing experience and clinical specialty; 
 Identify the prescribing information resources which prescribers at Birmingham Children’s 
Hospital report to use most frequently; 
 Identify which prescribing information resource is the most useful to prescribers at 
Birmingham Children’s Hospital and why; 
 Identify any areas of paediatric prescribing where prescribers at Birmingham Children’s 
Hospital report a lack of available prescribing information; 
 Identify the potential impact on patients of the current availability of paediatric 
prescribing information reported by prescribers at Birmingham Children’s Hospital. 
A self-completed online questionnaire was distributed to all prescribers at Birmingham Children’s 
Hospital at the time of the study. Further details of the method can be found on page 43.  
5.1 Context of this study 
Little is known about how often paediatric prescribers consult a resource before making a 
prescribing decision or how useful these resources are to paediatric prescribers. This study took 
place at Birmingham Children’s Hospital at a time when prescribing was undertaken by 
completion of handwritten charts. The exception was the use of the ChemoCare electronic 
prescribing tool for chemotherapy prescriptions.  
There are a range of environments where a prescriber may prescribe medication within 
Birmingham Children’s Hospital NHS Trust. These include: inpatients, outpatients, emergency 
department and prescriptions for use in the community on behalf of Birmingham Children’s 
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Hospital NHS Trust. Each of these environments may have differing processes for the steps taken 
when making a prescribing decision and differing access to resources. In the inpatient and 
emergency department setting at Birmingham Children’s Hospital prescribing is typically carried 
out by junior doctors who may or may not prescribe under the instructions or supervision of a 
senior colleague. In contrast outpatient prescribing is typically completed by senior doctors or 
consultants. Prescriptions for use in the community are written by prescribers with a range of 
experiences. Across all these environments there may also be prescribing by non-medical 
prescribers such as nurses and pharmacists.  
Birmingham Children’s Hospital ensures that all prescribers are provided with a copy of the British 
National Formulary for Children (BNFc). Currently paper copies of the BNFc are provided every 
twelve months; these are distributed by the Pharmacy Department to prescribers based within 
the hospital. Birmingham Children’s Hospital prescribers also have access to a number of other 
prescribing information resources including pharmacy staff (including specialist pharmacists), 
other healthcare professional colleagues, the internet, local and national guidelines, and the adult 
British National Formulary (BNF).   
This study aimed to provide a description of current practice of prescribing information resource 
use when making paediatric prescribing decisions at Birmingham Children’s Hospital to inform the 
development of the clinical decision support features in the electronic prescribing system that 
was under development at the time of this study.  
5.2 Results  
5.2.1 Response rate 
The sample size was 423. This figure does not include those whose emails were not delivered. 
There were 45 potential non-medical prescriber respondents and 378 potential medical 
prescriber respondents.  There were 192 responses to this study; a response rate of 46%. The 
response rate for doctors was 39%, whereas the response rate for non-medical prescribers was 
78%.  
Two respondents declined to complete the questionnaire at the consent stage on page one and 
seven identified themselves as staff who did not prescribe within Birmingham Children’s Hospital 
NHS Trust. These seven respondents were then excluded from the study. 183 prescribers began 
the questionnaire.  
5.2.2 Profession of respondent 
182 responses were received to this question. The responses are summarised in Table 11 below.  
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Table 11: Profession of prescriber respondents at Birmingham Children’s Hospital 
Profession Frequency (% responses to this question) 
Doctor 146 (80.2%) 
Nurse 32 (17.6%) 
Pharmacist 3 (1.6%) 
Other 1 (0.6%) 
Total 182 
The ‘other’ healthcare professional identified themselves as a dentist.  
The majority of the respondents were doctors. Nearly 20% of respondents were non-medical 
prescribers; this group was made up of nurses and pharmacists. Therefore non-medical 
prescribers were overrepresented in this study. Due to the small number of non-medical 
prescribers it was not possible to compare between professions the responses to the questions in 
this questionnaire study. 
5.2.3 Job title or grade of respondents 
Respondents completed a free text box asking them to describe their job title and/or grade. 169 
responses were received to this question. The remaining respondents chose not to answer this 
question. The responses are summarised below in Table 12.  
Table 12: Grade/job title of respondents at Birmingham Children’s Hospital 
Grade/Job Title Frequency 
Trainee doctor (FY, CT or ST) 58 
Consultant 81 
Other doctor 1 
Advanced nurse practitioner 10 
Trainee advanced nurse practitioner 3 
Other nurse 13 
Pharmacist 3 
Total 169 
(FY = foundation years, CT = core training, ST = specialist training) 
5.2.4 Number of years of prescribing experience in paediatrics 
Respondents completed a free text box where they reported the number of years of paediatric 
prescribing experience they had. 179 responses were received to this question (there was one 
respondent who had zero years’ prescribing experience – this respondent was a trainee non-
medical prescriber).  
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The mean length of paediatric prescribing experience in all staff groups was 10 years with a range 
of 30 years. When non-medical prescribers are grouped together (i.e. nurses and pharmacists) 
their mean experience was 2.5 years. The mean years of prescribing experience is described in 
Table 13 below. 
Table 13: Mean years of paediatric prescribing experience of respondents 
Prescriber group Mean years of experience Range of experience 
Doctor 11.8 29.8 
Nurse 2.4 8.0 
Pharmacist 3.0 0.0 
Other (dentist) 25.0 0.0 
The range of experience is not in whole years as some respondents reported part years or months 
of experience.  
There was a significant difference in average years of experience between the professional 
groups. The independent samples Kruskal Wallis test (value = 48.844) was significant with a p 
value of 0.000. If the nurses and pharmacists are grouped into one ‘non-medical’ prescriber group 
and compared to the medical (i.e. Doctors) prescribers there is a significant difference in 
paediatric prescribing experience between the two groups. (The Mann-Whitney U test, U = 577 
and p value 0.000) The mean ranks indicated that medical prescribers had the most paediatric 
prescribing experience. This is expected when you consider the number of consultant participants 
and the number of years non-medical prescribers have been legally able to prescribe.  
5.2.5 Clinical locations respondents prescribe in 
Respondents were asked which of the following areas they prescribed in: inpatients, outpatients, 
emergency department, in the community or other. Multiple responses could be selected. 179 
responses were received to this question. These findings are summarised in table 14. 
Table 14: Areas of Birmingham Children’s Hospital that respondents prescribed in 
Area of the hospital Frequency (% responses to this question) 
Inpatients 147 (82) 
Outpatients 118 (66) 
Emergency department 92 (51) 
In the community 28 (16) 
Other 13 (7) 
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This data shows that prescribers at Birmingham Children’s Hospital work in more than one area of 
the hospital. A small number work in the community where their access to prescribing 
information resources may be different to those based within the hospital. The areas that 
respondents considered as ‘other’ were: haemophilia walk in clinic; send prescriptions into the 
community; Paediatric Intensive Care Unit (PICU) (3); on retrieval; theatre (4); PICU & Emergency 
Department; healthcare at home and ‘limited to perioperative anaesthesia medicines so all 
procedure areas’.  
5.2.6 Most frequent area of prescribing for respondents 
Respondents were asked which clinical location they most frequently prescribed: inpatients, 
outpatients, emergency department, in the community or other. 179 responses were received to 
this question. The responses are summarised in Table 15.  
Table 15: Most frequent area of prescribing for respondents at Birmingham Children’s 
Hospital 
Area of the hospital Frequency (% responses to this question) 
Inpatients 102 (57) 
Outpatients 49 (27) 
Emergency department 18 (10) 
In the community 7 (4) 
Other 3 (2) 
Total 179 
 
More than half of the respondents most frequently prescribed for inpatients at Birmingham 
Children’s Hospital. A large proportion also most frequently prescribed for outpatients at 
Birmingham Children’s Hospital. Smaller proportions prescribed in the emergency department, in 
the community or elsewhere. It was not possible to test for differences between the profession of 
respondents and the most frequent clinical location of prescribing due to the large difference in 
numbers of respondents from each profession.   
There was a significant association between years of paediatric prescribing experience and the 
most frequent areas of prescribing. The independent samples Kruskal Wallis test (value = 11.769) 
was significant with a p value of 0.019. The average number of years of paediatric prescribing 
experience for participants who reported to work in inpatients most frequently was 8.7 years (i.e. 
less experienced), whereas the average number of years of paediatric prescribing experience for 
those who reported to work in outpatients most frequently was 13.2 years (more experienced).  
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5.2.7 Regularity that respondents prescribed for children 
Respondents were asked how often they prescribe for children. The question provided a number 
of set options; the responses to these are summarised in Table 16. 179 responses were received 
for this question. 
Table 16: How often do respondents prescribe for children? 
Regularity of prescribing for children Frequency (% responses to this question) 
Multiple times per day/shift 128 (72) 
Once daily 8 (4) 
Several times a week 23 (13) 
Weekly  9 (5) 
Monthly 4 (2) 
Less than monthly 7 (4) 
Total 179 
 
Most respondents prescribed for a child multiple times per day/shift. The next most common 
regularity of prescribing for a child was several times a week. Those who prescribed monthly or 
less often were mainly doctors, along with one pharmacist. Five of these doctors described their 
speciality as surgical and four reported it to be psychiatry. The majority of doctors in this group 
described their job role as ‘consultant’. The range of years of paediatric prescribing experience 
was from 4 years to 27 years and the prescribers specialised in a range of clinical areas. The other 
groups were made up of both medical and non-medical prescribers.  Due to the large difference in 
numbers of medical and non-medical prescribers it was not possible to statistically compare their 
regularity of prescribing for children.  
5.2.8 Specialty of respondents 
Respondents were asked to describe in response to an open question ‘when thinking about your 
prescribing in paediatrics, what is your specialist clinical area? (For example: PICU, oncology etc.)’ 
170 responses were received to this question. The responses are summarised in Table 17 below. 
Table 17: Summary of responses for specialist area in relation to paediatric prescribing 
Specialist area Frequency 
PICU 19 
Surgery (all areas) 16 
Emergency department 15 
Haematology/Oncology 14 
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General Paediatrics 13 
Respiratory medicine 10 
Psychiatry (inc CAMHS) 9 
Diabetes and endocrinology 8 
Anaesthesia, analgesia, sedation, inotropes 7 
Nephrology 6 
Cardiology 6 
Haemophilia, Haemoglobinopathy, 
anticoagulation and related bleeding 
disorders 
4 
Gastroenterology 4 
Rheumatology 3 
Neurology 3 
Pain management  3 
Hepatology 2 
Dermatology 2 
Orthopaedics 2 
Inherited metabolic disorders 2 
Hospital@Night 1 
Burns 1 
Dentistry 1 
Ophthalmology 1 
Microbiology 1 
Neonates 1 
Parenteral nutrition 1 
Tissue viability 1 
Total 170 
Three responses covered two distinct areas: ‘General medical/ED’, ‘Liver disease, metabolic 
diseases, transplantation’ and ‘ED/PICU’. These are not included in the above table. These 
responses demonstrate that a wide variety of specialties (28) were represented in this study and 
the questionnaire was delivered successfully to prescribers across Birmingham Children’s 
Hospital.  
85 
 
5.2.9 Regularity of information resource use when prescribing by 
prescribers 
Respondents were asked to select their frequency of resource use when prescribing for paediatric 
patients from a fixed option question. The responses are summarised in Table 18 below. 171 
responses were received. 
Table 18: Regularity of reported referral to reference sources when prescribing in 
paediatrics 
Regularity of reference source use when 
prescribing in paediatrics 
Frequency (% responses to this question) 
Every time I prescribe 45 (26) 
Several times a day 60 (35) 
Daily 14 (8) 
Several times a week 28 (16) 
Weekly  15 (9) 
Monthly 9 (5) 
Less often (than monthly) 0 (0) 
Total 171 
 
The majority of respondents were likely to use an information source at least daily when 
prescribing for paediatric patients. Due to the small numbers in the different professional groups 
it was not possible to test for statistical differences between the medical and non-medical 
prescribers and their frequency of resource use. However, there was a statistically significant 
association between frequency of resource use and years of experience in paediatric prescribing 
(Kruskal Wallis p = 0.004). When comparing the means of each group of respondents and their 
frequency of reported referrals to resources; those who referred to a resource weekly were the 
most experienced paediatric prescribers (15.6 years) and those who referred to a resource daily 
were the least experienced paediatric prescribers (6.9 years).  Respondents who referred to 
resources when prescribing in paediatrics every time they prescribed, several times a day/week or 
monthly had a mean experience of paediatric prescribing of 10-12 years.  
5.2.10 Frequency of particular resource use by respondents  
Respondents were asked to consider how often they used each resource when they prescribed 
for paediatric patients. 170 responses were received to this question.  
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5.2.10.1 British National Formulary for Children 
The BNFc is a nationally produced formulary that is updated monthly online and updated yearly in 
the paper format. Summary of responses of reported use of the paper version is summarised in 
Table 19 below. 
Table 19: Frequency of reported BNFc paper format use when prescribing for paediatric 
patients 
Regularity of use of BNFc (paper format) Frequency (% responses to this question) 
Every time I prescribe 32 (19) 
Several times a day 55 (32) 
Daily 13 (8) 
Several times a week 34 (20) 
Weekly 21 (13) 
Monthly 14 (8) 
Less often 0 (0) 
N/A I don’t use this resource 1 (1) 
Total  170 
 
The BNFc in the paper format was used by the majority of respondents at least weekly. Use of the 
BNFc several times a day was the most commonly reported practice, followed by use several 
times a week and use every time I prescribe. There was one respondent, a senior consultant with 
28 years of paediatric experience, who did not use this resource, but did report to use the BNFc 
smartphone app several times a week. There was a statistically significant association between 
reported use of the BNFc paper format and years of paediatric prescribing experience (Kruskal 
Wallis, p = 0.027). The mean years of paediatric prescribing experience was lowest for 
respondents who reported to use the BNFc paper format every time they prescribed (mean = 7 
years). The mean paediatric prescribing experience increased as regularity of use of the BNFc 
paper format decreased from several times a day to weekly (mean ranges of years of paediatric 
prescribing experience from 9 years to 15 years). The least frequent users of the BNFc paper 
format had a mean paediatric prescribing experience of 10 years.  
Respondents were then asked about their use of the online format of the BNFc. The responses are 
summarised in Table 20 below.  
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Table 20: Frequency of reported BNFc online format use when prescribing for paediatric 
patients 
Regularity of use of BNFc (online format) Frequency (% responses to this question) 
Every time I prescribe 0 (0) 
Several times a day 5 (4) 
Daily 3 (2) 
Several times a week 11 (6) 
Weekly 9 (5) 
Monthly 7 (4) 
Less often 42 (25) 
N/A I don’t use this resource 94 (55) 
Total 170 
 
The BNFc online format was not used by the majority of respondents. However, one quarter of 
respondents reported using it occasionally (less than monthly) and 17% used it at least weekly. 
The group of respondents who reported to use the online format at least weekly were likely to 
also be frequent prescribers (i.e. prescribed multiple times per shift). There was no statistical 
association between years of paediatric prescribing experience and regularity of use of the BNFc 
online format (Kruskal Wallis p = 0.206). There were both medical and non-medical prescribers 
who used the BNFc online format.  
Respondents were then asked about their use of the smartphone app format of the BNFc. The 
responses are summarised in Table 21 below.  
Table 21: Frequency of reported BNFc smartphone app format use when prescribing for 
paediatric patients 
Regularity of use of BNFc (smartphone app) Frequency (% responses to this question) 
Every time I prescribe 6 (4) 
Several times a day 9 (5) 
Daily 2 (1) 
Several times a week 12 (7) 
Weekly 5 (3) 
Monthly 5 (3) 
Less often 17 (10) 
N/A I don’t use this resource 114 (67) 
Total 170 
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The BNFc smartphone app was not used by the majority of respondents. However, 20% of 
respondents used it at least weekly and a further 13% used it monthly or less often. The 
respondents who used is at least weekly were frequent prescribers (21/25 prescribed multiple 
times per shift). There was a significant association in years of paediatric prescribing experience 
and regularity of BNFc smartphone app use (Kruskal Wallis, p = 0.04). The mean years of 
paediatric experience for respondents who used the BNFc smartphone app every time they 
prescribed and several times a day were 6 years and 3 years. For all other categories the mean 
years of paediatric prescribing experience was higher (between 9 and 13 years) demonstrating an 
inverse relationship between regularity of BNFc smartphone app use and years of paediatric 
prescribing experience.  
5.2.10.2 Guy’s, St Thomas’ & Lewisham Hospitals paediatric formulary 
The Guy’s, St Thomas’ & Lewisham Hospital paediatric formulary is a locally developed and 
produced paediatric formulary. It is updated annually. The majority of respondents did not use 
this resource, see Table 22 below. 
Table 22: Frequency of reported Guy’s St Thomas’ & Lewisham Hospitals paediatric 
formulary use when prescribing for paediatric patients 
Regularity of use of Guy’s St Thomas’ & 
Lewisham Hospital paediatric formulary 
Frequency (% responses to this question) 
Every time I prescribe 0 (0) 
Several times a day 0 (0) 
Daily 1 (1) 
Several times a week 0 (0) 
Weekly 1 (1) 
Monthly 4 (2) 
Less often 5 (3) 
N/A I don’t use this resource 159 (94)  
Total 170 
 
The numbers in each group of Guy’s etc Formulary use were too small to test for a statistically 
significant association between profession and regularity of Guy’s etc Formulary use. Both 
medical and non-medical prescribers reported to have used this resource, but the majority of 
respondents did not use it. The range of prescribing experience in paediatrics for reported users 
of this resource was less than one year to 20 years. 
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5.2.10.3 Pharmacy team member 
Pharmacy team members include pharmacists and pharmacy technicians. The frequency of use of 
these resources is described in Table 23 below.  
Table 23: Frequency of reported use of pharmacy team members as a resource when 
prescribing for paediatric patients 
Regularity of use of pharmacy team 
members 
Frequency (% responses to this question) 
Every time I prescribe 0 (0) 
Several times a day 7 (4) 
Daily 11 (6) 
Several times a week 18 (10) 
Weekly 25 (15) 
Monthly 31 (18) 
Less often 55 (32) 
N/A I don’t use this resource 23 (14) 
Total 170 
 
The majority of respondents used a member of the pharmacy team as a resource at least 
monthly. However, 14% of respondents never used the pharmacy team as a resource when 
making prescribing decisions for children.  The majority of those who never used the pharmacy 
team as a resource when prescribing were doctors who prescribed at least daily and described 
themselves as consultants (21 doctors (15 consultants, 6 other grades); in addition 1 dentist, 1 
nurse). Twelve of the respondents who did not use pharmacy as a resource worked in either 
surgery or the emergency department, where at the time of the study they would be unlikely to 
see a pharmacist to ask for advice. There was no significant association between years of 
prescribing experience and regularity of use of a pharmacy team member as a resource (Kruskal 
Wallis p = 0.754).  
5.2.10.4 Microbiology department 
The microbiology department may advice on the use of antimicrobials including which 
antimicrobial the infection is sensitive to and relevant local guidelines. The use of the 
microbiology department as an information source is described in Table 24.  
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Table 24: Frequency of reported use of microbiology guidance when prescribing for 
paediatric patients 
Regularity of use of microbiology Frequency (% responses to this question) 
Every time I prescribe 0 (0) 
Several times a day 1 (1) 
Daily 5 (3) 
Several times a week 16 (9) 
Weekly 10 (6) 
Monthly 31 (18) 
Less often 65 (38) 
N/A I don’t use this resource 42 (25) 
Total 170 
 
A quarter of respondents stated that they never used the microbiology department as a resource 
when prescribing for children. This group of respondents had a range of paediatric prescribing 
experience and worked in a variety of areas of the hospital. The majority of respondents stated 
they do make use of this resource. The most reported option was ‘less often’ than monthly, 
suggesting there is not a frequent need to use this source of information. There was no significant 
association between years of paediatric prescribing experience and the regularity of use of a 
microbiology team member as a resource (Kruskal Wallis p = 0.266).  
5.2.10.5 Other colleagues 
Other colleagues referred to a reference to any other colleague at Birmingham Children’s Hospital 
who was not a member of the pharmacy or microbiology team. The responses to this question are 
described in Table 25.  
Table 25: Frequency of reported use of other colleagues as a resource when prescribing 
for paediatric patients 
Regularity of use of other colleagues Frequency (% responses to this question) 
Every time I prescribe 4 (2) 
Several times a day 1 (1) 
Daily 10 (6) 
Several times a week 24 (14) 
Weekly 22 (13) 
Monthly 28 (16) 
Less often 50 (30) 
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N/A I don’t use this resource 31 (18) 
Total 170 
(NB trainee advanced nurse practitioners would be required to always prescribe in conjunction 
with a colleague who is a qualified prescriber) 
The majority of respondents reported to refer to other colleagues when prescribing for paediatric 
patients. The professions of colleagues referred to are described in Table 26.  Of the 18% of 
respondents who did not report to refer to other colleagues; 29/31 were doctors. There was a 
statistically significant association between years of paediatric prescribing experience and 
regularity of reported use of other colleagues as a resource (Kruskal Wallis p = 0.00). Respondents 
who reported to use other colleagues between several times a day and several times a week as a 
resource when prescribing were the least experienced (means between 2 and 4 years), but 
prescribed frequently. They were doctors or nurses or pharmacists. Respondents who reported to 
refer to other colleagues as a resource less often or didn’t refer to other colleagues as a resource 
had a mean experience of 13 years. The more experienced the respondent was the less likely they 
were to have reported to use other colleagues as a resource.  
Table 26: Profession of colleagues reported to be referred to for prescribing support by 
respondents at Birmingham Children’s Hospital 
Healthcare profession Frequency 
Pharmacy/pharmacist 78 
Doctor 66 
Microbiology/Microbiologist 12 
Nurse  8 
Non-medical prescriber 3 
Dentist 1 
Pharmacology 1 
Profession not specified 17 
Total 186 
 
The majority of respondents reported to refer to colleagues such as doctors and pharmacists as a 
resource when making a prescribing decision. Respondents also reported to refer to 
microbiologists, nurses, non-medical prescribers, dentists and pharmacologists. These responses 
are aligned with respondents’ previous responses that stated they report to refer to pharmacy 
team members more than microbiology team members.  
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5.2.10.6 Birmingham Children’s Hospital Results Systems  
The results may include blood results, other test results and imaging. The regularity of reported 
use of this system is described in Table 27.  
Table 27: Frequency of reported use of BCH results system as a resource when 
prescribing for paediatric patients 
Regularity of use of BCH results systems Frequency (% responses to this question) 
Every time I prescribe 10 (6) 
Several times a day 36 (21) 
Daily 25 (15) 
Several times a week 20 (12) 
Weekly 19 (11) 
Monthly 18 (11) 
Less often 24 (14) 
N/A I don’t use this resource 18 (11) 
Total 170 
 
Respondents’ reported use of the BCH results systems when prescribing for paediatric patients 
was varied.  There was no significant association between years of paediatric prescribing 
experience and regularity of use of BCH results system as a resource (Kruskal Wallis p = 0.178). 
There was a small proportion (11%) who reported to not use the BCH results systems as a 
resource when prescribing for children. This group contained a variety of professions (doctor, 
dentist, nurse) and years of experience of prescribing in paediatrics. Prescribers in this group 
reported a variety of clinical specialties.  
5.2.10.7 Patient notes 
Patient notes include a variety of resources; for example: medication and medical histories, 
letters from outpatient clinics and information on previous admissions. Table 28 describes how 
often respondents reported to use patient notes as a resource when prescribing for paediatric 
patients.  
Table 28: Frequency of reported use of patient notes as a resource when prescribing for 
paediatric patients 
Regularity of use of patient notes Frequency (% responses to this question) 
Every time I prescribe 37 (22) 
Several times a day 30 (18) 
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Daily 17 (10) 
Several times a week 29 (17) 
Weekly 14 (9) 
Monthly 12 (7) 
Less often 20 (12) 
N/A I don’t use this resource 11 (6) 
Total 170 
 
The majority of respondents reported to have used patient notes several times a week or more 
frequently. There was a significant association between years of experience of prescribing in 
paediatrics and reported regularity of use of patient notes as a resource (Kruskal Wallis p = 0.006). 
Generally respondents who reported to have referred to patient notes more frequently were less 
experienced than respondent who reported to have referred to patient notes less frequently. The 
mean number of years of paediatric prescribing experience for respondents who reported to have 
used patient notes every time they prescribed and daily was between 7 years and 9 years, 
whereas for respondents who reported to have used patient notes between several times a week 
and monthly the mean years of prescribing experience was between 13 and 15 years. There was a 
small proportion of 6% who reported to have never used patient notes when making prescribing 
decisions for children. This group contained respondents representing a range of years of 
experience in paediatric prescribing and a range of professions. The respondents who reported 
not to use patients notes were not located in a particular area of the hospital or clinical specialty. 
5.2.10.8 Google 
 Table 29 below describes their reported use of Google when prescribing for paediatric patients.  
Table 29: Frequency of reported use of Google when prescribing for paediatric patients 
Regularity of use of Google Frequency (% responses to this question) 
Every time I prescribe 0 (0) 
Several times a day 2 (1) 
Daily 2 (1) 
Several times a week 7 (4) 
Weekly 5 (3) 
Monthly 8 (5) 
Less often 32 (19) 
N/A I don’t use this resource 114 (67) 
Total 170 
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The majority of respondents did not report to have used Google as a resource when making 
prescribing decisions for children. Respondents who reported to use Google as a resource 
frequently (several times a week or more) were frequent prescribers, doctors and work in the 
inpatient setting. There was no significant association between years of paediatric prescribing 
experience and regularity of Google use (Kruskal Wallis p = 0.414).  
5.2.10.9 National Institute for Health and Care Excellence (NICE) guidelines 
The National Institute for Health and Clinical Excellence produces a range of guidelines in the UK 
that may be used by paediatric prescribers. Table 30 below described how often respondents 
reported to have used NICE guidelines when prescribing.  
Table 30: Frequency of reported use of NICE guidelines when prescribing for paediatric 
patients 
Regularity of use of NICE guidelines Frequency (% responses to this question) 
Every time I prescribe 2 (1) 
Several times a day 1 (1) 
Daily 5 (3) 
Several times a week 6 (4) 
Weekly 14 (8) 
Monthly 30 (18) 
Less often 61 (36) 
N/A I don’t use this resource 51 (30) 
Total 170 
 
The majority of respondents reported using NICE guidelines when prescribing; but most often 
they reported to have used them monthly or less often. There were 30% of respondents who 
reported that they did not use NICE guidelines when prescribing for children. This group of 
respondents had a range of professions and years of paediatric prescribing experience within it. 
Those that reported to use the guideline frequently (several times a week or more) were frequent 
prescribers and were not from one singular specialty or hospital setting. The NICE guidelines 
respondents reported to use are described in Table 31. There was no statistical association 
between years of experience in paediatric prescribing and regularity of use of NICE guidelines 
(Kruskal Wallis p = 0.159).  
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Table 31: NICE guidelines reported to have been used by respondents at Birmingham 
Children’s Hospital 
Name of NICE guideline (guideline reference 
number) 
Frequency 
Urinary tract infection in children (CG54) 11 
Attention deficit hyperactivity disorder 
(CG72) 
7 
Depression (CG28) 7 
Constipation (CG99) 7 
Feverish illness in children (CG160) 5 
Meningitis (CG102) 4 
Asthma (QS25) 3 
Epilepsy (CG137) 3 
Psychosis & Schizophrenia (CG155) 3 
Obsessive compulsive disorder (CG31) 2 
Diabetes (CG15 and CG66) 2 
Growth hormone (TA188) 2 
Upper respiratory tract infection (CG69) 2 
Tuberculosis (CG117) 2 
Sedation (CG112) 2 
Familial hypercholesterolaemia (CG71) 2 
Sepsis/febrile neutropenia (CG151?) 2 
Omalizumab (TA278) 2 
Continuous subcutaneous insulin infusion 
(TA151) 
1 
Inflammatory bowel disease (yet to be 
published) 
1 
Dental (CG19?) 1 
Idiopathic thrombocytopenia purpura (TA221 
or TA293) 
1 
Borderline personality disorder (CG78) 1 
Head injury (CG176) 1 
Neonatal sepsis (CG149?) 1 
Gastroenteritis (CG84) 1 
Trauma (TA74 or yet to be published) 1 
96 
 
Immunosuppression (TA99?) 1 
Chronic pain (?) 1 
Autistic spectrum disorder (CG128) 1 
Headache/migraine (CG150) 1 
Enuresis (CG111) 1 
Anxiety (CG159?) 1 
Non-specific reference 13 
Total 96 
The guideline reference numbers marked with a question indicate that it was not clear to the 
researcher if this was the specific guideline being referred to by the respondent. The name of the 
NICE guideline described by the respondent did not clearly match the guidelines listed on the 
NICE website. The researcher looked at the NICE website to establish the closest match to the 
responses given. 
The NICE guidelines reported to have been used were varied (33 different guidelines reported), 
potentially a reflection of the varied patient population within the hospital.  
5.2.10.10 Local guidelines 
Local guidelines refer to guidelines developed by Birmingham Children’s Hospital or other 
hospitals. The regularity of reported use of BCH guidelines when prescribing is described in Table 
32.   
Table 32: Frequency of reported use of local guidelines as a resource when prescribing 
for paediatric patients 
Regularity of use of local guidelines Frequency (% responses to this question) 
Every time I prescribe 7 (4) 
Several times a day 9 (5) 
Daily 12 (7) 
Several times a week 25 (15) 
Weekly 42 (25) 
Monthly 32 (19) 
Less often 29 (18) 
N/A I don’t use this resource 14 (8) 
Total 170 
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The majority of respondents reported to have used local guidelines when prescribing for children. 
The specific BCH guidelines used are described in Table 33.  There was a statistically significant 
association between years of experience of prescribing in paediatrics and use of local guidelines 
(Kruskal Wallis p = 0.00). Less experienced prescribers were more frequent reported users of local 
guidelines when prescribing. However a small proportion, 8%, reported that they did not use local 
guidelines. This group had significant paediatric prescribing experience (mean = 16 years).  
Table 33: Local guidelines reported to have been used by respondents 
Name of guideline Frequency  
Antibiotic 43 
Emergency department guidelines 11 
Haematology/Oncology 10 
Respiratory 6 
Cystic fibrosis 6 
Analgesia 6 
PICU 6 
Vitamin D 4 
Sedation policy 4 
Diabetic Ketoacidosis guideline 3 
Liver transplant/unit 3 
Pharmacy information 3 
Nephrotic syndrome 3 
Sickle cell management/crisis 3 
Nephrology protocol 2 
Rapid tranquillisation  2 
Sepsis pathway 2 
Anticoagulation  2 
Cardiac surgery protocol 2 
Kawasaki disease 2 
Microbiology 1 
Attention Deficit Hyperactivity Disorder 1 
Newly diagnosed type 1 diabetes 1 
Ischaemic limb 1 
Haemophilia unit guidelines 1 
Burns 1 
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Midazolam pathway 1 
Fluid and electrolyte guidelines 1 
Zoledronate/pamidronate 1 
Hypoglycaemia 1 
Congenital Adrenal Hyperplasia patients 
requiring surgery 
1 
Gastroenterology protocols 1 
Infusion charts 1 
Antiemetic 1 
Central Venous Line site policy 1 
TB 1 
Endocrine test protocols 1 
Parenteral nutrition prescribing guidelines 1 
Renal transplant protocol 1 
Anaesthesia good practice guide 1 
BCH app 1 
Bronchiolitis 1 
Malaria  1 
Asthma  1 
West midlands psychopharmacology forum 1 
No specific guideline response (e.g. ‘unit’) 20 
Total 168 
 
A wide variety of local guidelines (45) were reported to have been used by prescribers at 
Birmingham Children’s Hospital when prescribing for children. The most frequently reported 
guideline was the antibiotic guideline.   
5.2.10.11 Other national guidelines 
There are many organisations in the UK such a Royal Colleges and health charities who also write 
prescribing guidelines that be used as a resource by the respondents. The reported use of this 
type of guideline is described in Table 34 below. 
Table 34: Frequency of reported use of other national guidelines when prescribing for 
paediatric patients 
Regularity of use of other national guidelines Frequency (% responses to this question) 
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Every time I prescribe 0 (0) 
Several times a day 2 (1) 
Daily 3 (2) 
Several times a week 8 (5) 
Weekly 6 (4) 
Monthly 28 (16) 
Less often 61 (36) 
N/A I don’t use this resource 62 (36) 
Total 170 
 
The other national guidelines reported to have been used when prescribing are described in Table 
35. The majority of respondents reported to have used other national guidelines when prescribing 
for children. However, 36% of respondents used them less often then monthly when prescribing 
and a further 36% not at all. There was no statistical association between number of years of 
paediatric prescribing experience and use of other national guidelines (Kruskal Wallis p = 0.511). 
One third of the respondents who reported to use other national guidelines frequently (at least 
several times a week) described their speciality as haematology.  
Table 35: Other national guidelines reported to have been used by respondents at 
Birmingham Children’s Hospital 
Name of organisation Frequency 
British Thoracic Society 10 
British Committee for Standards in 
Haematology 
4 
Maudsley Guidelines 3 
British Inherited Metabolic Diseases Group 3 
British Society for Paediatric Endocrinology 
and Diabetes  
2 
Children’s Cancer and Leukaemia Group 2 
SIGN (Scottish Intercollegiate Guidelines 
Network) guidelines 
2 
European Society for Paediatric 
Gastroenterology, Hepatology and Nutrition 
2 
British Association of Dermatologists 1 
United Kingdom Haemophilia Doctors 1 
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Organisation 
British Society of Paediatric Dentistry 1 
Department of Health toolkit (dentistry) 1 
College of Emergency Medicine 1 
Royal College of Obstetricians and 
Gynaecologists 
1 
Retrieval guidelines 1 
British Society for Paediatric and Adolescent 
Rheumatology 
1 
American College of Rheumatology 1 
Cystic Fibrosis Trust 1 
UK ALL protocols 1 
Royal College of Paediatrics and Child Health 1 
Resuscitation Council 1 
European Society for Clinical Nutrition and 
Metabolism 
1 
British HIV Association 1 
Paediatric Intensive Care Society 1 
American Society for Parenteral and Enteral 
Nutrition 
1 
Association of Paediatric Anaesthetists of 
Great Britain 
1 
European Vasculitis Study Group 1 
Association of Anaesthetists of Great Britain 
and Ireland 
1 
British Association for Paediatric Nephrology 1 
APA guidelines (?) 1 
ASD (?) 1 
No organisation specified 10 
Total 61 
The researcher had to identify the likely solution of some of the acronyms listed. A question mark 
has been used to indicate where there was more than one possible option for the acronym 
provided by the respondent.  
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The most frequently reported guidelines used were those produced by the British Thoracic 
Society. There were also a wide variety of other professional organisation guidelines used with 31 
different organisations reported.  
5.2.10.12 Frank Shann 
Frank Shann is a paediatric drug dose booklet available in a variety of formats. The format most 
frequently reported to have been used by respondents was the paper format, which was reported 
to have been used by 11% of respondents. The online format was reported to have been used by 
1% and the smartphone application format was reported to have been used by 6% of 
respondents. Users of Frank Shann were likely to describe their speciality as PICU, emergency 
department or anaesthetics.  
5.2.10.13 Other resources 
Respondents were also asked to list any other resources that they used when prescribing for 
paediatric patients. 
Other resources included: Maudsley guidelines; ‘BAP’ guidelines; United Kingdom Haemophilia 
Doctors Organisation; ‘chemotherapy protocols’: ‘UK ALL protocols’, ‘CCLG National 
chemotherapy protocols’; ‘Epocrates’ phone app; Adult BNF; ‘Oncology formulary’; Lexicomp; 
‘pediatric & neonatal dosage handbook’ (app); Micromedex (online); Renal Handbook; ‘e 
medicines compendium’; ‘dose calc app’; ‘BCH App created by Barry Lambert’; international 
guidelines; Journals – clinical research papers. 
Maudsley guidelines were reported by four respondents and chemotherapy related guidelines 
were reported by four respondents. All other suggestions were reported by a single respondent.  
5.2.11 The most useful resources according to respondents when 
prescribing for paediatric patients  
Respondents were asked to list the references that were most useful to them and to provide a 
reason for this in an open question. 167 responses were received for the first part of the question 
(summarised in Table 36) and 124 reasons were recorded in the second part of this question. The 
reasons have been analysed qualitatively. The ranking was determined by how many participants 
listed the resource as the resource reported to be most useful to them.  
Table 36: The most useful resources according to respondents when prescribing for 
paediatric patients 
Rank Resource  Frequency 
1 BNF/BNFc (all responses) 130 
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 BNFc 68 
 BNFc paper 8 
 BNFc app 7 
 BNF 32 
 BNF app 5 
 BNF paper 8 
 BNFc online 2 
 Dental BNF 1 
2 Pharmacy or pharmacist 
(all responses) 
10 
 
 Renal pharmacist 2 
 PICU pharmacist 2 
3 Local guidelines or 
handbook (all responses) 
9 
 
 Liver unit guidelines 1 
 CF guidelines – BCH 1 
 Sedation policy 1 
 Transplant protocol 1 
 Oncology formulary 1 
4 Colleague 4 
5 Patient or case notes 3 
6 Frank Shann 2 
6 Microbiology  2 
8 Medicines for children 1 
8 Patient results 1 
8 UK ALL protocols 1 
8 ESPGHAN guidelines 2005 1 
8 PICS 1 
8 American academy of child 
and adolescent psychiatry 
1 
8 Lexicomp pediatric and 
neonatal dosage app 
1 
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Total   167 
It was not possible to confirm if all respondents meant the BNF or the BNFc in their responses. 
Therefore all references to the BNF/BNFc have been collated as well as reported as described by 
the respondents. 
The resource considered most useful when prescribing by respondents was the BNF/BNFc. This 
was reported to be the most useful resource by 78% of respondents to this question.  
Reasons resources are deemed to be the most useful by respondents 
This section summarises the open ended descriptions provided by respondents as to why they 
have selected the resources summarised in the above table as the most useful to them. Some 
respondents provided reasons for more than one resource. Therefore for some resources there 
may be more comments regarding why it is useful than the number of respondents who reported 
that resource as the most useful. 
The most useful reference source to respondents was the BNF/BNFc (131 of 167 responses). The 
reasons why have been grouped into five main themes. These are: ease of use and reliability; 
coverage of relevant information; familiarity; assessing drug options and references to specific 
information.  
The most frequently reported reasons for use of the BNF/BNFc were ease of use and reliability. 25 
out of 55 reasons why the BNF/BNFc was the most useful resource fell into this category. 
Information within the BNF/BNFc was described as “reliable” and “accurate”. The BNF/BNFc were 
also considered easy to use and easily accessible in the work environment. Respondents 
commented that the BNF/BNFc was the most available source of information on a ward and it was 
easy to take the BNF/BNFc to the bedside on the ward. Respondents also commented that the 
BNF/BNFc was regularly updated and information was presented clearly. The content of the 
BNF/BNFc was described as evidence based and authoritative. One respondent stated that the 
“BNFc should be the first reference source for prescribers in the UK”. Finally the BNF/BNFc was 
reported to cover the information needs of respondents and present this information with 
guidance.  
The second most frequently reported reason for use of the BNF/BNFc was the coverage of 
relevant information. This represented 9 out of 55 responses. The BNFc, according to 
respondents, was useful because it was “designed especially for children” and it provided 
“information on drugs that I am likely to use in my area of practice”. The BNFc was also likely to 
“cover every drug I would ever prescribe” and was “applicable to the majority of patients” for 
“standard paediatric drugs”.  
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Three respondents cited that familiarity was part of the reason why the BNF/BNFc was the most 
useful resource. One respondent described the BNF/BNFc as a resource they are “comfortable 
with” and one described it as “the only one I know”. Two respondents referred to the BNF/BNFc 
as being useful for helping “decide which drug to prescribe” and looking at “various options”.  
There were a further 16 comments that referred to specific functions of the BNF/BNFc that made 
it the most useful. This included available information regarding: licensing of drugs; interactions; 
adjustments for organ impairment; legal prescribing; checking doses; costs; side effects; and 
available formulations. There were five comments that referred to the smartphone app. These 
comments focussed on its accessibility: particularly when in the community and you can’t find a 
computer or a paper copy. Two comments mentioned that the speed of using the smartphone 
app was quicker than the use of the paper format of the BNF/BNFc and one comment praised the 
search function available within the smartphone app.  
The main reason why the pharmacy department and/or pharmacists were reported to be the 
most useful resource was the specialist knowledge they had. Seven of 13 comments referred to 
the specialist knowledge as the reason the pharmacy team were the most useful resource. The 
pharmacy team were described as “reliable” and “accessible”. One respondent referred to the 
pharmacist as their “first port of call”. Pharmacists were also valued for their “understanding of 
the patient” and their ability to adapt to the clinical scenario.  
The reasons why local guidelines were useful covered four main themes. These were: specific to 
local practice; information on non-standard treatments; evidence based and accessibility. The 
most frequently reported reason that local guidelines were useful was that local guidelines are 
specific to the local practice and method of working. This reason covered 8 out of 19 comments 
regarding local guidelines. Local guidelines were useful because they were specific to the task, 
specialty or BCH day to day working. The second most common theme, containing 5 comments 
related to the accessibility of local guidelines. Local guidelines were reported to be in “an easy to 
access format” and clearly presented. One respondent reported that the guidelines were 
“produced by the team” which meant they all worked within them. It is important to note local 
guidelines were also described in a contradictory manner by one respondent as “cumbersome, 
hard to find, and less useful”.  
5.2.12 Types of information that aids respondents’ prescribing decisions 
for paediatric patients 
Using information suggestions from the prior focus groups respondents were asked to select 
which types of information they needed to refer to when prescribing for children from seven fixed 
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options and an ‘other’ option. 165 responses were received for this question. The responses are 
summarised in Table 37. 
Table 37: Types of information that aids respondent’s prescribing decisions for 
paediatric patients 
Type of information Frequency (% responses to this question) 
Drug doses 158 (96) 
Contraindications 135 (82) 
Interactions  118 (72) 
Patient test results 109 (66) 
Formulation information 95 (58) 
Drug choice 89 (54) 
Compatibilities  77 (45) 
Other 12 (7) 
Total 793 
NB respondents could select more than one option for this question.  
Other information individual respondents referred to included: previous prescriptions; license 
issues; indication; clotting factor % correction levels; preparation/administration instructions; 
pharmacology; side effects. Some respondents also listed specific dosing issues as ‘other’. These 
were: renal doses and frequency. There was no statistical difference between profession/years of 
experience in paediatrics and the type of information sought when prescribing for paediatric 
patients.  
Respondents were then asked to select from the available options which type of information they 
were most likely to need when prescribing in paediatrics. The responses are described in Table 38 
where drug doses were reported as the most common type of query.  
Table 38: Type of information most frequently referred to when prescribing for 
paediatric patients 
Type of information Frequency (% responses to this question) 
Drug doses 136 (82) 
Patient test results 8 (5) 
Contraindications 6 (4) 
Drug choice 5 (3) 
Formulation information 5 (3) 
Interactions 1 (1) 
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Compatibilities  1 (1) 
Other 3 (2) 
Total 165 
165 responses were received to this question. 
5.2.13 Types of paediatric prescribing information lacking in current 
resources 
The literature review and the findings from the focus groups study established that there is a lack 
of paediatric prescribing information available to prescribers. This question sought to identify 
more specifically what this deficit was. 161 responses were received and these are described in 
Table 39. 
Table 39: What paediatric prescribing information do respondents feel is lacking from 
current resources? 
Type of information Frequency (% responses to this question) 
Lack of advice other than ‘caution’ 66 (41) 
Links to individual patient factors 43 (27) 
Availability of paediatric formulations 44 (27) 
There is no lack of information. 42 (25) 
Lack of access to information 26 (16) 
Paediatric doses 21 (13) 
Other  26 (16) 
 
One quarter respondents did not feel there was a lack of available prescribing information for 
paediatric patients. For respondents who felt there was a lack of paediatric prescribing 
information, the most common areas where they believed the lack occurred were: lack of advice 
other than ‘caution’ (i.e. in the paediatric dosing section of the prescribing resource the only 
comment is ‘caution’ and no further advice is provided).  
Individual respondents also identified other areas that lacked paediatric prescribing information. 
These are listed below:  
 An easier and less time consuming way of checking interactions (particularly for oncology 
drugs) 
 Information regarding difficult infusions 
 How to give some medications 
 Speciality specific or rare treatment information (e.g. pubertal induction) 
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 Off license (but recognised) indication doses (e.g. Clonidine for tics) 
 Costs to the trust and the community 
 Clotting factor % calculations are not published in one specific publication 
 Alternative drugs following a drug reaction 
 Compatibility of infusions 
 Information regarding colour of medicines 
 Suggested duration of treatment 
 Pharmacology and pharmacokinetics in paediatric and neonatal patients 
 Availability of medicines in a paediatric formulation 
 A formulary for PICU with all information in one place 
 Clearly stated frequency of side effects 
Those respondents who replied that there was a lack of dosing information were asked if this was 
in any particular area or whether this was a general problem. A total of 28 responses were 
received to this question. These are described in Table 40. The options for this question were 
derived from the focus group study that took place prior to this questionnaire where dosing in 
paediatric specialties was highlighted as an area lacking information. Respondents could select 
multiple answers to this question 
Table 40: Specific types of paediatric dosing information that respondents reported to 
have been unavailable at the time of the study 
Type of information Number of responses 
Paediatric doses in general 16  
Doses for premature babies 13  
Renal doses 12  
Hepatic doses 10  
CVVH/dialysis information 6  
ECMO doses 5  
Filtration dosing information 5  
Other 3  
Total 70 
(CVVH – Continuous veno-venous haemofiltration, ECMO – extracorporeal membrane 
oxygenation) 
Responses to other included: ‘none in my area’; drug handling in special patient groups and doses 
and formulation information on the few drugs available in my specialty.  
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There was a range of areas where there respondents reported a lack of paediatric prescribing 
information. 
5.2.14 Does lack of paediatric prescribing information have an effect on 
patient care 
Respondents were offered three fixed options. 158 responses were received. The responses are 
summarised in Table 41 below. 
Table 41: Does a lack of paediatric prescribing information have an effect on patient 
care? 
Answer selected Frequency (% responses to this question) 
Yes 79 (50) 
No  36 (23) 
Don’t know 43 (27) 
Total 158 
 
Half the respondents considered that a lack of paediatric prescribing information can have an 
effect on patient care. However approximately one quarter did not consider there was an effect 
on patient care and a further quarter of respondents were not sure. The respondents who 
weren’t sure had fewer years of paediatric prescribing experience than those who responded yes 
or no (mean years of experience 6 years compared to mean years of experience 12 years for 
yes/no respondents). Respondents were also asked to explain their response to this question and 
describe why they did or did not think patient care could be affected. 
Reasons why a current lack of paediatric prescribing information may have affected 
patient care 
The reasons provided by respondents as to why a lack of paediatric prescribing information could 
affect patient care can be summarised under five themes. These were: patient safety is 
compromised, delays for patients, factors affecting the prescriber, drug choice for patients and 
‘other’.  
Patient safety was reported to be at risk when there was a lack of paediatric prescribing 
information. 25 out of 58 comments referred to an aspect of patient safety that could be affected 
by a lack of paediatric prescribing information. One aspect was that the prescriber could be “over 
or undertreating” if the relevant information was not available. One respondent suggested this 
may mean that the “clinicians sometimes have to guess the right dose due to lack of information”. 
A second aspect was that a lack of information could lead to the wrong drug being chosen. Both 
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these aspects were confounded by the lack of evidence and data available in paediatrics according 
to respondents. One respondent highlighted that it was difficult to determine the dose of a 
medicine that was not licensed in children due to the lack of available information. Respondents 
also commented that a lack of information regarding side effects and/or interactions could put 
patients at risk. One example given was “I don’t know the risk of topical cleaning agents and 
medicines in neonates and exposed skin conditions like burns”. One respondent commented that 
the patient safety issue could be highlighted if prescribers were newly qualified or not used to 
working in paediatrics. Another respondent noted that “we are dependent on pharmacists” to 
check things are being done correctly and this was not fail proof as pharmacists are not available 
at weekends.  
The second most frequently reported reason was that delays to patient care could occur when 
information was being sought by prescribers. This theme accounted for 14 out of 58 comments 
that explained why a lack of paediatric prescribing information can affect patient care. 
Respondents also commented that delays can occur when general practitioners do not have 
access to the relevant prescribing information meaning the patient may have to return to the 
hospital in order to get a medicine prescribed. In addition, delays can occur when information is 
being sought and when information is being evaluated by the prescriber. Respondents also 
reported that delays can occur when combinations of medicines are needed or when computers 
are not working effectively to find information. Two respondents commented that when 
prescribers are searching for medication information time is taken away from direct patient 
contact.  
The third most common reason recorded by respondents was factors that affected the prescriber 
and their ability to make prescribing decisions. This theme was found in ten respondents’ 
comments. All of these comments suggested that without the right information prescribers may 
not feel confident or comfortable prescribing. One respondent stated it was “harder to take 
decisions” and a second respondent commented that prescribers “often have to make educated 
guesses”. This view was summed up by one respondent who stated “I am anxious about 
prescribing something on which the official line is to say there is no information available”. It was 
also recognised that clear prescribing information can improve doctors “autonomy and efficiency 
in prescribing”.  
The fourth theme was that a lack of paediatric prescribing information can limit drug choice. This 
was reported in comments from six respondents. One respondent suggested that a patient may 
not get the best available drug as it has not been tested enough in the paediatric population. This 
problem was noted to affect access to new medicines by one respondent. Two respondents noted 
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that there can be paediatric prescribing information unavailable for drugs that would be expected 
to be of benefit in paediatric patients.  
There were several further reasons that were reported by single respondents. The first reason 
was that prescribing information was not aimed at reducing costs and as resources were limited 
this could indirectly affect the availability of resources available to care for patients. Another 
respondent commented that parents can become very worried about a lack of research evidence 
that demonstrates a particular drug is safe. This could impact the consent to provide treatment. 
Finally, a respondent commented that when you don’t know what formulations are available 
children can be given preparations that are not ideal. The example given was that MUPS 
omeprazole can block nasogastric tubes and takes longer for families to administer compared to 
omeprazole syrup.  
Comments from respondents who were not sure if a lack of paediatric prescribing 
information affected patient care 
The comments from this opinion group were too contrasting to be grouped into themes. 
Examples of comments from respondents who were not sure if a lack of paediatric prescribing 
information can affect patient care are presented below.  
 “It is difficult to know whether small dosing errors or formulation errors have any effect 
on patient outcomes.” 
 “The excellent PICU pharmacy team are available to support prescribers which I believe 
may reduce negative effects on patient care that may arise from lack of information or to 
help prescribers understand the information available.” 
 “Within my area of prescribing I feel that I have enough information and resources about 
the drugs that I am prescribing. I am sure if I didn’t have this information however that it 
would impact on patient care.”  
 “It could be a case that lack of information regarding paediatric formulations could mean 
patients receive doses in unsuitable forms in an effort to achieve prescribed dose; for 
example a patient may receive crushed tablet, to achieve specific dose, when liquid form 
was available.” 
 “A number of our prescribing practices are already only performed because of consensus 
opinion and presumed best practice – a lack of clarity of prescribing information is not 
likely to affect this. Too much prescribing information can similarly affect patient care, as 
is seen with the sudden withdrawal of codeine from the BCH formulary.”  
 “A lot of prescribing decisions are based on ‘education (sic) guess’ rather than clear 
evidence. We often don’t know whether a deterioration in patient condition is due to 
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illness or adverse drug effect, particularly in patient with complex pharmacotherapy. 
Pharmacology data are limited in children, the critically ill and where medicines interact.”  
 “It can make finding an answer slower, but usually an answer of sorts can be found 
eventually.”  
 “A lot of the doses we use, especially in cardiology, are empirical, which can potentially 
have implications of safety and efficacy. “ 
 “In my area of practice I don’t think it does – emergency and urgently needed 
prescriptions are easily referenced. However in busier departments the availability of 
prescribing information may have an effect.”  
Reasons why a current lack of paediatric prescribing information may not have 
affected patient care 
There were twenty one respondents who provided reasons why patient care was not affected by 
a lack of paediatric prescribing information. These comments were grouped into four themes: 
information is available; pharmacy staff provide support; clinical experience and consensus on 
treatment.  
The most commonly reported reason that patients were not affected was that currently available 
information was suitable. This was stated in 12 of the twenty reported comments in this group of 
respondents. Respondents reported that the necessary information was available; however three 
respondents noted that it may take time to obtain the required information. “I think there is 
enough information you just sometimes have to search for it”. The second most common reason 
was that there were pharmacy staff to provide support for paediatric prescribers. This reason was 
reported by 5 of the respondents in this opinion group. One example is: “BCH has fantastic 
pharmacy support which means there is always somewhere to go if you have a question.”  
The themes of clinical experience and consensus on treatment were supported by two 
respondents each. Clinical experience was noted to partly mitigate for the limitations of studies in 
paediatric patients. One respondent commented that “My knowledge and experience over the 
last 5.5 years have ensured patient care is not affected.” With regard to consensus on treatment 
one respondent reported that “The drugs we use are often specialised and uses off license, but 
with consensus for doses etc. so I don’t think patient care is compromised”. This was supported 
by a second respondent who commented that although products may be unlicensed they can still 
be used in children. 
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5.2.15 Is there a difference in difficulty between prescribing for children 
and prescribing for adults? 
This open ended question was answered by 125 respondents. The responses have been 
summarised into five distinct categories: children are more difficult to prescribe for (n=81); adults 
are more difficult to prescribe for (n=3); there is no difference in difficulty (n=5) and an 
unsure/don’t know category (n=7), response unclear (n=19).  
Comments that supported that there was a difference in difficulty between prescribing 
for children and prescribing for adults 
The responses were organised into six themes. There were eleven respondents that simply 
answered “yes” children are more difficult to prescribe for than adults.  
The most frequently reported reason for why children are more difficult to prescribe for than 
adults was that children required varying doses. This was reported by 42 of 81 respondents with 
this opinion. This group of respondents noted that variety of calculations needed to be carried out 
in order to prescribe for paediatric patients. Dosing calculations were based on a variety of 
parameters including: age, weight, body surface area, varying units of measure (e.g. micrograms, 
milligrams, units) and changing organ function. These parameters then change as a child grows. 
This variety was considered to be the main reason prescribing for children is more difficult than 
prescribing for adults. A second reason was that “adult dosing is much more standardised” and 
therefore “easier to remember”. Another factor was that blood results vary with age in paediatric 
patients, rather than having one standard acceptable range as found in adult patients. One 
respondent commented that the range of doses prescribed “makes it more difficult to have an 
intuitive feel when the dose is wrong”. An additional complexity was that formulations “are 
designed for use in adults” and then additional calculations can be required in the manipulation of 
a paediatric dose from an adult formulation.  
The next most common reason for children being more difficult to prescribe for than adults 
according to the study respondents was there was a lack of evidence for paediatric prescribing 
compared to adult prescribing. This theme was supported by comments from 11 respondents. 
Respondents noted that there was less written evidence available in paediatrics and one 
respondent commented that trials in children could be “less rigorous”.  
The third most frequently reported reason in this study was that children are inherently more 
complex than adults to prescriber for. This theme was supported by comments from seven 
respondents. Children were reported to be more complex because of varying sizes/ages. One 
respondent, who was an adult trainee, stated that he/she didn’t understand why it needed “to be 
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so complicated” in paediatrics (i.e. using weight, age and body surface area to calculate doses) 
when body surface area was consistently used to calculate drugs in adult haematology patients.  
Comments that supported the opinion that adults are more difficult to prescribe for 
than children 
Three respondents commented that adults were more difficult to prescriber for than children. The 
reasons for this were that adults had more polypharmacy and comorbidities to consider when 
prescribing. One respondent stated that the comorbidities of adults gave them a greater chance 
of adverse drug interactions and that “elderly patients are particularly difficult as their tolerance 
to medication is affected by their ageing physiology”. 
Comments stated there was not a difference in difficulty between prescribing for 
children and prescribing for adults 
Five respondents commented that there was not a difference in difficulty for prescribing for 
children or prescribing for adults. Their comments were as follows: 
 “No, except simple maths.”  
 “No, different difficulties in both age groups. One not more difficult than the other.” 
 “Not once you are used to both patient groups.” 
 “Not really when following the guidelines, dose requirements etc.” 
  “No, I don’t think so.”  
Comments that did not support either direction or were unable to answer the question 
There were seven respondents who commented that they were unable to answer this question as 
they had either never prescribed for adults or not prescribed for adults for a long period of time. 
There were nine further comments that explained some of the reasons why prescribing in 
paediatric may be different to prescribing in adults, but did not state that this meant it was more 
difficult. There were no consistent reasons reported in this group of respondents so it was not 
possible to draw rational themes from the comments. The comments were: 
 Paediatric prescribing is less straight forward, but does highlight the fact that in adult 
practice we should be considering our patients weight, build and body composition with 
our prescribing decisions.  
 Probably not, I often wonder about dosing in adults not being related to their body weight 
 The resources available to inform prescribing for children with haemophilia or a related 
bleeding disorder are robust if consulted and implemented as advised and in consultation. 
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 The dosing is too general. For example some doses are given as age 6-12 years 250mg. 
not very useful as some 6 year olds are less than 20kg and some 12 year olds are over 
50kg.  
 Bringing together the varying age groups within the specialist care need can be 
challenging alongside the individual status of the patient.  
 Although there is not always sufficient evidence for prescribing decisions in certain adult 
populations this situation is worse in the paediatric population due to lack of clinical trial 
data and various paediatric age groups, children with rare conditions, lack of recruitment 
to clinical trials, small patient numbers etc. 
 On the whole many adult medicines are set doses which can be ‘learned’ – however in 
children this is different and reference to a text to ensure the correct dose per 
weight/body surface area is given.  
5.3 Discussion 
The prescribing habits of some prescribers at Birmingham Children’s Hospital have now been 
identified. The majority of prescribers were doctors who prescribed frequently (several times per 
shift) across more than one hospital setting (see tables 37 to 43). There was no dominant clinical 
specialty, reflecting the environment of Birmingham Children’s Hospital that provided secondary 
care for the local population alongside tertiary care for a range of specialties. Non-medical 
prescriber had less experience of prescribing in paediatrics, but also prescribed frequently in a 
range of specialties. There was a wide range of paediatric prescribing experience (range 30 years) 
and paediatric prescribing frequency (several times a shift to less than monthly) across the 
respondents which was linked to their differences in reported use of several paediatric prescribing 
information resources. 
The large number of consultants in this study and their high level of prescribing experience will 
have affected the reported prescribing information requirements. It was hypothesised that years 
of prescribing experience would not be associated with reported frequency of resource use. 
However, some of the reported resource use indicated that those with more prescribing 
experience used prescribing resources less frequently (see section 5.2.10). However, experience 
of prescribing in paediatrics did not eliminate the reported requirement of access to paediatric 
prescribing information. Over half of respondents reported to use a resource every day, with over 
a quarter reporting to use a resource every time they prescribed. In this study respondents 
reported to use a variety of paediatric prescribing sources irrespective of their years of paediatric 
prescribing experience. This suggests that future developments in electronic systems to support 
paediatric prescribing should include access to paediatric prescribing information and this access 
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need not be adjusted to prescriber experience. Removing the requirement to have varying levels 
of access to prescribing information or guidance may make the development of paediatric 
prescribing systems more straightforward.  
The paper version of the BNFc was reported to be used most frequently and to be the most useful 
by respondents (see Table 62).  The BNFc is a standard UK reference source for paediatric 
prescribing [110] and it is promoted by the GMC as a recommended resource for prescribing 
within its guideline on ‘Good practice in prescribing’. [91] Hence it may be expected that doctors 
would choose to use it as their ‘go to’ resource for prescribing. The frequent reported use of the 
paper version of the BNFc (the format reported to be used most frequently at BCH) may be aided 
by the fact it is distributed free to all hospitals annually in England and as such it should be readily 
available to hospital based prescribers.   
78% of respondents at BCH reported that the BNF/BNFc was the most useful reference source 
when prescribing for paediatric patients. The two main reasons reported were the 
reliability/authenticity of the information and the ease of use/availability of the BNFc. This is 
consistent with the reported priorities of clinicians when using a medicines information resource. 
[75] These were: “reliability of information” and “ease and speed of information retrieval”. [75] 
Respondents also reported that the BNFc was useful because it included all relevant prescribing 
information in one place and it was comprehensive. Again, consistent with a prior publication that 
stated the BNFc has got the breadth and depth of its coverage correct. [75] The type of 
information looked up when making prescribing decisions was primarily information required 
after the respondent has decided which drug to give. This may partially explain why information 
on drug choice was not looked up so often by prescribers at BCH in prescribing resources; 
although guidance on prescribing was reported to be one feature of the BNFc that made it useful 
to prescribers at BCH. The most frequent type of information required was dosing information, 
consistent with prior focus group findings by Mehta. [75] Dosing information is contained in the 
BNFc alongside information on contraindications and interactions. These three types of 
information were reported to be required from prescribing resources by the respondents in this 
study; hence the BNFc could be a potential one stop paediatric prescribing reference source for 
prescribers.  
The BNFc online was not in widespread use at BCH and was reported no to be used by the 
majority of respondents, unlike the paper format of the BNFc. The BNFc online does not require a 
subscription. One reason the BNFc online may have been less frequently used than the paper 
BNFc was that it was less accessible at BCH. The online BNFc required the user to have access to 
the internet via a computer or tablet and access to computers was reported to be difficult in the 
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focus groups held prior to this study. These devices may not have been available in the location 
where the resource needed to be used, for example, few computers may have been located by 
the patient bedside. However, despite this there was a very small group of users who used the 
online format on a daily basis. The BNFc app is available at no charge to healthcare professionals 
who have a NHS Athens password both in iPhone and Android formats. The BNFc app has a higher 
number of regular users than the BNFc online format at BCH. The BNFc app does not require 
internet access to function and can be accessed on a portable device, which may partly explain 
why it has more regular users at BCH than the BNFc online format, i.e. it is suitable for use in any 
location.  
Respondents reported that one aspect of the BNFc that made it useful to them was its authority. 
This authority was implied by the GMC when it recommended that its members use the BNF to 
support ‘good prescribing practice’. [91] During a recent 2013 review of information resources by 
the National Institute for Health and Social Care Excellence (NICE) the BNF and the BNFc were not 
granted approval. [111] The reasons for this were linked to the lack of defined process for 
assessing strengths and weaknesses of evidence; lack of relevant stakeholder involvement and 
finally the reader cannot ascertain when each section was last updated. [111] Respondents 
reported that the BNFc was useful because it was evidence based and up to date, but NICE did not 
agree that the BNFc had a transparent robust process for assessing evidence or clearly displaying 
when each section of the BNFc was last updated. This NICE report was available at the time of the 
study, but no respondent referred to it in any comments they made. This suggests that the NICE 
accreditation of a prescribing resource does not have an impact on the authority of the BNFc to 
respondents of this study.  
Respondents were also asked to list other resources they used that had not been referred to 
specifically in the questionnaire. These mainly fell into the category of other national guidelines, 
such as Maudsley. However, there were several different smart phone apps mentioned in this 
question, perhaps linked to the earlier trend of the BNFc smartphone app being reported to have 
been used more frequently than the online version of the BNFc. The development of smartphone 
apps to support paediatric prescribing may allow direct access to relevant information in an 
accessible location due to the portability of smartphones and tablets. However, errors in local 
development of prescribing support tools have been reported previously therefore any 
development of ‘in house’ apps should proceed with great care to ensure that appropriate quality 
control can be applied to avoid errors being built into the app. [67] 
Some resources reported to be used in this study may only be useful to certain specialties due to 
their content. Future electronic prescribing systems would need to consider if access to these 
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should be limited to specific clinical specialties. For example, the Guy’s and St Thomas’, King’s 
College and University Lewisham Hospitals Paediatric Formulary is intended to be a reference 
source for prescribing in paediatrics that also includes additional information on off license or off 
label uses of medication. Therefore developers should consider if this resource should be 
restricted to clinical areas where unlicensed prescribing has the potential to be more prolific; this 
may include the paediatric intensive care unit. A further example is Frank Shann, a collection of 
paediatric critical care guidelines; its content may only be useful to those respondents who 
worked in PICU.  
Respondents to this study reported that it can take longer to become familiar with paediatric 
doses than it does to become familiar with adult doses. This may partially explain why 
respondents with fewer years of paediatric prescribing experience used the BNFc (an information 
source with dosing information) more frequently than experienced prescribers. However, as 
evidenced by the reported use of many other sources of paediatric prescribing information, the 
BNFc does not contain all the information required for all paediatric prescribing decisions.  
Half of respondents believed that a lack of paediatric prescribing information could have an effect 
on patient care. Factors that affected the accuracy of paediatric prescribing were the most 
frequently reported reason a lack of paediatric prescribing information could affect patient care. 
Respondents reported that a lack of paediatric dosing information could lead to a risk of under or 
over treating and that this could come from prescribers reporting they were required to ‘guess’ 
the right dose or extrapolate a dose from adult data. Another way that patient care was reported 
to be affected was that lack of prescribing information could have led to delays in administration 
of medication and other aspects of patient care. Respondents reported delays could occur when 
the prescriber needed to consult several resources, which in turn led to delays in decision making 
regarding medication for that patient. Recognising that this type of delay to patient care can 
happen is important. Ideally all paediatric prescribing information would be contained in a single, 
easy to use and comprehensive formulary, i.e. an improved BNFc. However, it is apparent that the 
current formulary does not meet the needs of prescribers in this study.  
Approximately a quarter of respondents did not think patient care was affected by current levels 
of paediatric prescribing medication. This group of respondents recognised that there were a 
wide range of resources available to paediatric prescribers and this was complimented by the 
support offered from the pharmacy team at BCH. Pharmacy support in prescribing has also been 
recognised by the EQUIP study as an important way of reducing prescribing errors made by 
foundation doctors. [62] However, this group of respondents also reported that it can take time 
to find paediatric prescribing information. Despite differences in opinions respondents recognised 
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that limitations in paediatric prescribing information stem from the lack of trials in this 
population. This is an international issue, reflected in the decreasing quantity of paediatric 
prescribing information in the Physician’s Desk Reference and the legislation put in place to 
encourage more research to include paediatric populations. [73, 112]  
Respondents reported that there was a lack of paediatric prescribing information across a range 
of information types. The most common response option selected by respondents was ‘lack of 
advice other than caution’. This statement was also discussed in the focus groups and the overall 
view from participants was that a simple statement of ‘caution’ was unlikely to be helpful to 
prescribers as it provided no direction as to the best course of action. Another information type 
that was reported to be lacking was links to individual patient factors, for example prescribing 
guidance on what adjustments should be made when a patient has poor renal function. This is 
consistent with an American review paper that described current resources as not adequate for 
individual patient dosing. [71] Increased use of electronic prescribing and electronic patient 
records may allow for the development of software that uses individual patient results in 
combination with decision support to provide individualised prescribing advice. However, it is 
difficult to see how a comprehensive paediatric clinical decision system could be accomplished 
when prescribers report that some there are some areas of paediatrics that do not have the 
necessary research taking place to provide the data required.  
The results of this study should impact the way in which electronic prescribing and clinical 
decision support systems are configured in paediatrics. The respondents in this study 
demonstrate via their reported frequent use of information sources that access to paediatric 
prescribing information is required. Information regarding dosing, interactions and 
contraindications was reported to be the most frequently required information and as such 
should be prioritised when developing electronic prescribing and clinical decision support in 
paediatrics. Respondents also reported the frequent use of patient notes as a source of 
information indicating the need for high quality and readily accessible patient notes. In order for 
patient notes to be accessible to more than one user at a time an electronic patient record system 
is required. The majority of respondents believed that prescribing for children was inherently 
more difficult than prescribing for adults. The most frequent reason for this was that adult dosing 
is generally more standardised and does not necessitate the individual dosage calculations 
required in paediatric patients. It was these variations in doses that respondents felt made 
prescribing for paediatric patients more difficult, hence the requirement to frequently access 
dosing information. The difficulty in these dose calculations has been recognised as a source of 
prescribing errors in paediatric patients and is trying to be solved through the provision of 
computerised clinical decision support at the point of prescribing. However, there have been 
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difficulties in adapting current commercial clinical decision support systems for use in the 
paediatric environment. [113] 
The use of local information sources such as patient notes, patient results and local guidelines by 
respondents indicates that the development of future paediatric prescribing system should allow 
for customisation to local practice. The guidelines reported to have been used most frequently by 
prescribers at BCH were local guidelines rather than NICE or other national guidelines. Local 
guidelines may incorporate the advice found in national guidelines and apply this information to 
local protocols and practices. The practical application of national guidelines could be an 
important area of future information systems in paediatric prescribing. The large number of local 
guidelines reported to be used in this study indicates the need for the hospital to develop its own 
guidelines that bring together relevant information to guide prescribers in the use of medication. 
This process would need to be translated to an electronic system proposed to be used for 
paediatric prescribing to remove the need for prescribers to consult several resources before 
being able to make a prescribing decision. The requirement to review several sources of 
information was one reason respondents reported that could cause delays to patient care. Hence 
electronic systems developed should try and reduce the burden on prescribers and provide easy 
access to the required information.  
5.4 Limitations 
The pilot of this study confirmed that the questions were worded appropriately. This was 
demonstrated by the answers to the open ended questions clearly answering the question as 
intended by the researcher. The clarity of the questions and the choice of language used were 
also influenced by the early focus groups in this research programme. The early focus groups 
enabled the researcher to gain an understanding of the language use of the participants as well as 
a general understanding of current practice in the research area. These factors ensured that the 
research instrument was suitable for use. 
This study had a moderate response rate of 46%. This exceeded the researcher expectations as 
studies involving questionnaires completed by medical doctors typically have a low response rate. 
[102] Reasons why invited participants did not respond are indicated by the responses to two 
early questions where several participants refused to provide consent or did not currently 
prescribe at BCH. There may well be further invited participants who did not want to participate 
or did not prescribe at BCH, but did not go as far as to click through the questionnaire link to 
indicate this. Other reasons identified by previous published research include: doctors have a lack 
of time to spend filling in research questionnaires and they consider patient related tasks more 
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important. [102] These reasons may also be reasonable to apply to the non-respondents in this 
study.  
The response rate for non-medical prescribers was higher than the response rate for medical 
prescribers, indicating that they were overrepresented in this study. Non-medical prescribers 
were significantly less experienced at prescribing in paediatrics than medical prescribers. This may 
have had an impact on the reported frequency of use of some resources; some resources had less 
experienced prescribers report to use them more frequently. Therefore when using this data to 
inform the design of clinical decision support systems it is important to consider resources may 
have been reported to be used more frequently in this study than on average in practice.  
The demographic questions indicated that the medical respondents to this study had considerable 
experience of prescribing in paediatrics. The study was conducted at a specialist paediatric 
hospital where there were a larger proportion of consultant and senior specialist trainees than 
expected at an average paediatric service provision in a general hospital. This was required at the 
study site due to the high concentration of specialist services present alongside general paediatric 
services. Some resources in this study had more experienced prescribers report to use them less 
frequently. Prescribers with considerable experience may have undergone routinisation of their 
tasks; meaning they have written the same type of prescription many times and do not believe 
they require the use of a resource when working within their usual area of practice. Therefore is it 
is important to consider that the frequency of resource use may have been underestimated due 
to the overrepresentation of senior medical prescribers in this study.  
This study was conducted at a single site. Therefore the results may not be generalizable to all 
paediatric hospital prescribers. The majority of paediatric services are provided by paediatric 
wards in general hospitals rather than specialist paediatric hospitals. Specialist paediatric 
hospitals provide a wider range of specialist paediatric services than paediatric provision in a 
general hospital. Additional data from paediatric prescribers working in other hospitals should be 
collected to determine if this has skewed the data of this study.  
This study was conducted at a single specialist paediatric hospital, which may or may not be 
representative of paediatric prescribers as a whole. However, it fits the purpose of informing 
service development in electronic prescribing at BCH. It would not be expected that the results of 
this study would be reproduced exactly in other paediatric NHS Trusts in England because of local 
variation in access to resources and differing local prescribing practices in each place. There may 
also be differences in the people who prescribe between different hospitals. Lastly, access to 
resources can change over time as new editions of books are published or made available online 
and new mobile phone applications are developed.  
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Finally, there was no method of tracking if a respondent had filled out the questionnaire more 
than once. However, given the challenges in obtaining a reasonable response rate in healthcare 
professionals, it is unlikely that many will be willing to give up their time to complete the 
questionnaire multiple times.  
5.5 Conclusion 
 Prescribers at BCH reported to prescribe frequently across a range of hospital settings. 
They had a wide range of paediatric prescribing experience and reported an array of 
clinical specialties.  
 Prescribers at BCH reported to have used a wide range of resources when prescribing for 
children. 
 Prescribers at BCH recognised the BNFc as the most useful and most frequently used 
resource when prescribing in paediatrics. It was valued for its authority, ease of use and 
ease of access.  
 Prescribers at BCH reported there was a lack of paediatric prescribing information across 
a range of areas and hypothesised that this was a result of the lack of research in 
paediatric populations. 
 Prescribers at BCH felt that a lack of paediatric prescribing information could affect 
patient care, predominantly through difficulty in determining correct doses for paediatric 
patients and delays in care when information as being sought.  
 This study will inform electronic prescribing developers about the resource needs of 
paediatric prescribers when making prescribing decisions and the type of prescribing 
information that an electronic prescribing system would ideally provide.  
5.6 Recommendations for practice  
 A single source of paediatric prescribing information would be a valuable and potentially 
patient care improving resource. For example, an enhanced version of the BNFc with 
additional information covering off label and unlicensed uses of medication. 
 A clinical decision support system for paediatrics needs to have the ability to provide 
recommendations and advice that is patient specific. For example, a dose 
recommendation should consider the patients age, weight, kidney function etc.  
 Prescribers use the knowledge of a range of other healthcare professionals. Therefore 
there should be multidisciplinary working in place to enable effective use of the expertise 
available.   
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6. Use of information sources by 
members of the Neonatal and 
Paediatric Pharmacist Group (NPPG) 
when providing paediatric pharmacy 
services 
The aim of this study was to examine the use of, and satisfaction with, information resources used 
by pharmacists in paediatrics. This study was completed by pharmacist members of the NPPG. 
The results of the previous study reported in chapter 3 identified that access to patient’s 
medication information was an important component of electronic medicines management and 
the prior focus groups identified that pharmacists were used as a source of information by 
paediatric prescribers. Therefore, as an important part of the medication process in hospitals, the 
resource use of pharmacists when providing paediatric pharmacy services was investigated 
further.  
The method of this study was an online self-completed questionnaire; the details of the method 
are described fully in chapter 2, page 47. The objectives of this study were to: 
 Identify the current  paediatric pharmacy services provision reported by NPPG pharmacist 
members in terms of frequency of service provision, paediatric pharmacy experience and 
clinical specialty, 
 Identify the prescribing information resources pharmacist members of the NPPG report to 
use most frequently, 
 Identify which prescribing information resource was the most useful to pharmacist 
members of the NPPG and why, 
 Identify areas of paediatric prescribing information where pharmacist members of the 
NPPG report a lack of available prescribing information, 
 Identify the potential impact on patients of the current availability of paediatric 
prescribing information reported by pharmacist members of the NPPG. 
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6.1 Context of this study 
Little is known about how often pharmacists consult a resource whilst providing a paediatric 
pharmacy service or how useful these resources are to pharmacists. This study of information 
resource use by pharmacists working in paediatrics was conducted in collaboration with the 
NPPG.  
The NPPG is an organisation for paediatric and neonatal pharmacists that is based in the UK. It 
aims to improve the care of neonates, infants and children by assisting the development of 
pharmacists and of quality pharmacy services. Since there are no other organisations in the UK 
that have direct access to a similar number of paediatric pharmacists, the NPPG members were 
chosen as the target population for this study. The NPPG membership is made up mainly of 
pharmacists from the UK who work or have an interest in paediatrics, neonates or children and 
women’s health.  
6.2 Results 
6.2.1 Response rate 
The questionnaire was successfully sent to 280 potential participants. 133 initial responses were 
received, of whom 96 were able to complete the membership validation question, resulting in a 
response rate of 34.3%. Provision of NPPG membership number was designed to validate the 
respondent as a member and avoid any repeat completions of the questionnaire. There was 
difficulty encountered with this question as it was reported to the researchers that some 
respondents did not know their membership number and almost a third of respondents did not 
continue beyond this question.  
6.2.2 Provision of paediatric pharmacy services 
All 96 respondents to this question confirmed that they provided paediatric pharmacy services.  
6.2.3 Job title of respondents 
Respondents completed a free text box asking them to describe their job title and/or grade. 90 
responses were received to this question and are summarised in Table 42 below.  
Table 42: Grade/job title of pharmacist respondents 
Grade Frequency 
Band 7 11 
Band 8a 30 
Band 8b 12 
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Band 8c 4 
 
Job title Frequency 
General paediatric/women and children 38 
Pharmacist (no specialty declared) 13 
Specialist paediatric - oncology/haematology 4 
Specialist paediatric – neonates 3 
Specialist paediatric- Medicines 
information/formulary 
2 
Specialist paediatric – intensive care 2 
Consultant pharmacist  2 
Specialist - Education and training  1 
Specialist paediatric – rheumatology 1 
Specialist paediatric – cystic fibrosis 1 
Specialist paediatric – cardiothoracic 1 
Dispensary lead 1 
Locum pharmacist – paediatrics 1 
Resident pharmacist 1 
Multiple specialties 1 x MI & clinical trials 
3 x MI & paediatrics 
1 x PICU & paediatric nephrology 
1 x Chief pharmacist & oncology/haematology 
Total (number of responses) 90 
 
The most frequent grade of pharmacist reported was NHS band 8a (pharmacists upon 
qualification are band 6, usually moving to band 7 after 2/3 years, then band 8a after a similar 
period of time), indicating respondents to this study were senior pharmacists. Most pharmacists 
reported to be general paediatric pharmacists or pharmacists covering women and children, 
rather than a paediatric clinical specialty. There was a group of pharmacists who did not declare 
any specialty in their description of their job title or grade (n=7). There were no respondents who 
identified themselves as a community pharmacist.  
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6.2.4 Number of years of experience of providing paediatric pharmacy 
services 
Respondents completed an open question asking them to state in years how much experience 
they had in providing pharmacy services in paediatrics. There were 94 responses received to this 
question, two responses were not in the format requested and were not included in the analysis. 
The mean years of paediatric experience was: 9.7 years. The range of paediatric experience was: 
32 years (1 year to 33 years).  
6.2.5 Clinical areas where respondents provided paediatric pharmacy 
services 
Respondents were asked which of the following areas of the hospital they provided paediatric 
pharmacy services in: inpatients, outpatients, emergency department, in the community or other. 
Respondents could select more than one option. There were 94 responses received to this 
question and these are summarised in Table 43 below. 
Table 43: Areas where respondents provided paediatric pharmacy services 
Area  Frequency  
Inpatients  94  
Outpatients 73  
Emergency department 25  
In the community 23  
Other  5  
Total 94 
  
All respondents reported to work in the inpatient area with the majority of these respondents 
also working in the outpatient area. Approximately one third of respondents reported to work in 
three areas (both inpatients and outpatients plus either the emergency department or in the 
community). There were 10 respondents who reported to work in all four areas presented to 
them. The areas that the respondents considered as ‘other’ included: advice to community 
paediatric staff and hospice; homecare; community children’s nursing team pharmacist; 
ambulatory; neonatal and paediatric ITU/HDU.  
6.2.6 The most frequently reported area of work for respondents when 
providing pharmacy services for paediatric patient 
Respondents were asked which area they most frequently provided paediatric pharmacy services. 
There were 93 responses received to this question, which are summarised in Table 44 below. 
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Table 44: The area in which respondents provided pharmacy services for paediatric 
patients most frequently 
Area Frequency (% of responses to this question) 
Inpatients  86 (92) 
Outpatients  5 (5) 
Emergency department  0 (0) 
In the community  1 (1) 
Other  1 (1) 
Total 93 
 
Only one respondent reported to work in the community. The respondent who responded ‘other’ 
reported to work in paediatric intensive care most frequently.  
6.2.7 When on duty, how often did respondents provide pharmacy 
services for paediatric patients? 
Respondents were asked how often they provided pharmacy services for children. There were 91 
responses received to this question, these are summarised in Table 45 below.  
Table 45: When on duty, how often do you provide pharmacy services for a paediatric 
patient?  
Regularity of providing pharmacy services 
for children 
Frequency (% of responses to this question) 
Multiple times per day/shift 82 (90) 
Once daily  4 (4) 
Several times a week  3 (3) 
Weekly  2(2) 
Monthly 0 (0) 
Less than monthly 0 (0) 
Total 91 
 
Most respondents provided pharmacy services for children multiple times per day/shift. All 
respondents provided pharmacy services for children at least weekly.  
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6.2.8 Clinical specialty of respondents 
Respondents were asked to input in an open question “When thinking about your pharmacy 
services in paediatrics, what is your specialist area? (For example: PICU, oncology etc.)”. There 
were 87 responses received to this question, these are summarised in Table 46 below.  
Table 46: Specialties of respondents regarding paediatric pharmacy services 
Specialty Frequency 
General paediatrics 24 
NICU 11 
General and neonates/NICU 10 
Oncology/Haematology 7 
Neonates 6 
PICU 5 
Cystic fibrosis 3 
Rheumatology 2 
Medicines information 1 
Liver 1 
N/A rotational 2 
Total 87 
 
The most frequent response was general paediatrics. The two next most frequent responses were 
NICU and ‘general and neonates/NICU’. Many of the responses of general and neonates were 
accompanied by a comment stating these were the areas of service provided by their district 
general hospital. One response did not refer to a specialty. There were 14 responses that referred 
to more than one specialty.  
6.2.9 How often did respondents consult a reference or resource when 
providing pharmacy services for paediatric patients? 
Respondents were asked how often they consulted a reference or resource when providing 
pharmacy services for paediatric patients. The options were closed and the 88 responses are 
described in Table 47 below.  
Table 47: How often did respondents consult a reference or resource when providing 
pharmacy services for paediatric patients? 
Incidence of reference source use Frequency (% of responses to this question) 
Every time I provide paediatric pharmacy 5 (6) 
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services 
Several times a day 66 (75) 
Daily  9 (10) 
Several times a week 8 (9) 
Weekly 0 (0) 
Monthly 0 (0) 
Less than monthly 0 (0) 
Total 88 
 
Most respondents referred to a reference frequently (at least daily) and all respondents referred 
to a reference source at least several times a week. There were no respondents who reported 
using a reference source less than several times a week. The data was tested for an association 
between reported frequency of pharmacy services to paediatric patients and reported frequency 
of reference source use.  The independent samples Kruskal Wallis test was not significant. This 
indicates that reported frequent use of reference sources was not associated with frequent 
reported provision of pharmacy services to paediatric patients. 
6.2.10 Reported frequency of particular reference source use by 
respondents 
This question asked respondents to consider how often they used a series of reference sources 
when providing pharmacy services to paediatric patients. Each question was closed, with eight 
options presented. There were 88 responses were received to this question and the responses are 
summarised in each section below.   
6.2.10.1 British National Formulary for Children 
The BNFc is a UK nationally produced formulary. Responses are summarised in Table 48 below.  
Table 48: Frequency of reported BNFc paper format use when providing paediatric 
pharmacy services 
Regularity of use of BNFc (paper format) Frequency (% of responses to this question) 
Every time I provide pharmacy services 6 (7) 
Several times a day 46 (52) 
Daily  14 (16) 
Several times a week 11 (13) 
Weekly  6 (7) 
Monthly  2 (2) 
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Less often 1 (1) 
N/A I don’t use this resource 2 (2) 
Total 88 
 
There were five respondents who did not use this resource frequently (at least weekly). Three of 
these five reported that their specialist area of work was the neonatal intensive care unit.   
Frequency of BNFc online format use is summarised in Table 49 below.  
Table 49: Frequency of reported BNFc online format use when providing paediatric 
pharmacy services 
Regularity of use of BNFc (online format) Frequency (% of responses to this question) 
Every time I provide pharmacy services 1 (1) 
Several times a day 13 (15) 
Daily  11 (12) 
Several times a week 15 (17) 
Weekly  11 (12) 
Monthly  11 (12) 
Less often 12 (14) 
N/A I don’t use this resource 14 (16) 
Total 88 
 
The BNFc online format was used by the majority of respondents less frequently than the BNFc 
paper format. Nearly half of respondents (13/28) who reported to use it at least daily worked in 
paediatric or neonatal intensive care. The defining characteristic of respondents who did not use 
this resource was their experience in paediatrics – mean 14 years. This is double the number of 
years of paediatric experience compared to the respondent that reported to use the BNFc online 
format at least daily (mean - 7 years experience).  
The frequency of BNFc smartphone app use is summarised in Table 50 below.  
Table 50: Frequency of reported BNFc smartphone app format use when providing 
paediatric pharmacy services 
Regularity of use of BNFc (smartphone app) Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 13 (15) 
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Daily  3 (3) 
Several times a week 6 (7) 
Weekly  2 (2) 
Monthly  4 (5) 
Less often 3 (3) 
N/A I don’t use this resource 57 (65) 
Total  88 
 
The BNFc smartphone app was the format of the BNFc reported to be used least frequently by 
respondents. Similarly to the online format of the BNFc the respondents who reported to use the 
BNFc smartphone app at least daily had less paediatric experience compared to those who did not 
use the BNFc smartphone app (7.25 years vs 10.3 years).  
The BNFc paper format was the format reported to have been used most often by respondents; 
75% of respondents reported to have used it daily or more frequently. There were 98% of 
respondents who reported to have used the BNFc in the paper format, 84% reported to have used 
the online version of the BNFc and 35% reported to have used the BNFc smartphone app.  
6.10.2 Guy’s, St Thomas’ & Lewisham Hospitals paediatric formulary 
The responses regarding Guy’s, St Thomas’ & Lewisham Hospitals paediatric formulary use are 
summarised in Table 51 below.   
Table 51: Frequency of reported use of Guy’s, St Thomas’ & Lewisham Hospital paediatric 
formulary when providing paediatric pharmacy services 
Regularity of use of Guy’s, St Thomas’ & 
Lewisham Hospitals paediatric formulary 
Frequency (% of responses to this question) 
Every time I provide pharmacy services 2 (2) 
Several times a day 14 (16) 
Daily  6 (7) 
Several times a week 14 (16) 
Weekly  14 (16) 
Monthly  18 (20) 
Less often 16 (18) 
N/A I don’t use this resource 4 (5) 
Total 88 
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25% of respondents used this reference source at least daily. A small group of respondents (5%) 
did not use this resource. This group provided pharmacy services to paediatric patients frequently 
and reported to use an information source to support their provision of paediatric pharmacy 
services several times a day.  
6.2.10.3 Pharmacy team member 
Table 52 summarises the responses to this question. 
Table 52: Frequency of reported use of pharmacy team members as a resource when 
providing paediatric pharmacy services 
Regularity of use of pharmacy team 
members 
Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 8 (9) 
Daily  7 (8) 
Several times a week 31 (35) 
Weekly  9 (10) 
Monthly  11 (13) 
Less often 18 (20) 
N/A I don’t use this resource 4 (5) 
Total 88 
 
The majority of respondents referred to another member of the pharmacy team at least weekly. 
However there was a small group of respondents (5%) who did not. This group of respondents did 
not have any defining characteristics. 
6.2.10.4 Microbiology department 
Table 53 summarises the responses to this question. 
Table 53: Frequency of reported use of microbiology guidance when providing paediatric 
pharmacy services 
Regularity of use of microbiology Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 0 (0) 
Daily  2 (2) 
Several times a week 13 (15) 
Weekly  22 (25) 
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Monthly  17 (19) 
Less often 31 (35) 
N/A I don’t use this resource 3 (3) 
Total 88 
 
Over one third of respondents (35%) used microbiology as a resource less often than monthly and 
3% of respondents did not use microbiology as a resource.  
6.2.10.5 Other colleague 
‘Other colleagues’ was intended to include a reference to any other colleague the respondent 
works with who was not a member of pharmacy or microbiology. The question was “Please state 
how often you use each of the following resources” and the option was named “other colleague”. 
The randomisation of the options may have meant this was not clear. Table 54 summarises the 
responses to this question. 
Table 54: Frequency of reported use of other colleagues as a resource when providing 
paediatric pharmacy services 
Regularity of use of other colleagues Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 5 (6) 
Daily  11 (13) 
Several times a week 14 (16) 
Weekly  21 (24) 
Monthly  15 (17) 
Less often 20 (23) 
N/A I don’t use this resource 2 (2) 
Total 88 
 
The majority of respondents refer to other colleagues at least weekly when providing paediatric 
pharmacy services. Respondents then identified which colleagues they referred to in the next 
question. Respondents could list as many colleagues as they wanted to in their answer. 
Respondents most frequently referred to pharmacy or medical colleagues. They also referred to 
members of the multidisciplinary healthcare team such as nurses, dieticians, physiotherapists and 
pharmacy technicians. Respondents also contacted colleagues who worked outside of their 
hospital/Trust when providing paediatric pharmacy services. Respondents did not report to refer 
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to healthcare professionals working in primary care such as community pharmacists or general 
practitioners.  
6.2.10.6 Hospital results system 
 Table 55 summarises the responses to this question. 
Table 55: Frequency of reported use of hospital results systems when providing 
paediatric pharmacy services 
Regularity of use of hospital results systems Frequency (% of responses to this question) 
Every time I provide pharmacy services 6 (7) 
Several times a day 40 (45) 
Daily  23 (26) 
Several times a week 13 (15) 
Weekly  1 (1) 
Monthly  0 (0) 
Less often 1 (1) 
N/A I don’t use this resource 4 (5) 
Total 88 
 
A small group of respondents (5%) did not report to use the results system as a resource when 
providing paediatric pharmacy services. This may have been the result of a type which labelled 
this option as ‘BCH results systems’ rather than ‘results systems’.  
6.2.10.7 Patient notes 
Table 56 summarises the responses to this question. 
Table 56: Frequency of reported use of patient notes as a resources when providing 
paediatric pharmacy services 
Regularity of use of patient notes Frequency (% of responses to this question) 
Every time I provide pharmacy services 16 (18) 
Several times a day 48 (55) 
Daily  16 (18) 
Several times a week 6 (7) 
Weekly  0 (0) 
Monthly  0 (0) 
Less often 0 (0) 
N/A I don’t use this resource 2 (2) 
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Total 88 
 
The majority of respondents referred to patient notes when providing paediatric pharmacy 
services at least several times a day. There were 2% of respondents who reported not to use 
patient notes (one of these respondents reported to work in the community most frequently, an 
area where patient notes would be unlikely to be available). 
6.2.10.8 Frank Shann 
Frank Shann is a specialist paediatric intensive care drug dose resource available in a variety of 
formats. The most used format was the paper format that was reported to have been used by 
20% of respondents. The online format was reported to have been used by 11% of respondents 
and the smartphone app was reported to have been used by 10% of respondents. The majority of 
respondents who reported to use the Frank Shann resources reported paediatric or neonatal 
intensive care as their specialty. 
6.2.10.9 Google 
Table 57 summarises the responses to this question. 
Table 57: Frequency of reported use of Google when providing paediatric pharmacy 
services 
Regularity of use of Google Frequency (%) 
Every time I provide pharmacy services 0 (0) 
Several times a day 7 (8) 
Daily  3 (3) 
Several times a week 21 (24) 
Weekly  20 (23) 
Monthly  9 (10) 
Less often 21 (24) 
N/A I don’t use this resource 7 (8) 
Total 88 
 
Over half of the respondents used Google at least weekly as a resource when providing paediatric 
pharmacy services. Approximately 34% used Google monthly or less often. 
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6.2.10.10 NICE guidelines 
The National Institute for Health and Care Excellence produces a range of clinical guidelines in the 
UK that may be used by respondents when providing paediatric pharmacy services. Table 58 
summarises the responses to this question. 
Table 58: Frequency of reported use of NICE guidelines when providing paediatric 
pharmacy services 
Regularity of use of NICE guidelines Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 0 (0) 
Daily  1 (1) 
Several times a week 11 (13) 
Weekly  12 (14) 
Monthly  37 (42) 
Less often 25 (28) 
N/A I don’t use this resource 2 (2) 
Total 88 
 
The majority of respondents reported using NICE guidelines, however most respondents used 
them monthly or less often. Respondents were then asked to specify which NICE guidelines they 
used. Respondents were free to list as many guidelines as they wanted to in their answer. Table 
59 summarises the responses to this question. 
Table 59: Approximated NICE guidelines used by respondents when providing paediatric 
pharmacy services 
Name of NICE guidelines (guideline reference 
number) 
Frequency 
Epilepsy (CG137) 10 
Urinary tract infection (CG54) 7 
Neonatal sepsis (CG149) 4 
Feverish illness in children (CG160) 4 
Asthma (QS25) 4 
Meningitis (CG102) 3 
Sepsis/febrile neutropenia (CG151) 3 
Growth hormone (TA188) 2 
Constipation (CG99) 2 
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Cystic fibrosis, nebulised antibiotics (TA276?) 2 
Crohn’s disease (CG152) 2 
Tocilizumab in juvenile arthritis (TA238) 2 
Infliximab (TA187) 2 
Diarrhoea and vomiting in children (CG84) 1 
Attention deficit hyperactivity disorder 
(CG72) 
1 
Sedation (CG112) 1 
Intravenous fluids (yet to be published) 1 
Hepatitis C (TA300?) 1 
Renal transplant (TA99) 1 
Diabetes (CG15/CG66?) 1 
Anaemia (CG114?) 1 
Specific guideline not mentioned 26 
Total 81 
The data in Table 28 was compiled by matching the responses with the list of resources on the 
NICE website and establishing the closest match. A question mark after the guideline in the above 
table indicates that it was not possible to make a definite identification of the guideline from the 
information provided by the respondent.   
There was a wide variety of guidelines referred to with 22 different guidelines being identified in 
total.  
6.2.10.11 Local guidelines 
Table 60 summarises the responses to this question. 
Table 60: Frequency of reported use of local guidelines as a resource when providing 
paediatric pharmacy services 
Regularity of use of local guidelines Frequency (% of responses to this question) 
Every time I provide pharmacy services 3 (3) 
Several times a day 15 (17) 
Daily  25 (28) 
Several times a week 26 (33) 
Weekly  13 (15) 
Monthly  0 (0) 
Less often 0 (0) 
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N/A I don’t use this resource 3 (3) 
Total 88 
 
The majority of respondents used local guidelines at least several times a week to support their 
provision of paediatric pharmacy services. Respondents were then asked to specify which local 
guidelines they used. Respondents were free to list as many local guidelines as they wanted to in 
response to this question.  
A wide variety of local guidelines (32) were referred to by respondents as resources used when 
providing paediatric pharmacy services. The most frequently referred to guideline was the 
antibiotic guideline. There were 34 responses that did not refer to a specific guideline, but instead 
referred to a hospital or department guideline in general.  
6.2.10.12 Other national guidelines 
There are many organisations in the UK such as Royal Colleges that develop guidelines for clinical 
conditions that may be used as a resource by the respondents when providing paediatric 
pharmacy services. Table 61 summarises the responses to this question. 
Table 61: Frequency of reported use of other national guidelines as a resource when 
providing paediatric pharmacy services 
Regularity of use of other national guidelines Frequency (% of responses to this question) 
Every time I provide pharmacy services 0 (0) 
Several times a day 2 (2) 
Daily  3 (3) 
Several times a week 12 (14) 
Weekly  18 (20) 
Monthly  27 (31) 
Less often 18 (20) 
N/A I don’t use this resource 8 (9) 
Total 88 
 
The majority of respondents reported to use other national guidelines. They were reported to 
have been used by most respondents between weekly and monthly. 9% of respondents did not 
use other national guidelines. Respondents were then asked to specify which other national 
guidelines they used in a free text response. Respondents could list as many other national 
guidelines in their answer as they wanted. The most frequently reported other national guidelines 
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used were from SIGN and the British Thoracic Society. There were also a wide range of other 
organisations referred to with 29 different organisations reported. This demonstrates that 
information required for provision of paediatric pharmacy services comes from a wide range of 
sources.  
6.2.10.13 Other resources 
Respondents were also asked to record any further resources that they reported to use. 
Respondents identified 42 further sources of information that they used when providing 
paediatric pharmacy services. The most frequently reported additional resource was the Neonatal 
Formulary (NNF) followed by the Electronic Medicines Compendium (EMC). This provides further 
evidence that a large number of sources of information are required to provide paediatric 
pharmacy services  
6.2.11 The most useful information resource when providing paediatric 
pharmacy services 
Participants were asked to list up to three reference sources that were most useful to them and 
to provide a reason for this. 88 responses were received to this question with 79 respondents 
providing reasons for their choice. Table 62 summarises the responses to this question. 
Table 62: The most useful resources as reported by respondents when providing 
paediatric pharmacy services 
Rank Name of resource Frequency 
1 BNFc  60 
2 Guy’s and St Thomas’ 
paediatric formulary 
7 
3 Neonatal formulary 6 
4 Trust/Local guidelines 4 
5 Local formulary 2 
5 Local neonatal formulary 2 
5 Paediatric and Neonatal 
dosage handbook (Taketomo) 
2 
8 Martindale 1 
8 Original protocol (trial) 1 
8 Paediatric formulary 1 
8 Local NICU IV guidelines 1 
Total  88 
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The BNFc was described as being the most useful resource to respondents for the following 
reasons: 
 It was accessible. 
 It was up to date. 
 It was easy to use. 
 It covered the drugs and information needed in paediatrics. 
 It was evidence based. 
 It was the national standard for paediatric doses, therefore it was authoritative. 
 It contained information on licensing and products available. 
 It had useful background information. 
 It was a familiar resource; therefore respondents were confident in using it. 
 App/paper version – these are useful to show information to others and when computers 
are not available. 
6.2.12 What types of information do respondents look up to support their 
decisions in paediatrics 
Respondents were asked to select which types of information they ‘looked up’ to support their 
decisions in paediatrics from a fixed list of options and an ‘other’ option where additions could be 
typed. Respondents were able to select more than one response. There were 88 responses 
received to this question. Table 63 summarised the responses to this question. 
Table 63: Types of information reported to be have been looked up to support decisions 
in paediatrics 
Type of information Frequency  
Doses 87  
Interactions  80  
Formulation information 79  
Contraindications 78  
Patient test results 73  
Drug choice 72  
Compatibilities 71  
Other  20  
Total 560 
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Respondents reported to have accessed all of the information types listed when providing 
paediatric pharmacy services. They also reported an additional twenty types of information that 
may be ‘looked up’ to support decisions in paediatrics. The other types of information used by 
respondents demonstrate the breadth of information required when providing paediatric 
pharmacy services.  
Table 64 below describes the type of information most frequently required by respondents when 
providing paediatric pharmacy services.  
Table 64: Type of information reported to have been ‘looked up’ most often 
Type of information Frequency (% of responses to this question) 
Doses 76 (86) 
Patient test results 6 (7) 
Formulation information  2 (2) 
Drug choice 1 (1) 
Contraindications 1 (1) 
Interactions  1 (1) 
Compatibilities 0 (0) 
Other 1 (1) 
Total 88 
The ‘other’ response was “remains a combination of all”. 
The most frequently looked up type of information by respondents when providing paediatric 
pharmacy services was doses.  
6.2.13 What information did respondents report current resources 
lacked to support their paediatric decisions? 
Respondents were asked to select which types of information were lacking in current resources to 
support their paediatric decisions from a fixed list of options. Respondents could select as many 
options as they felt appropriate or “there is no lack of information”. 87 responses were received 
to this question. Table 65 below summarises the responses to this question. 
Table 65: What information did respondents report current resources lacked to support 
paediatric decisions? 
Type of information Frequency  
Availability of paediatric formulations 56  
Lack of advice other than ‘caution’ 44  
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Paediatric doses 28  
Links to individual patient factors 24  
Lack of access to information 13  
There is no lack of information 5  
Other  25 
Total 195 
 
Respondents were most frequently reported that there was a lack of information on availability of 
paediatric formulations. Five respondents reported that there was no lack of information.   
Other areas respondents reported a lack of information in can be summarised as the following: 
 Dosing guidance for obese children 
 Dosing guidance for children with renal impairment 
 Administration information, particularly concerning the effect of dissolving medication in 
fruit juice or other food/drink to mask the taste 
 Further information on off-label or unlicensed use of medication in children, doses that 
have been given safely 
 Pharmacokinetics in paediatric patients 
 Impact of medication on baby/child when mother is breastfeeding.  
Those who gave a positive response to the option “lack of paediatric dosing information” were 
directed to an additional question which asked respondents to identify the specific areas of 
paediatric practice which they considered to be lacking dosing information. Respondents could 
select as many responses as they felt appropriate. Table 66 below summarises the responses to 
this question. 
Table 66: Types of paediatric dosing information reported that are lacking in current 
resources 
Type of dosing information Frequency  
Doses for premature babies 27  
Renal doses  24  
Hepatic doses 23  
Paediatric doses in general 21  
CVVH/dialysis information 16  
ECMO doses 5  
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Filtration dosing information  5  
Other  8  
Total 129 
 
The type of dosing information most respondents felt was lacking paediatric specific information 
was doses for premature babies. The responses to other areas that respondents reported to have 
a lack of paediatric dosing information included: dosing in obese children; doses for unlicensed 
drugs; which filters are appropriate with which drug; incidence of side effects in paediatrics; 
dosing in plasmapheresis/plasma exchange.  
6.2.14 Does a lack of paediatric prescribing information have an effect on 
patient care? 
There were 85 responses received to this question. Table 67 summarises the responses received.  
Table 67: Does a lack of paediatric prescribing information have an effect on patient care 
Answer selected Frequency (% of responses to this question) 
Yes  53 (62) 
No 12 (14) 
Don’t know 20 (24) 
Total 85 
 
Although a majority of respondents considered that a lack of prescribing information in 
paediatrics could affect patient care, just under one quarter of respondents were not sure and 
about fifteen percent considered that there was no effect on patient care. Respondents were also 
asked to explain the reasons for their response, 69 responses were received to this part of the 
question.  
Reasons why a lack of prescribing information may affect patient care 
 There can be a difficulty obtaining paediatric information quickly, which can lead to a 
delay in treatment. 
o Sometimes several reliable resources have to be checked, having one good 
resource would hasten this. 
 Decisions are not always informed by evidence. 
 Educated/extrapolated ‘guesses’ on doses have to be made from minimal data. 
o It relies heavily on clinical interpretation/experience.  
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 No data/information even when the drug has an indication for use in children makes 
selecting a dose very difficult.  
Reasons why current paediatric prescribing information does not affect patient care 
 The establishment of Medicines for Children and the BNFc has improved things 
substantially.  
 We have many different resources available. 
 You can contact colleagues in tertiary centres for information.  
 Responses (of the patient) need to be monitored and then dose/choice of medication can 
be adjusted as needed. 
Reasons why respondents are not sure if currently available paediatric prescribing 
affects patient care 
 Each time we have a lack of information, we have a n=1 study, so it is difficult to day if 
outcomes are changed.  
 We are quite good at finding information. 
 We use clinical judgement to make the decision.  
 It can be difficult getting a specific answer to a specific question, which is frustrating.  
 There is a lack of evidence base but I query whether this makes care substandard.  
 There is limited safe drug choice in some conditions, but this makes paediatric prescribers 
more familiar with the medications they use and cautious in their prescribing habits.  
 It is impossible to know if too much or too little of a drug is used when information is 
based on extrapolation of adult data.  
6.2.16 Is there a difference in difficulty between prescribing for children 
and prescribing for adults? 
Respondents were asked: “in your opinion is there a difference in difficulty between prescribing 
for children and prescribing for adults? Please explain your answer.” This open ended question 
was answered by 79 respondents. The responses have been summarised and grouped into three 
distinct categories: children are more difficult to prescribe for (n=53); there is no difference in 
difficulty between prescribing for adults and prescribing for children (n=1) and an unsure/don’t 
know category (n=25).  
Comments that support the option children are more difficult to prescribe for than 
adults 
Comments from respondents have been summarised into four distinct categories representing 
the most prominent themes found in their answers. These were:  
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 Factors relating to calculations of drug doses: 
o Doses need to be calculated on an individual basis for children. 
o Calculations have to be done considering different factors for different drugs; e.g. 
age, weight and body surface area. 
o Dose rounding needs to be considered more often for paediatric patients to 
enable the chosen dose to be measurable. 
 Factors relating to the changes that happen as children grow: 
o Children have a constantly changing profile in terms of drug adsorption, 
distribution, metabolism and elimination.  
o The dose for a child can vary for different age groups on a dose/kg basis.  
o There are more risks in prescribing for children because there are more variables 
that affect the dosing.  
 Factors that relate to the information available on prescribing in paediatrics: 
o There may not be a dose in the BNFc, therefore the difficulty lies in deciding what 
dose to use.  
o There is less data/information available to support paediatric prescribing. For 
example, there may be a dose for 12-18 years olds but not a dose for under 12 
year olds.  
 Additional knowledge required for prescribing in paediatrics: 
o The lack of paediatric friendly formulations makes prescribing more difficult in 
paediatrics. For example, the alcohol content of some formulations is very high.  
o Greater knowledge of pharmacology and pharmacokinetics is required when 
prescribing in paediatrics.  
o There is greater use of off-label/unlicensed prescribing, where there is less 
evidence to support decisions.  
 Other comments outside of these four areas included:  
o There is an increased likelihood that errors won’t be picked up because there are 
a variety of correct doses rather than a single correct dose often seen with adults.  
o In paediatrics pharmacists may have to make value based decisions and as they 
are educated as scientists it is not something they are used to doing.  
Comments that do not support either option of adult or paediatric patients being more 
difficult to prescribe for: 
The comments were grouped into four categories to reflect the most prominent themes in the 
respondents’ answers. These were: 
 Factors relating to data available for paediatric prescribing: 
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o There is definitely less definitive or clear cut prescribing information/data.  
 Factors relating to personal perceptions of paediatrics: 
o Not really, I think it is a confidence issue if you are not used to prescribing for 
children.  
o Possibly, but a lot of this is perception rather than reality. 
 Factors relating to prescribing difficulties in adult and paediatric populations 
o Perhaps, but then again maybe adult medicine makes too many assumptions.  
o It is more difficult to make a risk/benefit decision to prescribe a medication at 
either extreme of life.  
o Each has their own problems. There is less polypharmacy in paediatrics and the 
smaller range of drugs helps to ensure familiarity with them.  
o Adults have more complex medicines, but less complex dosing. Children generally 
have fewer medicines but more complex dosing.  
o These issues aren’t unique to paediatrics but are more common.  
In addition to the two main opinions described above, a single comment was received where the 
respondent identified that prescribing for children was not more difficult than prescribing for 
adults. This respondent stated “Complex yes, difficult no. It is a question of practice and very 
frequent exposure.” 
6.3 Discussion 
This study identifies the current practice of pharmacist members of the NPPG who provide 
pharmacy services to paediatric patients. The majority of respondents provided pharmacy 
services to paediatric patients several times a day and had considerable experience of providing 
pharmacy services in paediatrics (see Table 14 and Section 6.2.4 Number of years of experience of 
providing paediatric pharmacy services). Respondents in this study reported a wide range of 
clinical specialties as their specialist area when providing pharmacy services to paediatrics (see 
Table 15). The majority of respondents reported using an information source to support their 
provision of pharmacy services in paediatric several times a day (see Table 16).  
The BNFc was the resource that respondents reported to use most frequently (see Table 17) and 
reported to be the most useful in their practice (see Table 31). Two of the most reported reasons 
for using the BNFc were that it was up to date and authoritative. The evidence underlying each of 
these reasons could be questioned. One could query the authority of BNFc as it did not pass the 
initial assessment to be a NICE approved resource. [111] The reliability of the BNF’s information 
has previously been reported as a priority for clinicians, although this is also questioned in the 
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report by NICE. [75] One reason it did not pass the NICE accreditation was it did not sufficiently 
demonstrate a transparent and robust method for assessing the evidence base. [111] However, 
this could also demonstrate that respondents in this study do not consider NICE to be the 
authority on medicines information. This is supported by the data in this study that respondents 
use local guidelines more frequently than NICE guidelines. The second common reason the BNFc 
was reported to be useful is that it is up to date. The most frequently used format of the BNFc, 
the paper version, is updated annually, although electronic updates are provided monthly via 
email if the user has requested them. [114] This information highlights that a resource 
respondents consider to be up to date and authoritative may be neither.  
Pharmacists are regulated by the General Pharmaceutical Council (GPhC). As a result of this the 
GPhC could be considered a source of authority for pharmacists. The GPhC states that the BNF is a 
resource that it “expects trainees to use regularly when they are in training and once they are 
registered”. [115] This may partially explain why the respondents in this study consider the BNF to 
be authoritative. However, the GPhC recognises that the BNF is not the only source of information 
pharmacists are required to interpret in order to practice safely. This is recognised by inclusion of 
education about critical appraisal in the ‘Standards for the Initial Education and Training of 
Pharamcists’ and the recent inclusion of other sources of information, such as summary of 
product characteristics for drugs and medication charts, within the new registration assessment. 
[115] Recognition by the pharmacy regulator that more than the BNF is required in practice 
indicates that pharmacists are expected to be able to interpret and use information from multiple 
sources in practice. The Royal Pharmaceutical Society (the professional membership body for 
pharmacists in Great Britain) also provides guidance for pharmacists on how to use the BNF; 
providing further assurance on its ‘authority’ to pharmacists. [116] 
This study has raised concerns about the information available to support the provision of 
pharmacy services in paediatrics. Respondents reported that there were many types of medicine 
information that are lacking paediatric specific data (see Tables 34 and 35). The lack of paediatric 
information has been recognised for several years. There is legislation from the European 
Medicines Agency in place to drive further paediatric data collection from pharmaceutical 
companies. [112] However, this study suggests that this information is not yet at levels suitable to 
provide sufficient support in paediatric pharmacy service provision. Respondents have reported 
that they agree that the current level of paediatric prescribing information may have an effect on 
patient care (see Section 4.2.14). They described scenarios where inadequate paediatric 
information may lead to inappropriate dosing and searching for paediatric information may lead 
to a delay in the receipt of care.  
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The accessibility of current paediatric prescribing information is also highlighted by this study. 
Respondents reported using Google to support their provision of paediatric pharmacy services as 
well as numerous other sources of information. The variety of resources reported may highlight 
that the information required for paediatric pharmacy services is not available in a single 
accessible resource. Over fifty different sources of paediatric information were reported to be 
used by respondents. Despite this, two thirds of respondents reported the same resource to be 
the most useful to them; the BNFc. The aim of the BNFc was to “provide all available information 
from all available sources on medicines used in children”. [117] This study suggests it is not 
meeting this aim demonstrated by the large number of additional resources reported to be used 
when providing pharmacy services to paediatric patients. 
Respondents in this study recognised that prescribing for children is more difficult than 
prescribing for adults. This is a recognised difficulty and has been highlighted again in recent 
literature. [16, 17] The difficulties of paediatric prescribing have been well described and are 
reinforced by the respondents in this study who state that there are many more factors to 
consider when prescribing for a child and this is the principal issue that makes prescribing for 
children more difficult than prescribing for an adult. The NICE Guideline on medicines 
optimisation recommends that clinical decision support should be considered to support 
prescribing. [88] It could be inferred that this is in response to the vast quantities of data across a 
range of sources that is now available and needs to be assessed when making a prescribing 
decision. The data from this study would support use of a clinical decision support system as 
respondents recognised that manual and individual evaluation of available information can lead 
to delays in patient care and errors in dosing recommendations.   
The study had a response rate of 34.3%. There was a single respondent who did not provide 
consent to complete the survey and as such was not asked any further questions. Some 
information was received about non-respondents as they made contact with the researcher to 
explain why they could not complete the survey. The reasons included: working in industry rather 
than hospital pharmacy and working outside the UK. The NPPG is not solely open to hospital 
pharmacists so it is reasonable that a proportion of the potential respondents chose not to 
respond to the questionnaire as it was not applicable to them. The chances of non-pharmacist 
respondents completing the questionnaire have been minimised as it has been sent out via a 
professional group (The Neonatal and Paediatric Pharmacist Group). 
The pilot of this study with pharmacists has helped ensure the validity of the questionnaire as a 
research instrument. The pilot and the prior focus groups confirmed that an appropriate choice of 
language had been used. This was demonstrated by the answers to open ended questions in the 
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pilot, which answered the question as the researcher had intended it to be answered. This 
confirmed that the researcher that an appropriate understanding of the subject area and 
language had been gained from the initial focus groups. There were no additional options 
suggested to closed questions; this suggested all reasonable options within the question had been 
presented. 
6.3.1 Limitations of the study 
The main limitation of this study was that there is poor access to the pharmacist population. 
There is not an easy method of contacting and inviting specialist groups of pharmacists to 
participate in research. The pharmacy regulator does not record the areas of practice of its 
registrants and does not usually provide contact details to enable a researcher to invite its 
registrants to participate in a research study. Therefore the researcher used a specialist paediatric 
pharmacist group (The NPPG) to disseminate the study to potential respondents. This group has a 
voluntary membership scheme and therefore not all pharmacists in paediatrics were available to 
invite to participate in this study. However, it was decided that delivering this study via the 
professional group the NPPG was significantly more efficient that individually contacting each 
hospital to determine who their paediatric pharmacists were. 
This study may not represent the views accurately of the entire population of pharmacists who 
provide paediatric pharmacy services. There may be many more pharmacists who provide these 
services, but who were not a member of the NPPG and as such were not included in this study. 
The experience and frequency of provision of paediatric pharmacy services by NPPG members 
may not reflect the general paediatric pharmacist population in this country. For example, the 
most frequently reported grade of respondent was “band 8”; this is a senior pharmacist position 
in the NHS. There are likely to be more junior pharmacists who work in paediatrics on a 
permanent or rotational basis that have chosen not to join the NPPG. Therefore the high level of 
experience of the respondents in this study may have led to underestimation of the frequency of 
use of resources when providing paediatric pharmacy services.  
The responses in this study may not reflect the reality of providing paediatric pharmacy services 
because respondents may not have accurately reported their current experiences. The 
membership of the NPPG may not reflect the average pharmacist who provides paediatric 
pharmacy service. It is possible that members of the NPPG may be more interested in the 
provision of clinical pharmacy services than those who are not members. Extension of this study 
to non-NPPG pharmacists who provide pharmacy services to paediatric patients would be 
valuable.  
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There was an error in one question of this study where ‘BCH results systems’ rather than ‘hospital 
results systems’ was displayed. The responses to this question seem to indicate the question 
remained understood as respondents reported using patient results. The understanding of this 
question would have been improved by the examples provided after it in brackets; these included 
blood results, imaging.  
Respondents reported that they did not know their membership number for the NPPG so 
respondents could not be verified to be paediatric pharmacy service providers. There were also a 
number of respondents who left the questionnaire at this point, possibly because they thought 
that the membership number was a required field to continue. This loss of potential respondents 
could have been avoided with more thorough piloting in the pharmacist population.  
It was anticipated that non-paediatric pharmacists would not have had access to the 
questionnaire as it was distributed by the NPPG directly to each respondent and the link to the 
questionnaire was not made available elsewhere. It was not possible to confirm if any participant 
chose to complete the questionnaire on more than one occasion. However, given that prior 
research has suggested that healthcare workers have little time to complete research 
questionnaires and will prioritise patient focussed tasks it seems unlikely that this will have 
occurred. [102] 
6.4 Conclusion 
 The majority of respondents provided paediatric pharmacy services daily and used an 
information resource to support the provision of paediatric pharmacy services several 
times a day.  
 The most frequently used information resource within this study was the BNFc. It was the 
most useful resource due to its ease of use, its comprehensive coverage of paediatrics 
and its current information.  
 Respondents reported that there was a lack of paediatric data across a range of 
information types, for example paediatric doses and availability of suitable formulations. 
 Respondents believed that the lack of paediatric medicines information could have an 
effect on patient care. This would be most likely seen as delays in treatment whilst 
information was sort and the inability to determine doses accurately in paediatric 
patients.  
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6.5 Recommendations for practice 
 This study identified the information needs of pharmacists when providing paediatric 
pharmacy services. It indicates the requirement for a single comprehensive paediatric 
resource. For example, an enhanced BNFc, as this resource was reported to be used 
most frequently.  
 Delays in treatment can occur whilst paediatric medication information is found and 
evaluated, therefore the development of a single point of access for complex 
paediatric data is recommended. 
 Respondents reported using a range of online resources, indicating that a reliable 
method of access to these sources is required to provide paediatric pharmacy services 
effectively. 
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7. Paediatric prescribing support in 
board meeting minutes of English 
paediatric NHS trusts 
The aim of this study was to investigate the reported discussions of paediatric prescribing support 
at board level for hospitals with paediatric services. In order to confirm solely paediatric support 
was being referred to the four specialist paediatric trusts in England were selected as the study 
sites for this study. These were: Alder Hey Children’s NHS Foundation Trust; Birmingham 
Children’s Hospital NHS Foundation Trust; Great Ormond Street Hospital for Children NHS 
Foundation Trust and Sheffield Children’s NHS Foundation Trust. The objectives of this study 
were: 
 To investigate what tools/systems are reported to be used to improve paediatric 
prescribing practice at the study sites, 
 To examine the effect these tools/systems are reported to have on paediatric prescribing 
practice and/or paediatric medication errors at the study sites?  
The board meeting is the strategic level of decision making in each NHS Trust. Therefore it was 
decided that the incidence of references to paediatric prescribing support should be measured in 
the documents from these meetings to determine if this was an issue being considered seriously 
by the decision makers in each Trust. Board meeting minutes and their associated papers are 
public documents in England. This means that they should be freely available to members of the 
public. These documents are usually available on the Trust’s website, but on occasions this may 
not be the case. When this happened a freedom of information request was sent to the hospital 
to request the documents. One freedom of information request was sent to each hospital to 
request any papers that were not available on the hospitals’ websites. On every occasion there 
was a positive response to such requests.  
The papers and minutes for each board meeting from January 2010 to December 2012 were 
qualitatively analysed using applied thematic analysis; the focus of the themes was supporting 
prescribing in paediatrics. A total of 85 sets of minutes were analysed (33 from Sheffield, 32 from 
Alder Hey, 24 from Great Ormond Street (GOSH) and 16 from Birmingham Children’s Hospital 
(BCH)) The full details on the method can be found in chapter 2, page 48.  
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7.1 Results and discussion 
The results and discussion are presented together for this qualitative study in the themes that 
were developed in the qualitative analysis process. 
7.1.1 Support for prescribers 
Training for all prescribers has been identified in each of the hospitals’ minutes as a way of 
providing support for prescribing. It was the most frequently referred to intervention (n=25) and 
it was reported in nineteen meetings. Much of this came in the form of mandatory training which 
would have covered antibiotic prescribing and paediatric early warning scores. New staff often 
received one off training sessions on medicines management, paediatric prescribing and risk 
management.  
“Training activities: antimicrobial prescribing is provided for medical induction and annual 
update.” GOSH 
According to a prior study training on paediatric prescribing and information about common 
prescribing errors was often provided by a pharmacy-led presentation at induction. [60]  
However, there was no evidence to support this in the data collected from this study. There is no 
further information provided on the effect this mandatory training had on prescribing practice at 
any of the study sites: 
“No evidence could be identified to support a causal link between … training and 
medication errors.” Sheffield  
However previous research has identified prescriber education as a key factor in reducing 
prescribing errors, which was consistent with the provision of training described in the minutes of 
the hospitals in this study. [118, 119]  
Prescribing support specific to a certain area of practice (e.g. use of antimicrobials) was reported 
in the papers from all hospitals in the study. There were a total of thirteen references to this type 
of prescribing support across seven meetings. This usually involved a specialist pharmacist and/or 
specific prescribing guidelines. The most common area of specific prescribing support reported in 
the minutes was for the use of antimicrobials.  
“We implemented antimicrobial pharmacist ward rounds targeting specific antibiotics.” 
BCH 
Three hospitals reported having antimicrobial pharmacists in place to help support good 
prescribing practice in this area. Policies designed to improve prescribing in the area of 
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antimicrobials included: targeted ward rounds for high use antibiotics and care bundles that 
directed the prescriber to rational and safe antimicrobial prescribing. BCH papers referred to 
further tools designed to improve antimicrobial prescribing. These included the use of reminder 
stickers to promote prescribing in accordance with guidelines; an easy to access intranet page on 
antibiotic prescribing; an eLearning module on antibiotic prescribing that forms part of the 
mandatory training and a campaign on prudent antibiotic prescribing as part of European 
Antibiotic Awareness Day. Further examples of specific prescribing support include: one to one 
training with a ward pharmacist in haematology/oncology and clinical practice guidelines for high 
risk drugs (e.g. insulin).  
“The ward based pharmacists have continued their package to reduce prescribing errors 
(including initial close supervision of prescribing and regular feedback of errors.” GOSH 
Credit card sized support tools were in use at two hospitals: Sheffield and GOSH. At Sheffield after 
an audit regarding accuracy of prescribing in dentistry, one of the actions implemented was the 
introduction of a credit card-sized weight adjustment card for calculating medication doses.  
“credit card size handy weight adjustment card for calculation of prescription dose”. 
Sheffield. 
These were designed to be practical and easy to keep on your person when prescribing. They may 
be attached to clinical staff ID badges, which presumably were in frequent use and as such were 
seen often, thereby providing regular reminders to improve prescribing. No subsequent report on 
the success of this tool was made within the minutes or papers at Sheffield. The credit card tool at 
GOSH was used as a memory prompt for the child early warning score intervention and the 
‘SBARD’ communication tool.  
“They are also given laminated credit card sized memory prompts to attach to their ID 
badge.” GOSH 
SBARD stands for ‘situation, background, assessment, recommendation, decision‘. This 
communication tool is also referred to as ‘SBAR’ and it is recommended on the NHS Institute for 
Innovation and Improvement website as a tool to improve the communication of critical 
information, particularly information requiring the attention of a doctor. [120] There was no 
further information reported within the minutes and documents on the effectiveness of either of 
these tools.  
Feedback to clinicians about their prescribing habits was reported in the GOSH minutes and 
associated papers. It was referred to in seven meetings. However, this process may be easier in 
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hospitals that already have electronic prescribing in place due to system features such as 
prescribing reports. Collating individual prescribing feedback in hospital with paper based 
prescriptions would involve significantly more staff time. Feedback to clinicians at GOSH could be 
provided with  
“Analysis of JAC (electronic prescribing system name) data.” GOSH 
Pharmacists at GOSH were also providing daily feedback to the whole prescribing team on other 
errors or trends and could include 
“one to one feedback on any significant errors.” GOSH 
According to the EQUIP study on prescribing errors, pharmacists make many interventions 
including identifying prescribing errors that contribute to improvements in prescribing. [62] 
Minutes from GOSH and Sheffield both referred to pharmacy support in relation to prescribing. 
This covered areas such as prescription checks and providing a safety net for prescribers.  
At GOSH the prescribers were encouraged to put actions in place before prescribing mistakes 
were made and this was supported by dashboards that communicated information related to 
drugs commonly featured in prescribing errors such as paracetamol and morphine. Similar actions 
were not reported within the other minutes and papers from the other hospitals. 
The minutes of one Trust (GOSH) referred to medicine or infusion calculators on five occasions. 
Medicine calculators are used to assist prescribers in calculating the correct medication dose for a 
patient. GOSH has developed an infusion calculator designed to reduce prescribing errors on one 
of the cardio-respiratory wards – CICU.  
“CICU have continued their package of innovations aimed at reducing prescribing errors. 
In addition, an electronic infusion calculator too is used, and further improvements to the 
tool are being tested.” GOSH. 
There were no references to this infusion calculator tool that indicated the effect it had (if any) on 
prescribing errors. Medicine calculators have been demonstrated to show improvement in 
prescribing. For example, in one study, students using a PICU calculator were able to write more 
accurate emergency drug infusions than consultants using the BNFc. [121] A further study 
demonstrated that an online calculator for parenteral nutrition reduced calculation errors and 
other dosing errors such as issues with inappropriate osmolality. [45] It would be useful to other 
paediatric centres if GOSH had data that it could publish on the effect of the infusion calculator on 
infusion prescribing errors.  
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7.1.2 Electronic patient records and medical records 
Medical records are not often thought of as a prescribing support tool, but the quality of medical 
records could certainly have an impact on the quality of prescribing. Information recorded in 
medical records can be used to inform prescribing decisions. The importance of medical records is 
demonstrated by the frequent referral to this subject in the minutes of each of the hospitals’ 
board meetings (n=18). There were references to poor record keeping in the minutes and papers 
studied (n=5 at GOSH and n=3 at Sheffield). GOSH minutes reported that there was a  
“Failure to follow basic standards of record keeping and failure to document key events in 
the patient journey”. GOSH 
There were also reports of problems with inconsistent filing which led to it being difficult to find 
key parts of the patient record such as discharge summaries. The minutes from GOSH reported 
the poor quality of medical records in further detail. 
“It was reported that 33% of records contained an illegible medical entry; and 35% of 
records contained loose filing.” GOSH 
Illegible or missing information has the potential to affect a prescribing decision. 
All hospitals acknowledged that moving to an electronic patient record would be required in the 
future and they were at various stages in their progression towards this. Electronic patient 
records have the potential to improve access to patient information as they could remove the 
need to wait for paper records to be found and delivered to the department/ward. The minutes 
from BCH referred to the trial of a system called “me@BCH” which would be used for frequent 
attenders of the emergency department.  
“This will be an electronically stored document that can be accessed in the emergency 
department and will hold all current treatment management plans, plus medication so 
children and young people can be cared for appropriately without parents/carers having 
to repeat their history on each occasion.” BCH 
The BCH minutes reported that this could ensure that patients would receive appropriate medical 
care whilst the full record was brought to the department and it would reduce the need for 
parents/carers to repeat their child’s medical history so frequently.  
The hospitals in this study were considerably behind the standard set by the electronic National 
Patient Summary used in Sweden. [122] This electronic system contains current care contacts, 
personal details, chronic diseases, medical alert information and current medical examination 
results in a format accessible to all care providers. In the UK a similar system, the summary care 
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record is being introduced. This could provide comparable information to the system used in 
Sweden. The summary care record system is designed to be accessible to healthcare services to 
enable them to quickly identify patient’s current health issues, medication, allergies and other key 
information. [123]  
7.1.3 Healthcare professional involvement in projects 
The importance of clinician and other healthcare professional involvement in patient related 
projects was referred to in the minutes of all hospitals in this study (n=6). Clinician involvement 
was deemed important from the start of the procurement process to the completion of 
implementation of the new systems.  
“It is imperative that more linkage with clinicians and nurses is included”. Alder Hey 
It was also reported by one hospital that regular communication was required to engage staff and 
to ensure that expectations were managed during the development of new systems and tools. 
The practice of engaging staff in the development process is consistent with recommendations of 
the current literature that advises clinicians and nurses involvement is recommended in the 
development of decision support. [107, 109] Involving healthcare professionals in the 
development of interventions was also recommended as a conclusion of the study on electronic 
medicines management (chapter 3) where further involvement of pharmacy staff in the 
development of the electronic medicines management system was described as one method of 
improving the development, application and implementation of the system.  
7.1.4 Electronic prescribing 
Electronic prescribing is not standard practice in UK hospitals. Instead prescribing is usually 
carried out on charts specifically designed for recording prescriptions and medication 
administration. Only one paediatric hospital (GOSH) in this study used electronic prescribing 
according to the board meeting minutes and associated papers. However, two further hospitals 
(BCH and Alder Hey) have had the initial business cases approved by the hospital as the first step 
in working towards electronic prescribing. The reports from BCH and GOSH suggest that 
electronic prescribing was one way that the hospitals have identified to improve prescribing 
practice.  
“Most organisations see (electronic prescribing) as the way they will drive more prudent 
prescribing”.  GOSH 
“In relation to medication incidents… we are looking at ePrescribing”. BCH 
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Driving the implementation of electronic prescribing was identified as a priority in 2013 by the UK 
Department of Health and PricewaterhouseCoopers (national auditors), [124] so it is promising to 
report the majority of the hospitals in this study are already working towards this objective. A 
previous study regarding the use of electronic prescribing at GOSH has demonstrated that it can 
lead to a reduction in prescribing errors even when inbuilt clinical decision support is not 
provided. [25, 33] A further benefit of the system was reported in the minutes from GOSH; the 
electronic prescribing system holds  
“A wealth of data.” GOSH 
The data from the electronic prescribing system could be used to provide more detailed 
information on prescribing errors and be used in prescribing improvement strategies. An 
anecdotally reported issue with the electronic prescribing system at GOSH was that the electronic 
prescribing system had made in harder to promote good prescribing practice in some areas. One 
example given was in relation to antimicrobial stewardship. In this example, the minutes reported 
that the system was unable to record some important information for antimicrobial prescriptions. 
This is an example of an innovative technology not being able to mimic good practice that can 
easily be managed on a traditional paper drug chart. 
“The system does not enable clinicians to easily record reason for prescribing.”  GOSH   
7.1.5 Junior doctors 
The papers from all four hospitals referred to the workload or need for prescribing support for 
junior doctors (n=10). The minutes from BCH reported that all new doctors were given training in 
“medication for children” and assessed on their ability to prescribe for paediatric patients. There 
was no information included on the effect this has had on prescribing errors, but the fact that it is 
in place suggests both tools are needed to ensure a certain standard of prescribing practice in 
maintained across the hospital. A previous study across several different study sites has identified 
that lack of prescribing education can cause problems with junior doctor prescribing so there is 
evidence for having these tools in place at BCH. [62] 
The minutes from GOSH reported that a different approach had been taken by some wards to 
ensure the safety of junior doctor prescribing. On oncology/haematology wards pharmacists 
provided  
“One to one supervision of prescribing by all new doctors during their first week”. GOSH 
These initiatives are in line with current literature that has reported a lack of confidence in 
prescription writing and poor drug chart completion upon qualification as a doctor in the UK. 
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[125] Workload pressures on junior doctors were recognised in the papers from Alder Hey, BCH 
and Sheffield. At BCH sharing of workload with other healthcare professionals (e.g. advanced 
nurse practitioners) had helped reduce the reliance on junior doctors in the paediatric intensive 
care unit. The emphasis in the minutes of each hospital was on education of junior/new doctors 
and assessment of their prescribing ability. This seems appropriate as a previous study reported 
that junior doctors complete a large proportion of prescribing in hospitals. [62] 
The minutes identified the use of prescribing tests to test the paediatric prescribing competency 
of new doctors at both BCH and GOSH (n=4). The prescribing test aimed to identify prescribers 
who need further support/education regarding paediatric prescribing and as such reduce the 
likelihood that they will commit a prescribing error. The Royal College of Paediatrics and Child 
Health has also developed a Paediatric Prescribing Tool designed to inform senior doctors of staff 
who may need extra paediatric prescribing support. [126] The introduction of a paediatric 
prescribing test at a further hospital, St Mary’s Hospital, London, also allowed staff to identify 
prescribers in need of extra support at an induction session and provide support to them at the 
start of their employment. [127] This body of evidence suggests that junior paediatric prescribers 
should be tested on their paediatric prescribing competence to enable less competent prescribers 
to be identified for further training. Further training should then reduce the likelihood of a 
prescribing error being committed.  
7.1.6 Dedicated prescribing area 
The minutes from one hospital (GOSH) referred on several occasions to dedicated prescribing 
areas (n=9). These were areas reserved for prescribing that were in a quieter location where 
interruptions and distractions would be minimised. Minutes from GOSH had stated that 
interruptions could be a contributory factor to prescribing errors, hence the introduction of 
dedicated prescribing areas. There was no report on the success of this intervention in improving 
paediatric prescribing in the minutes. However, there is a report in the literature that the 
introduction of a dedicated prescribing area as part of a zero tolerance prescribing policy had 
reduced prescribing errors on the PICU at GOSH. [66]  
Using a dedicated prescribing area to improve prescribing has evidence to support its use. 
However, this tool has not been introduced by the other paediatric hospitals in this study. This 
suggests that there is a lack of collaboration or learning across the different study sites. It is 
concerning that a hospital would choose to pursue an intervention without such evidence, for 
example credit card sized support tools, when there are interventions with an evidence base that 
they could implement instead.  
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7.1.7 Paediatric trigger tool 
The paediatric trigger tool is one method of measuring harm caused by providers of paediatric 
healthcare. It can be used to identify areas where harm is occurring, for example due to 
prescribing errors. [128] The paediatric trigger tool is a monthly case note review intervention 
designed to identify adverse events and areas of care where harm is occurring. [128] The use of 
this tool was only reported in the minutes from GOSH (n=7). The minutes from GOSH did not 
report any actions arising from the use of the paediatric trigger tool that related to prescribing 
support. The Institute of Innovation and Improvement recommended that this tool was employed 
on a monthly basis to review a random set of case notes. The information should then be used to 
inform areas of priority for actions to take place. [128] If information from this tool found harm 
caused by prescribing errors, it could be used to inform future prescribing support to avoid a 
similar incident happening again.  
7.2 Limitations  
There are many other hospitals that provide paediatric services which may also be using tools to 
improve paediatric prescribing and reduce prescribing errors. The tools used in these hospitals 
could be different from the ones described above. However, in order to be certain the data in the 
board meeting minutes related to paediatric practice only the standalone paediatric hospital 
trusts were included in this study. Initial evaluations of larger hospitals with paediatric wards led 
to the conclusion that it was not possible to confirm if prescribing improvement initiatives were 
be used in the paediatric areas of the hospital or not.  
Using original documents as the data set also provides some limitations. These include that the 
data that was available to the researcher was limited. Some sections of the board meeting are 
carried out in private and no public record is provided of this. Therefore there may have been 
further discussions relating to paediatric prescribing that were not available. It also cannot be 
confirmed if the data set is entirely complete due to the lack of control over the data collection. 
However, as the minutes are a public record of the board it is unlikely that they will be inaccurate. 
[94] 
The validity of this study has been improved through the use of documentary sources. Use of data 
directly from the hospital studied is one method of ensuring validity. This is real world data that 
has been recorded for a purpose other than research, which maximises the external validity of 
this data set. Finally, the analysis has been carried out using as transparent procedure as 
described in the method chapter.  
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The second objective was not fully met as the data set did not provide full information describing 
the effectiveness of the interventions employed by each study site. In order to meet this objective 
further research and investigation into the success of each intervention at improving paediatric 
prescribing is required.  
7.3 Conclusion 
 Initiatives reported to support improvement of paediatric prescribing included: electronic 
prescribing (4 hospitals); electronic patient records (4 hospitals); feedback/specialty 
specific support to prescribers from pharmacists (4 hospitals); junior doctor education 
and tests (4 hospitals); credit card size reminder tools (2 hospital); medicine calculators (1 
hospital);  dedicated prescribing areas (1 hospital); the paediatric trigger tool (1 hospital).  
 The lack of follow up data in the hospital minutes about the tools trialled to improve 
prescribing practice made it difficult to assess their effectiveness. The lack of follow up 
and completion of the audit cycle for these tools was a concern. 
 Different hospitals, and often different wards in the same hospital, trialled several 
different techniques to improve prescribing practice simultaneously. As a result, it was 
difficult to determine which intervention is responsible if a change in prescribing practice 
or prescribing error rate occurs.  
 Paediatric hospitals should be encouraged to share their experiences of these tools so 
best practice can be developed and efforts are not wasted on tools proven to be 
unsuccessful.  
 There was no clear collaborative approach to improve and/or support paediatric 
prescribing practice within the study sites. 
7.4 Recommendations for practice 
 Complete evaluation or audit cycles of methods trialled to improve paediatric prescribing 
practice should be reported back to the hospital board to ensure money is spent 
effectively on methods that have an evidence base. 
 A quality assurance tool should be developed for hospitals to use for the evaluation of 
their own tools. This would enable a quality statement to be applied to each method 
trialled and enable successful methods to be prioritised.  
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8. Interviews with leaders in 
electronic prescribing 
The aim of this final study was to identify experiences and advice from the leaders in electronic 
prescribing and decision support that will provide evidence and support to hospitals yet to 
implement such systems. The objectives of this study were to: 
 Identify the current reported benefits of electronic prescribing and decision support 
 Identify the current reported barriers that prevent hospitals introducing electronic 
prescribing systems 
 Identify reported issues related to electronic prescribing systems  
 Identify the potential reported developments or improvements that may occur to 
electronic prescribing systems within the next five years 
 Identify the advice leaders in electronic prescribing would provide to hospitals where 
electronic prescribing has yet to be initiated.  
The researched described in chapter 7 identified that electronic prescribing was one method 
paediatric hospitals are using to improve paediatric prescribing practice. Another method 
identified was specific prescribing support, for example antimicrobial advice. Leaders in electronic 
prescribing were asked to provide examples of clinical decision support designed to improve 
prescribing to determine if this feature was also identified by the leaders in electronic prescribing. 
Finally questions regarding the level of integration with some of the information sources reported 
to be used by pharmacists and prescribers in chapters 4 and 5 were also asked.  
Leaders in electronic prescribing were defined as senior staff at hospitals or companies with 
significant expertise or relevance to the research area. Participants from leading electronic 
prescribing companies and experienced hospital were interviewed alongside the independent 
paediatric hospital trusts. They were invited to give their views alongside the experiences that 
may be specific to their organisation. This ensured expertise in electronic prescribing and clinical 
decision support was fully explored and a paediatric perspective was included.  A full description 
of the method can be found on page 50. 
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8.1 Results and discussion 
The themes were largely led by the interview questions. The main themes were: benefits of 
electronic prescribing and decision support; features and functions of electronic prescribing and 
decision support; barriers to electronic prescribing and decision support; current issues with 
electronic prescribing and decision support; the future of electronic prescribing and decision 
support; and advice for those implementing electronic prescribing and decision support. Relevant 
interesting or abstract comments are included to ensure the full range of views and topics are 
presented from the data set.  
Each leader in electronic prescribing has been anonymised. The code for each leader is: 
 IV1 = hospital with electronic prescribing 
 IV2 = hospital with electronic prescribing 
 IV3 = hospital with electronic prescribing 
 IV4 = electronic prescribing system representative 
 IV5 = electronic prescribing system representative 
 IV6 = paediatric hospital 
 IV7 = paediatric hospital 
8.1.1 Benefits of electronic prescribing and decision support 
Six participants in this study could name many benefits that electronic prescribing and decision 
support could bring to the hospital environment. There were eight benefits that were most 
frequently referred to (n = number of references to this code/theme).  
The first benefit was that electronic prescribing ensures that prescriptions are clear, legible and 
complete (n=10). Completeness covered ideas such as ensuring the correct units are included, 
removing inappropriate abbreviations, and full patient details.  
“It’s legible; it’s always filled in correctly”. IV4. 
“Everything is legible when it’s typed compared to when it’s handwritten.” IV6.   
The data from this study is consistent with the conclusions of previously published literature that 
states the quality of prescription writing in terms of legibility and completeness has been 
described as a benefit of electronic prescribing.  [21, 23] In studies where a reduction in 
prescribing errors was not seen, illegible and incomplete prescriptions were eradicated when 
electronic prescribing was introduced. [22] A more recent review of the benefits of electronic 
prescribing in paediatrics confirmed that errors related to illegible prescriptions are removed. [3]  
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The second benefit was that electronic prescribing systems are continuously improving and 
developing, which allows the system to drive improvements within the hospital (n=8). One 
hospital based interviewee referred to the fact that the system had much more functionality than 
they were currently able to use and that the company who owned the system were responsive to 
requests for changes and functions. A company interviewee reported that the electronic 
prescribing system is flexible and can be adapted to suit the individual hospital and the responses 
of the users within that hospital.  
“You can do so much with the system that you are really improving it all the time”. IV4. 
The third benefit was prescribing decision support is available to prescribers (n=7). The level of 
decision support in the electronic prescribing systems known to each interviewee was varied. One 
electronic prescribing system at the time of the study only provided decision support for 
morphine and methotrexate. In comparison another electronic prescribing system provided 
decision support for 25 of the most common paediatric drugs. In this system the decision support 
could provide suggestions based on the weight or age of the patient.   
“The doctors are guided to the right choice of frequency and dose”. IV4. 
The fourth reported benefit of electronic prescribing was that it improves the speed of access to 
information (n=6). Saving prescribers’ time has been identified as a feature that can influence the 
success of a clinical decision support system. [107] However, this benefit is not often reported in 
the literature; therefore this study provides limited additional evidence to support this claim. 
Electronic prescribing was reported to allow the prescriber to access information easily as well as 
the pharmacy to receive information regarding drug orders quicker. One interviewee also 
reported that it allows medication to be written up for a patient quicker as the prescriber does 
not need to come to the ward to do so.  
“Overall it saves time for the doctors next time the patient’s in”. IV4.  
The fifth benefit was that order sets and pathways can be built to inform prescribers using 
electronic prescribing (n=6). This can range from predefined doses being offered at the point of 
drug selection in the electronic prescribing system to doses based on age/weight of the patient. 
The use of order sets or clinical pathways can be used to guide prescribers to the right drug choice 
and dosing regimen.  
“When you pick a product we offer you the doses of the product that hopefully you 
normally use to prescribe”. IV3.  
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The sixth reported benefit of electronic prescribing was that it improves safety (n=5), consistent 
with the conclusions of earlier publications that confirmed electronic prescribing can reduce 
medication errors. [129]  The improvement in safety can be from providing prescribers with 
information to inform their prescribing choices and providing nurses with clear administration 
information. One interviewee reported that their electronic prescribing system does a lot of cross 
checking to ensure the prescriber is making the correct choices.  
“Pharmacy staff spend a lot of time and resource ensuring that the information entered 
into the system maximises patient safety”. IV1. 
The seventh reported benefit was that electronic prescribing can be used to improve prescribing 
quality and/or practice (n=5). This is consistent with conclusions of published literature. [130] 
Changes could be introduced by modifying order sets or instructions to the prescriber or editing 
the available formulary.  
“We can implement change rapidly by changing over the order sets and instantly that 
practice is changed”. IV1.  
The final reported benefit was that having an electronic prescribing system means there is easy 
access to data to use for audits and to provide data to demonstrate the meeting of certain targets 
(n=5). The participants had built reports were for antibiotics audits, billing of commissioning 
bodies, stock management using the data available. 
“You can pull lots of reports out of the system so it’s helped with CQUINS and QIPP 
projects”. IV2.  
(CQUIN – commissioning for quality and improvement payment framework, QIPP – 
quality, innovation, productivity and prevention). 
Novel benefits identified in this study were: easy access to audit data and the ability to 
continuously improve and develop your electronic prescribing and decision support system.  
8.1.2 Barriers to electronic prescribing and decision support 
Participants in this study from both hospitals and companies described a range of barriers that 
prevent hospitals implementing electronic prescribing and decision support. Four main barriers 
were described. These were: available resources (including finance), management, government 
policies, and system choice.  
The most frequently reported barrier to implementing electronic prescribing was available 
resources (n=12). One interviewee reported that their clinical systems team were not able to 
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support the introduction of electronic prescribing until recently. Another interviewee reported 
that you needed to be able to mobilise various professions to enable electronic prescribing to be 
implemented.  
“It’s not only the electronic prescribing programme that you have to have; you have to 
make sure you’ve got all the equipment”. IV2.  
“We don’t have the resources. We don’t have the man-power. We don’t have the expertise 
to support it”. IV7.  
Financial resources were referred to six times. Electronic prescribing systems were reported to be 
expensive. The two paediatric hospitals without electronic prescribing reported that money was a 
barrier to implementation.  
“I think we’d do it if we had the money.” IV7.  
“They’re enterprise wide, across the whole hospital and have a price tag to match”. IV4.  
The hospitals with electronic prescribing systems also identified that financial reasons would be a 
barrier for hospitals yet to implement these systems. Lack of resources in terms of finance (for 
implementation, training and maintenance) and technology (for example, existing IT hardware 
and systems are not sufficient to support electronic prescribing) was identified some time ago as a 
barrier. [23] These issues were reported at the time of this study also.    
The next barrier reported to prevent implementation of electronic prescribing was system choice 
(n=8). One interviewee from a hospital where electronic prescribing was already in use reported 
that selecting the right system is important and the use of different vendors supplying different 
systems could lead to problems with interfacing. Another interviewee from a hospital already 
using electronic prescribing noted that were was no paediatric system available at the time and 
this was supported by an interviewee from a paediatric hospital also.  
“I think we were lucky we selected a good system at the time.” IV3.  
“If you look at the electronic prescribing systems that are currently available; they’re not 
very good frankly”. IV7.  
The lack of a “dedicated paediatric system” was identified as a system selection related barrier. A 
different participant stated they were “lucky” to have selected a good system at the start. These 
comments identify that it was difficult to select a system for electronic prescribing, particularly 
perhaps in paediatrics where there was not a specialist system available. Sufficient development 
of systems has been identified as a reason for the small scale of electronic prescribing 
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implementation in secondary care. [80] More recent conclusions from the literature confirms that 
the immaturity of the electronic prescribing system supplier market and availability of information 
on the options available is still a reason that choosing an electronic prescribing system may be 
difficult. [131] 
Another reported barrier to implementation of electronic prescribing was management within the 
hospital (n=5). One interviewee from a hospital using electronic prescribing reported that 
leadership was important. This interviewee noted that other hospitals failed to implement the 
same electronic prescribing system as them and one reason for their failure was leadership.  
“We are struggling to implement our new system due to lack of commitment from some of 
the senior Trust management team.” IV1.  
“From a supplier perspective experience shows that biggest obstacle to a successful 
implementation is clinical and executive level engagement”. IV4.  
The importance of management/organisational backing has previously been identified as 
important in implementing electronic healthcare systems. [80, 132] Management support in each 
hospital was identified by three participants in this study as a barrier to electronic prescribing.  
The importance of this barrier was highlighted by one participant when several hospitals had 
successfully implemented a particular electronic prescribing system, whereby another hospital 
could not.  
“We’ve got the same system as a couple of other hospitals did and another one of them 
made it work in terms of electronic prescribing and one of them didn’t. That probably 
came down to again leadership in the hospital.” IV3. 
The final barrier reported by interviewees was government policies (n=4). Two interviewees 
reported that this was an issue. The strategies of the government and national health policies 
were thought to be counterproductive. One example given was the current requirement for 
hospital to implement electronic prescribing for chemotherapy. This interviewee thought this 
policy encouraged hospitals to acquire a system to fill in a tick box, but was unlikely to be 
compatible with the hospital’s existing clinical systems.  
“I do however blame government and central NHS management, they throw far too many 
changes and initiatives that are usually short lived, distracting and counterproductive in 
the long term.” IV1.  
“I think sometimes the national picture was confusing and that might have delayed 
trusts”. IV3  
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Recent literature provides evidence that barriers to electronic prescribing are being slowly 
dismantled. Advice on functional specifications provided by Connecting for Health and the 
development of a tool kit to support implementation of electronic prescribing are two examples 
of assistance available to hospitals yet to implement electronic prescribing. [131] However, these 
interviews identify that there are still barriers in place that prevent implementation of electronic 
prescribing. This is consistent with existing evidence that large numbers of hospitals are 
interested in implementing electronic prescribing, but only a small number have begun 
implementation. [133] 
8.1.3 Current issues with electronic prescribing and decision support 
Participants identified a wide range of issues that maybe encountered during implementation 
and/or maintenance of electronic prescribing and decision support systems. The main issues 
identified by participants were: project team staffing; system/technology related; training; slow 
roll out of the system; and deskilling the prescriber.  
The first issue identified was having sufficient project team staffing available (n=13). More than 
one participant commented that working on electronic prescribing was done in addition to their 
“day job” (IV1) and this made it difficult to commit sufficient time to the project.  
“The roll out team was very small. I think this made it hard for them to commit a lot of 
time to the project as they were doing this in addition to their day jobs rather than being 
seconded to it.” IV6.  
This also related to the labour intensive nature of rolling out and maintaining electronic 
prescribing systems and their decision support features. One interviewee reported that there was 
always more content to create and that maintenance of this content can be an issue. Another 
interviewee commented that there was just their team to input the data required for decision 
support, so there was a lot to do. Finally, an interviewee noted that maintaining up to date access 
for users of the system was another feature that added to the labour involved in using electronic 
prescribing systems.  
“The system is actually very labour intensive to maintain so while we’ve got the freedom 
to customise it, it’s actually very time consuming to do and needs some very specific skill 
sets to do it as well. So sometimes just adding drugs to the catalogue or putting in 
pathways can just take, you know, quite a lot of time to change.” IV1.  
It is recognised that setting up a good way to support the implementation of an electronic 
prescribing system can be complex. [80]  
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The second issue identified were those related to the technology required by electronic 
prescribing systems and the electronic prescribing systems themselves (n=12). These issues were 
likely to be local to the system familiar to each interviewee. One issue that was not system 
specific was the availability of mobile technology to be used on the wards. System specific issues 
that may be of relevance to other organisations were: ensuring log on/off times are efficient and 
do not waste clinicians’ time; considering how the system will work in highly specialist areas (for 
example: is the system capable of complex dose frequency regimes or is the system suitable for 
areas such as anaesthetics where an exact dose may not be known?); the record of doses 
administered needs to be clearly viewable to nursing and other staff. 
“We’ve got a lot of software issues which we’ve got to address.” IV1. 
“One problem with the system is the way it does frequencies.” IV2. 
“The system is actually very labour intensive to maintain.” IV3.  
Training was identified as the third issue: both the need to train a large number of staff during roll 
out and then maintain staff training after the system is live (n=6). Managing training for non-
regular staff was highlighted as a particular area of focus. Training was reported to be time 
consuming and you needed to have permanent trainers to keep the training going after the 
system was live. One participant identified the large amount of information junior doctors were 
required to take in at induction and commented that it was difficult for them to take in all the 
information.   
“When we do it on the doctors’ induction they’re learning so many other things that day 
that they don’t remember”. IV2.  
“You need strategies for locums and all the other people that come into the organisation.” 
IV1.  
Managing training effectively is reported to be an important part of in implementing electronic 
prescribing successfully. [80, 107] The electronic prescribing toolkit was built to assist hospitals to 
successfully implement electronic prescribing and it recommends that a training needs analysis is 
conducted to cover all potential users of the new system being implemented. [131] By following 
this recommendation future electronic prescribing implementers may be able to avoid some of 
the training issues identified by the participants of this study.  
The fourth issue related to electronic prescribing systems and decision support was having a slow 
roll out of the system (n=5). One interviewee commented that it took about 15 months to roll out. 
A second interviewee noted that having a small project team meant the system roll out was 
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slower than intended. Slow roll out of an electronic prescribing system was also identified in a 
previous study to be an issue as it can cause confusion when you have more than one system in 
place. [80]  
“Our problems really stemmed mainly from the slow nature of the project in rolling the 
project out between wards.” IV1. 
The final issue identified was that electronic prescribing and decision support could deskill the 
prescriber (n=4). Deskilling is where complex tasks are divided down into simpler smaller tasks 
and as a result of this the person may lose the comprehensive knowledge or integrated skills of 
that area of work. Interviewees recognised that prescribing staff could become reliant on the 
system and could face difficulties if they then moved to a hospital without this type of supportive 
system in place. One paediatric based interviewee was concerned that doctors would not ever 
have to work out the doses for medication and this could deskill them.  
 “Care needs to be taken to ensure we do not de-skill medical staff.” IV1.  
8.1.4 The future of electronic prescribing and decision support 
Participants identified a range of future developments that they anticipated that their system 
might gain or that might be developed on a wider scale to improve existing electronic prescribing 
and decision support systems. Future features and developments identified were: 
 Administration guidance 
o “Guidance on how to administer”. IV4. 
 Allergy checking 
o “Interactive allergy checking”. IV3. 
 Better interaction checking 
o “More intelligent interactive systems”. IV1 
 Calculators 
o “A few more calculators”. IV4. 
 Clinical pathways  
o “We plan to build order sets so prescribers can click and order various items in one 
place.” IV7. 
 Data analysis of prescribing data 
o “We really need to get more out of the information that we’ve got.” IV2. 
 Real time drug administration 
o “One of our goals with our project now is to move to real time drug 
administration.” IV3.  
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 Electronic discharge/discharge prescriptions 
o “When we do our discharge letters at the end to feed information back to GP 
systems.” IV3.  
 Better hardware options 
o “What mobile device is best in what situation?” IV4.  
 Invisible decision support 
o “A classic example is the decision support, in actual fact decision support is best 
when it’s invisible. Really the majority of the time I don’t want the system in front 
of me, I want to be talking and working with the patient. And again, working 
through that so that we’re actually almost invisible to the user, to the clinician 
that, a bit like Google now, it’s offering you the right information at the right 
time.” IV4.  
 Intravenous drug prescribing 
o “We will have the IV software.” IV2. 
 Medicines reconciliation 
o “We’re just still working out if the functionality is adequate and you know 
basically safe enough at the moment to use.” IV3. 
 Non-stock orders sent directly to pharmacy 
o “The orders for non-stock drugs to come down to pharmacy directly.” IV2. 
 Paediatric friendly system. 
o “We will have to adapt the system to our needs but there is the capability to build 
mg/kg dosing, ml/kg dosing, age-banded dosing etc. for the paediatric setting.” 
IV6.  
There is some overlap with this list of future developments and the features already available in 
electronic prescribing systems. This suggests that not all electronic prescribing systems have the 
same functionality available currently. The variety of features available from different suppliers of 
electronic prescribing systems may make identification of the best system for a particular hospital 
challenging.  
8.1.5 Advice from electronic prescribing leaders regarding electronic 
prescribing and decision support 
All interviewees were able to provide advice to organisations that were yet to implement 
electronic prescribing and decision support. This included the interviewees from organisations 
that had not got electronic prescribing in place at the time of the interview.  
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8.1.5.1 Advice regarding integration of electronic prescribing and decision support 
with other hospital IT systems 
The theme of integration was brought up frequently by the participants (n=17). Specifically they 
were referring to integration of the electronic prescribing and decision support systems with 
other existing hospital systems or having one system that provided all necessary functions. 
Integration was recognised by four participants as important to the usability and success of the 
system. This was consistent with prior research that recognises that clinical decision support 
systems can be more successful if they are integrated with electronic health records and/or 
existing health systems. [107]  
Specific advantages of integrated systems reported by participants were: 
 The amount of training required is minimised as there is a common system for all 
functions across the hospital.  
 It is easy to move between the different parts of the system (compared to using separate 
systems, with separate log ins). 
 There are reduced transcription errors when the pharmacy system is integrated with the 
prescribing system. 
 “Full integration is the key to safety, efficiency and maximising benefits”. IV1.  
8.1.5.2 Advice regarding engaging staff about electronic prescribing and decision 
support 
All but one participant recognised the importance of engaging staff when introducing electronic 
prescribing and/or decision support. Several prior published studies have also reported the 
importance of end user engagement in this type of project. [80, 107, 131, 133] Participants 
emphasised that the system implementation needs to engage staff from a variety of healthcare 
professions. One participant reported having formal user groups that allowed staff to feedback 
ideas to the electronic prescribing team. This is line with a recently published study that stated 
that “it is important to be seen to respond to end users’ ideas”. [131] Ideas of ways to engage 
staff from one hospital (in the system development stage) included: showing and demonstrating 
the system to staff; taking part in large meetings; carrying out departmental visits; using email 
and the trust’s intranet to tell staff about the system.  
 “You have to sell to everyone involved:  pharmacy, chief executive, medical and 
nursing staff. It’s got to benefit them because otherwise they’re going to drag their 
feet and not cooperate.” IV1 
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“We’ve got various formal user groups. We’ve got a medical, a clinical which is mainly 
nursing and allied health professionals, we’ve got an operational which is for again 
clerical and support staff.” IV3. 
“So the priorities of the, of the IT system should be decided by clinicians.” IV3. 
One hospital recognised that it was difficult to get the main users of this type of system – nurses 
and junior doctors – to engage in the development process because they are so busy. This 
participant recognised that it is often the senior staff who influence the system design although 
they will be using it less frequently. Again, this is consistent with a recent study that has reported 
the difficulty of getting clinical staff freed from their duties in order to contribute to this type of 
system development and implementation. [131] 
Interviewees in this study also provided the following advice which reiterated the importance of 
having a plan in place to manage training and your resources as described earlier in this chapter.  
 Train people at the right time so they can remember their training when the system goes 
live. 
“The most important thing is to train people just before they are going to use it 
otherwise they forget what they’re doing.” IV2. 
 Ensure you have a core team set up from early in the project. 
“I think it’s important to have a core team from the beginning. Some of us have been 
seconded quite recently and it takes time to get into the project and understand it all.” 
IV6. 
Electronic prescribing is not just a “plug in the wall and away it goes” (IV1) project. It 
is an ongoing project that will require continual support. 
8.1.6 Important singular or abstract comments 
There were three interesting comments that arose during the interviews that were not common 
enough to be identified as themes, but were unusual and/or abstract so added depth to the 
dataset.  
The first interesting comment by a company representative was that the manager of the 
electronic prescribing and/or decision support system may become the most clinically important 
person in the hospital.  
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“Your system manager has just become the most clinically influential person in your 
hospital. That all templates, predefined prescription etcetera are now under the control of 
the system manager. What the doctor gets to see to prescribe, what the doctor chooses 
first off the list; all of these things are now under that person’s control. And that’s actually 
the most clinically, I can’t think of the right word for it, powerful role probably in the 
hospital…” IV4.  
This was interesting because it highlights that the manager of the system if not a clinician could 
still hold a powerful clinical role in the hospital. This could raise concerns with clinical staff 
because of the lack of clinical knowledge and understanding the system manager may have. This 
issue was not identified by any of the hospital based participants in the study. This could be 
attributed to the fact that all hospital participants referred to having the system as being clinically 
led.  
The second interesting abstract comment, again made by the same company representative, was 
that clinical decision support systems don’t really offer decision support.   
“Runs really once you’ve made your choice and really you’re into harm reduction or harm 
avoidance, which is really what decisions support, which isn’t decision support, is”. (IV4)  
It was then suggested that the systems are not offering decision support, but are in fact providing 
harm avoidance/reduction. This is an important point to make as if the decision has already been 
made before the doctor uses the system, how beneficial can the system be in terms of decision 
support? In the UK junior doctors are often tasked with prescription writing after the drug choice 
has been made in conjunction with other doctors during the ward round. In this type of scenario 
the participant’s comments fit with current practice as by the time the prescription writing occurs 
the decisions have already been made.  
8.2 Limitations 
Interview five was provided as a written interview as the company was unable to provide an 
interview face to face or over the phone. The responses in this interview were very much shorter 
and briefer compared to any of the other interviews conducted. Therefore, it was not possible to 
determine the full views of this company representative. The strength of evidence for each theme 
may have been different if a full interview with a second company representative had been 
obtained.  
The audio recorder failed during the course of interview six. This meant the transcript was 
completed from the researcher’s notes and was not as accurate as the audio transcripts. The 
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transcript was approved as an accurate record of the interview by the participant, but it will not 
have the same precision as the other transcripts.  
Interviews were conducted solely with senior staff working in electronic prescribing. Their views 
may not be representative of an experienced end user who may have different experiences and 
recommendations to share. Therefore it would be useful to conduct a similar series of interviews 
with users of electronic prescribing systems, particularly users working in paediatrics.  
8.3 Conclusion 
 Leaders in electronic prescribing report to recognise benefits of electronic prescribing 
consistent with existing literature in addition to novel benefits such as easy to access data 
for audits and the ability to continuously improve your system.  
 Leaders in electronic prescribing report barriers to electronic prescribing consistent with 
the existing  literature suggesting that there are was still not sufficient resources or 
support to implement this type of electronic clinical system.  
 Leaders in electronic prescribing report that current issues in electronic prescribing are: it 
is resource intensive to implement and maintain the system effectively and each system 
can have its own specific technical issues. 
 Leaders in electronic prescribing report a wide range of developments to electronic 
clinical systems that may exist in the future.  
 Two pieces of advice supported by electronic prescribing leaders are: to integrate your 
clinical system as much as possible to ensure they are usable and effective and reiterated 
the need to engage your staff at all stages of the development and implementation 
processes.  
8.4 Recommendations for practice 
 Consultation with hospitals already using electronic prescribing is recommended for 
hospital that are yet to implement electronic prescribing.  
 Engage with a wide range of potential end users of an electronic system during its 
development and implementation.  
 Where possible implement a single integrated clinical systems rather than separate 
standalone clinical systems.  
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9. Discussion 
The specific objectives of this research programme were: 
 Identify and describe the experience of pharmacy staff of the implementation of an 
electronic medicines management system at Birmingham Children’s Hospital; 
 Identify the current practice of prescribers at Birmingham Children’s Hospital concerning 
their resource use to support prescribing decisions for paediatric patients; 
 Identify the current practice of pharmacist members of the Neonatal and Paediatric 
Pharmacist Group concerning their resource use to support the provision of pharmacy 
services for paediatric patients; 
 Identify the current practice of independent English paediatric hospitals provision of 
paediatric prescribing support as recorded in the minutes of their board meetings; 
 Identify the current views and experiences of leaders in electronic prescribing concerning 
current benefits/barrier/issues, and their advice for hospitals to ensure successful 
implementation.  
An important part of the medication process in hospitals is the efficient supply and management 
of medicines. The responsibility for this part of the medicine supply process usually lies with the 
pharmacy team in each hospital. As part of wider strategies to drive efficiency of medication 
supply the introduction of electronic tools to support medicines management has gathered pace. 
An example of this is the medicines management module in the Ascribe pharmacy software. This 
module enables pharmacist to send requests for supplies of medication electronically to the 
dispensary and record patients medication histories electronically. The implications of using the 
Ascribe medicines management electronic system had not been studied previously and there is 
not any published literature of staff experiences of moving from paper based clinical processes to 
electronic clinical systems. The present study on implementing an electronic medicines 
management system has provided data regarding the staff perspective and experience during the 
implementation of the electronic medicines management system in a paediatric hospital. It 
suggested that pharmacy staff should be highly involved at all stages of the development and 
implementation process to ensure the system is practical to use. In this case study, the medicines 
management system implemented was an efficient way of managing the supply of inpatient 
medication, but did not work as efficiently for the supply of discharge medication. Pharmacists 
reported that the system was not set up in a style that easily integrated into their previous 
workflow and had concerns that the time using the system would take away time that could have 
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been spent with patients. Although the data from this case study may not be generalizable to all 
hospitals, due to the specific electronic system used and the specialist patient population at BCH, 
it has provided insight into the opinions of staff that used the system that may be valuable to 
other hospitals considering electronic clinical systems in the future.  
There is a distinct lack of published research on the medicines information resources used by 
healthcare professionals working in paediatrics.  Currently there is no UK wide data available on 
this type of resource use by prescribers when they are making prescribing decisions for children in 
hospitals. It is important to collect this information now as government plans for healthcare 
indicate that hospitals are required to have plans for effective and patient centred use of IT 
particularly in relation to medicines. [88] It will be difficult to meet the future information needs 
of healthcare professionals if the current information needs are unknown. The information from 
the literature regarding prescribing support describes alert fatigue and prescriber dissatisfaction 
with the current decision support available demonstrating the need for further research in this 
area. [52]The study at BCH has now improved the information available to those designing 
prescribing support tools for paediatric prescribers as they have identified the most frequently 
used source of paediatric prescribing information – the BNFc (refer to Table 36). Prescribers 
reported to use the BNFc several times every shift and reported it to be the most useful source of 
information as it was easy to use, accessible and reliable.  
Paediatric pharmacists work alongside paediatricians in hospitals and provide a check that the 
prescriptions written are appropriate for each individual patient. This role involves the use of 
many resources to check the appropriateness of each prescribing decision made by the 
prescriber. Prior to the research described in this thesis the frequency and range of resource use 
to support the provision of paediatric pharmacy services was not known. There was no published 
information available on what resources pharmacists need to use when checking paediatric 
prescriptions. Similarly it was not known if the resources used had the necessary paediatric 
prescribing information available. This study has provided a description of current resource use by 
pharmacists providing paediatric pharmacy services and this could be used by electronic 
prescribing system designers to ensure their information needs are met. Pharmacists in this study 
also reported that the BNFc was the most frequently used source of information and the most 
useful (refer to Table 62).  
The respondents from the NPPG and BCH reported similar practice with regards to their working 
habits in paediatrics. Respondents from the NPPG and BCH reported a similar mean number of 
years of working in paediatrics. However, the pharmacist respondents from the NPPG reported to 
work more frequently in the inpatient hospital environment compared to the prescriber 
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respondents from BCH. The majority of both groups of respondents reported to use an 
information resource to support their work in paediatrics at least several times a day. When 
comparing specific information resource use the pharmacist respondents were more likely to 
report to use each resource than the prescriber respondents and if they did use a resource they 
reported that they did so more frequently. Pharmacists may have used information sources more 
frequently than prescribers due to their role of providing the final check for safety and 
appropriateness of prescriptions. This role was reported in the minutes from board meetings of 
paediatric hospitals and is consistent with the published literature. [54, 63, 64] Although there 
have been no randomised studies demonstrating the effect of this type of intervention, a 
systematic review identified 18 studies examining the role pharmacists can have in paediatrics. 
[63] Despite the variety of methods, settings and definitions used within the studies, the 
systematic review concluded that pharmacists are important in identifying paediatric medication 
errors. [63]  The other resources identified by participants that had similar reported patterns of 
use to pharmacists were: other colleagues, NICE guidelines, local guidelines and other national 
guidelines. It would be useful to explore further the reasons that led to NPPG respondents 
reporting to use more resources more frequently. The respondents from the NPPG and BCH 
studies agreed that the BNFc was the most useful resource when working in their current role in 
paediatrics. The reasons for this were consistent across both studies and included that it was easy 
to use, accessible and familiar.  
Both respondents from the NPPG and from BCH reported that there was a lack of data to support 
prescribing decisions in paediatrics (see Tables 39 and 65). This demonstrates that despite their 
different roles and responsibilities relating to the use of medicines in paediatrics there is a need 
for further information to be available about prescribing in paediatrics. Both groups of 
respondents reported that the current lack of information in paediatrics could have an effect on 
patient care (see Tables 41 and 67). Respondents from both studies reported prescribing for 
paediatric patients is more difficult than prescribing for adult patients. This is consistent with the 
limited published literature. [16, 17] It also indicates that there is a need for the currently 
available information to be accessible and easy to use, rather than requiring the healthcare 
professional to investigate several information sources before being able to make a decision.  
When identifying the current use of information resources by prescribers and pharmacists 
working in paediatrics the wide range of resources reported to be used indicated that there is not 
a single resource that meets the information needs of this group. Based on this assertion it could 
also be suggested that the clinical decision support in electronic prescribing systems used in 
paediatrics cannot be based on a single source of information if it is to be successful. This is 
particularly relevant in paediatrics where information on off label and unlicensed dosing is often 
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required to be able to offer paediatric patients treatment. Currently off label and unlicensed 
paediatric prescribing information is not available in a single easy to access resource or within the 
decision support of a commercial electronic prescribing system. Off label and unlicensed 
prescribing in paediatrics is critical and as such clinical decision support regarding this type of 
medication use needs to be available in any electronic prescribing system that is to be successfully 
used in paediatrics. From a commercial perspective it could be deemed risky to include 
information in a clinical system that does not have high quality evidence to support it. The 
challenge of finding a suitable commercial electronic prescribing system for use in paediatrics is so 
difficult that BCH have begun to develop a paediatric drug catalogue that could be used in such a 
system. [134] One could argue that it commercially irresponsible to not provide the same level of 
decision support to paediatric patients as one does to adult patients, particularly when there is 
data that describes the higher level of medication errors and challenges encountered when 
prescribing for children. [16, 17] The quality of medication error studies in UK paediatric 
populations is limited to case studies, therefore this evidence should be used with caution until 
cohort or randomised studies have been conducted. However, the cost of developing a 
commercial paediatric clinical decision support system for a specialist area such as paediatrics is 
unlikely to be borne by a commercial company given the limited size of the market for such a 
system. Therefore it is likely that ‘home-grown’ solutions such as that in development as BCH will 
be the only resolution to this issue.  
At the time of the studies the BNFc was not accredited by NICE. [111] It is not clear from the 
studies what NICE accreditation meant to the participants, but as the BNFc was reported to be the 
most frequently used resource, it suggests that its lack of accreditation does not affect their 
reported use of this information resource. This questions the value of the NICE accreditation 
process if the paediatric resource reported to have been used most frequently did not have NICE 
accreditation. Information sources that NICE has accredited, for example the British Thoracic 
Society guidelines, were also reported to have been used by the participants but not as frequently 
as the unaccredited BNFc. This adds further support that the accreditation of paediatric 
prescribing resources by NICE does not infer that they are the most useful in practice. Although 
the BNFc was reported by respondents from BCH and the NPPG to be comprehensive, the wide 
range of individual patient factors combined with the use of off-label or unlicensed medicines in 
paediatrics, means there is likely to be clinical scenarios that it does not cover. This may partly 
explain the reported use of many additional resources by respondents from the NPPG and BCH.  
The importance of individual patient factors (e.g. weight, current medical conditions or blood test 
results) in informing prescribing decisions was highlighted by the frequent use of patient results 
(e.g. blood results) and patient notes by both prescribers and pharmacists when prescribing for 
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paediatric patients or providing paediatric pharmacy services. The lack of guidance relating to 
individual patient factors such as renal function has been identified previously as a fault of 
resources which were deemed unsuitable for devising individual dosing recommendations. [71] 
The ability of a resource to support patient specific recommendations is particularly important in 
paediatrics where doses are often based on weight. Participants in the leaders in electronic 
prescribing interview study also reported that integration of electronic prescribing with other 
clinical systems was important so that individual factors that could affect prescribing choice were 
easily available to prescribers. This supports the need for prescribing support to be able to 
provide guidance on doses for individual patients rather than a single generic dose.    
The documentary analysis of paediatric hospital board minutes aimed to identify prescribing 
support initiatives that were discussed at hospital board level in paediatric hospitals. The 
discussion of topics at the highest level of decision making in hospitals could indicate the 
importance of this issue. Several different initiatives related to paediatric prescribing support and 
improving the quality of paediatric prescribing were identified. Upon further evaluation of these 
initiatives only one published article, on the use of electronic prescribing, described in the board 
meeting minutes and papers could be identified. [33] This study identified that paediatric 
hospitals often trial initiatives to improve paediatric prescribing but do not publish the results of 
prescribing improvement initiatives. However, a new method of sharing good practice regarding 
safe prescribing in paediatrics has been launched since this study was completed. The ‘Meds IQ’ 
initiative of the Royal College of Paediatrics and Child Health encourages the reporting of 
interventions that have successfully improved medication safety in children. [92] The Meds IQ 
initiative is a platform that allows paediatric hospitals to share good practice via a single 
accessible website without having to invest the time required to run a study and produce an 
article that meets the stringent standards of a peer reviewed journal. The ‘Meds IQ’ initiative may 
encourage further studies that are lower on the hierarchy of evidence rather than the required 
randomised studies that are needed to demonstrate evidence based methods of improving 
paediatric medication safety.   The initiatives most frequently reported in the paediatric hospital 
board minutes were: supporting prescribers to improve their prescribing practice, using electronic 
patient medical records and ensuring healthcare professionals are involved in the development of 
new initiatives.  
There is evidence from the studies within this thesis that multidisciplinary working is important 
when working in paediatrics and designing new initiatives to improve paediatric prescribing 
practice. Prescribers at BCH valued the expertise in medication that the pharmacists could provide 
and were disappointed that the expertise was not easily available outside normal pharmacy 
operating hours. The support of clinical pharmacy services and pharmacist double checking (for 
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example, using a pharmacist to check a calculation conducted by another healthcare professional 
has been completed correctly) has been identified by the Co-operative of safety of medicines in 
children: scoping study to analyse interventions used to reduce errors in calculation of paediatric 
drug doses (COSMIC) report as two interventions that can be used to reduce paediatric 
medication calculation errors in hospitals. [135] The COSMIC report used a mixed methodology to 
reach this conclusion, although it did not include any cohort or randomised study methods, thus 
its conclusions should be used with caution as they cannot be used to provide a causal link 
between the interventions studied and the reduction of paediatric medication errors. In the board 
meeting minutes of paediatric hospitals clinical pharmacy services were reported to have been 
extended to provide frequent reports on medication errors and to include direct supervision of 
new prescribers. Pharmacists may also provide pharmacy support through the provision of 
introductory sessions and tests for prescribers. [135] Tests for new prescribers and induction 
sections were reported in the minutes and papers from paediatric hospital board minutes also. 
Another report, the EQUIP study on causes of prescribing errors also noted the reliance of doctors 
on pharmacists to correct and identify prescribing errors. [62] The EQUIP study was a multisite 
study (conducted at 20 hospitals) indicating that there is good evidence to support the use of 
pharmacists in reducing prescribing errors. [62] The usefulness of pharmacists in improving 
medication safety for children was further supported by the participants in the study at 
Birmingham Children’s Hospital who report using pharmacists regularly to support their 
prescribing decisions.  
Electronic prescribing and decision support has been used for more than ten years in several 
hospitals in England, although the widespread use of this technology is not yet in place. Whilst 
there have been several US based studies that provide guidance to those considering 
implementing electronic prescribing there is a paucity of similar data with a UK focus. There have 
been some conference papers delivered on this subject but there is a lack of peer reviewed 
published information. The electronic prescribing toolkit has been developed recently to reduce 
the burden of work of implementing electronic prescribing as well as improve the likelihood of a 
successful implementation programme. [131] The interviewees described many benefits of 
electronic prescribing such as clear prescriptions and clinical decision support. The interviewees 
also reported that potential barriers to the implementation of electronic prescribing were 
availability of resources (staff and financial) and functionality of the system chosen. The 
interviews with key stakeholders in electronic prescribing and electronic prescribing project 
members in paediatric hospitals have allowed the advice and expertise of these people, 
particularly regarding paediatrics, to be shared. The most frequently reported advice was that 
integration of all clinical systems was recommended as well as ensuring engagement and 
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involvement of end users throughout the development and implementation stages. As a result of 
this study there is now more practical implementation related UK focussed information available 
to hospitals who are considering implementing electronic prescribing.  
The studies within this thesis have identified the following key points for successful 
implementation of a new initiative or clinical system designed to improve prescribing practice in 
paediatrics:  
 The initiative should aim to improve efficiencies of hospital processes to enable 
healthcare professionals to have more direct patient contact time; 
 Healthcare professionals should be involved at all stages of development and 
implementation of electronic clinical systems with the aim of improving its usability and 
acceptability in clinical practice; 
 New electronic initiatives or systems should be integrated with existing electronic 
systems. This should reduce the time burden on healthcare professionals for tasks such as 
data entry and logging on to different systems.  
The initial focus groups and interview study identified that using electronic systems could deskill 
the prescriber or result in the prescribers making decisions that are not independent. Prescribers 
are healthcare professionals and professionals are defined by their standards of education and 
training; their license to practice and their ability to work autonomously. [136] Electronic systems 
to support decision making could reduce the ability of the prescriber to work autonomously, 
particularly if the system is managed by an information technology specialist rather than a 
healthcare professional. The increase in control of the healthcare professional by the information 
technology team may reduce the professional’s authority in their specialist area. [136] As 
healthcare becomes further corporatized there are less healthcare professionals involved in 
decision making about how the hospital is run and with increasing use of technology healthcare 
professionals may have less personal autonomy. [136, 137] The loss of professionalism of 
healthcare professionals associated with the introduction of technology and corporatisation of 
healthcare is a subject that also requires further research.  
Pharmacists and prescribers may become deskilled as the corporatisation of healthcare increases 
through increased use of technology and bureaucratisation. [137] For example, clinical guidelines 
and standard operating procedures reduce the level of decision making required by the prescriber 
or pharmacist. Use of electronic clinical systems in the pharmacy and for prescribing could also 
deskill professionals by reducing these complex tasks into simpler repetitive jobs. When a process 
has been subdivided into smaller routine tasks the healthcare professional has less independent 
control over their work. Where this happens individuals can lose the integrated skills and 
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comprehensive knowledge required for their profession. [137] Traditional autonomy of 
professionals can be removed by bureaucracy through the use of rules and regulations; 
specialised roles and hierarchies. [136, 137] There is no published literature that describes the 
effect of electronic health systems on the deskilling and professional status of healthcare 
professionals.  
9.1 Proposed future research areas and implications for policy 
This area of research is lacking studies that have used methods to generate high quality data and 
evidence to support the interventions trialled. Therefore all future work should consider the likely 
strength of the study method to ensure high quality evidence can be provided. The first area of 
future work that should be considered is extension of the current studies on the resource use of 
paediatric prescribers and pharmacists to ensure a generalisable dataset is available. This will 
address some of the limitations identified in previous chapters regarding the study population and 
ensure the data is applicable across a wider range of paediatric hospital settings. Suggested 
extensions to the questionnaire studies would be to take a random sample from all prescribers 
and pharmacists that work in paediatric hospital settings in England. Identifying these participants 
could be challenging as there is no accessible register or record of people who work in these 
positions.  However, in order to ensure the results are generalizable to the field of paediatrics this 
work is necessary, particularly as the current literature in this field of research is largely provided 
by methods involving single study sites. Another consideration is to include community 
pharmacists and general practitioners in the studies on the use of paediatric prescribing 
information. It would be worthwhile to explore if healthcare professionals in the community have 
the same or different experiences regarding the availability of paediatric prescribing information. 
Further data supporting the findings of the studies in this thesis could provide support for the 
development of a single comprehensive paediatric resource.  
The second area of work that is required is an observational study to determine the behavioural 
process that occurs when decisions regarding paediatric medicines are made. It is important to 
understand when and how these decisions are made in order to develop clinical decision support 
that provides guidance prior to and/or at the point of decision making. Defining the optimum time 
at which decision support is provided is vital to the development of effective clinical decision 
support systems. If information continues to be provided in a reactive manner to decisions about 
medicines (for example, providing drug interaction information after an electronic prescription 
has been written and is about to be confirmed) it is difficult to predict an improvement in 
prescribing practice and ultimately clinical outcomes. A lack of improvement in clinical outcomes 
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is not value for money and the current financial climate demands that clinical and cost effective 
measures to improve prescribing practice are required.  
The implications of this research for policy are:  
 to ensure efficient receipt of required paediatric prescribing information when making 
paediatric prescribing decisions there is a clear need for a further single comprehensive 
paediatric prescribing resource (the BNFc needs to provide more comprehensive 
paediatric prescribing information);  
 paediatric hospitals should be encouraged to publish and share information regarding 
successful and unsuccessful strategies implemented to improve prescribing practice to 
ensure that successful solutions can be extended to other hospitals; 
 to ensure appropriate paediatric decision support is provided in electronic prescribing 
systems the development should include the information from the broad range of 
paediatric specific resources reported to be used in chapters 4 and 5 as well as support 
based on individual patient factors such as test results and existing medical conditions. 
The best method of presenting this information to impact decision making should be 
determined prior to implementation of a clinical decision support system.  
9.2 Conclusions 
 Pharmacy staff reported that use of electronic medicines management improves the 
efficiency of supply of medication to inpatients. For more comprehensive use of 
electronic medicines management, the systems need to be developed further to allow 
existing medication related processes to be translated efficiently. 
 The current resource use of paediatricians and pharmacists specialising in paediatrics now 
has the first UK specific data and it will be of use to developers of paediatric electronic 
prescribing and clinical decision support systems. 
 The BNFc was reported to be used most frequently and to be the most useful resource to 
paediatricians and pharmacists specialised in paediatrics.    
 Respondents reported that patient care can be affected by the lack of comprehensive and 
accessible sources of paediatric prescribing information. 
 Paediatric hospital board meeting minutes reported a range of initiatives trialled to 
support good paediatric prescribing practice. However, there was a lack of evidence for 
collaboration and sharing of this information between paediatric hospitals and this may 
delay the rate of improvement in the quality of paediatric prescribing. 
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 Leaders in electronic prescribing reported a wide range of benefits of electronic 
prescribing, but described a lack of resources available to hospitals to implement these 
systems. They advised that hospitals should aim to have integrated systems and should 
involve healthcare professional end users as much as possible in their design and 
implementation processes.   
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11. Appendices  
Appendix 1 – focus group topic guide 
 
Paediatric prescribing support – any tool or information source electronic or otherwise that aids 
your decision making during the paediatric prescribing process. 
1. What is your profession? What is your level of experience – F1/2, ST, consultant or years 
of independent/supplementary prescribing experience?  
2. Usual prescribing habits.  
a. How often do you prescribe?  
b. What setting do you prescribe in? IP, OP? Speciality? 
3. How often do you need to find extra information or guidance before prescribing? 
a. Daily/several times a week/weekly/several times a month/monthly/less often? 
4. What type of information do you look up most frequently, i.e. doses, guidelines, 
formulations available? 
a. What tools do you use to access this information? BNFc, online resources, 
colleagues, local guidelines, etc. 
5. What types of information do you struggle to access?  
a. Why? Information not available for children? BCH not signed up for most useful 
reference source? 
b. Are there any other difficulties currently in the prescribing process? Reading Rxs, 
availability of medicines? 
6. What prescribing support would you want/expect to be included in an electronic 
prescribing tool? 
a. How would you want to view this? Links to information, alerts (click or no click to 
acknowledge?), information displayed with no active reaction required (e.g. no 
clicking to continue with prescribing)? 
7. Do you have any concerns about how an ePrescribing system would be implemented? 
a. Disruption to your workflow? Training? Any effects on patient care during 
implementation/early use?  
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Appendix 2 – electronic medicines management questionnaire 
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Appendix 3 – Birmingham Children’s Hospital prescriber’s 
questionnaire 
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Appendix 4 – Neonatal and Paediatric Pharmacists Group 
questionnaire 
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Appendix 5 – interview guide 
 
Current status regarding ePrescribing: 
 Please summarise your electronic prescribing history to date: when did it 
begin and what changes have you been through to come to the current 
product? 
 Companies: what functions do your products currently provide? (e.g. 
dosing support) 
Currently, what works well with ePrescribing and what doesn’t work so well? 
 Works well:  
 Doesn’t work well:  
 Are end users expectations met? 
What is the history of ePrescribing: what are the main wins and losses it has brought about thus 
far? 
 Wins:  
 Losses:  
What are the biggest constraints/obstacles to getting and/or outcomes/achievements of using 
ePrescribing? 
 Obstacles/constraints to getting ePrescribing:  
 Outcomes/achievements when using ePrescribing:  
Where will you be in five years with ePrescribing?  
 Functions you would envision: 
 Improvements you want to achieve: 
What are the lessons you have learnt and/or your advice to others yet to implement electronic 
prescribing? 
 Lessons learnt: 
 Advice to others: 
 Future guidance for the NHS: 
 What importance should electronic prescribing have in NHS IT strategies? 
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